BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889-2934. [PMID: 24239923 DOI: 10.1016/j.jacc.2013.11.002] [Cited by in Crossref: 2463] [Cited by in F6Publishing: 2461] [Article Influence: 273.7] [Reference Citation Analysis]
Number Citing Articles
1 Kartoun U, Khurshid S, Kwon BC, Patel AP, Batra P, Philippakis A, Khera AV, Ellinor PT, Lubitz SA, Ng K. Prediction performance and fairness heterogeneity in cardiovascular risk models. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-16615-3] [Reference Citation Analysis]
2 Nakagawa C, Yokoyama S, Hosomi K. Association of Statin Adherence With the Development of Nonalcoholic Fatty Liver Disease: A Nested Case-Control Study Using a Japanese Claims Database. Ann Pharmacother 2022;:10600280221126971. [PMID: 36168669 DOI: 10.1177/10600280221126971] [Reference Citation Analysis]
3 Lang R, Humes E, Hogan B, Lee J, D'Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, Lyass A, Cheng D, Kim HN, Klein MB, Cachay ER, Bosch RJ, Gill MJ, Silverberg MJ, Thorne JE, McGinnis K, Horberg MA, Sterling TR, Triant VA, Althoff KN. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection. J Am Heart Assoc 2022;:e026473. [PMID: 36129038 DOI: 10.1161/JAHA.122.026473] [Reference Citation Analysis]
4 Braet DJ, Pourak K, Mouli V, Palmon I, Dinh D, Osborne NH, Vemuri C, Brandt EJ. Non-high-density lipoprotein cholesterol and treatment targets in vascular surgery patients. Vascular. [DOI: 10.1177/17085381221126232] [Reference Citation Analysis]
5 Ajani RA, Adefegha SA, Oboh G. Hypolipidemic effect and antioxidant properties of cassava-wheat flour composite bread in rats. Food Measure. [DOI: 10.1007/s11694-022-01600-1] [Reference Citation Analysis]
6 Shen M, Aghajani Nargesi A, Nasir K, Bhatt DL, Khera R. Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States. JAHA. [DOI: 10.1161/jaha.122.026075] [Reference Citation Analysis]
7 Xie G, Myint PK, Sun Y, Li X, Wu T, Gao RL, Wu Y. Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in China. BMJ Open 2022;12:e056236. [PMID: 36104136 DOI: 10.1136/bmjopen-2021-056236] [Reference Citation Analysis]
8 Wu TH, Lin YC, Hwu CM. Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia. Medicine (Baltimore) 2022;101:e30352. [PMID: 36086734 DOI: 10.1097/MD.0000000000030352] [Reference Citation Analysis]
9 Hu WS, Lin CL. Association of venous thromboembolism between hydrophilic and lipophilic statin users among diabetic subjects. Medicine (Baltimore) 2022;101:e30542. [PMID: 36086736 DOI: 10.1097/MD.0000000000030542] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Yao T, Xiao H, Wang H, Xu X. Recent Advances in PROTACs for Drug Targeted Protein Research. IJMS 2022;23:10328. [DOI: 10.3390/ijms231810328] [Reference Citation Analysis]
11 Wang C, Pang W, Du X, Zhai J, Zhong M, Zhuang M, An J, Cao L, Zhang L, Zheng W, Zhang J. Efficacy and safety of zhibitai in the treatment of hyperlipidemia: A systematic review and meta-analysis. Front Pharmacol 2022;13:974995. [DOI: 10.3389/fphar.2022.974995] [Reference Citation Analysis]
12 Heleniak Z, Illersperger S, Małgorzewicz S, Dębska-Ślizień A, Budde K, Halleck F. Arterial Stiffness as a Cardiovascular Risk Factor After Successful Kidney Transplantation in Diabetic and Nondiabetic Patients. Transplant Proc 2022:S0041-1345(22)00511-5. [PMID: 36064673 DOI: 10.1016/j.transproceed.2022.07.007] [Reference Citation Analysis]
13 Qian J, Li Z, Zhang X, Chen J, Ding C, Yang P, Liu Y, Shi M, Ren X, Ge J. Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-Dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-Controlled Study in Chinese Patients. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.08.013] [Reference Citation Analysis]
14 Fitch KV, Fulda ES, Grinspoon SK. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions. Curr Opin HIV AIDS 2022;17:293-300. [PMID: 35938463 DOI: 10.1097/COH.0000000000000752] [Reference Citation Analysis]
15 Kim S, Choi K, Kim J, Suh HS. Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea. Front Pharmacol 2022;13:924141. [DOI: 10.3389/fphar.2022.924141] [Reference Citation Analysis]
16 Corpataux N, Hochholzer W, Valina CM, Ferenc M, Löffelhardt N, Westermann D, Neumann FJ, Nührenberg TG. Serum lipoprotein(a) and 3-year outcomes in patients undergoing percutaneous coronary intervention. Curr Probl Cardiol 2022;:101362. [PMID: 36028053 DOI: 10.1016/j.cpcardiol.2022.101362] [Reference Citation Analysis]
17 Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Covington AM, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr, Waring AA, Wilkins JT; Writing Committee. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2022:S0735-1097(22)05594-2. [PMID: 36031461 DOI: 10.1016/j.jacc.2022.07.006] [Reference Citation Analysis]
18 Arabi SM, Chambari M, Malek-ahmadi M, Bahrami LS, Hadi V, Rizzo M, Sahebkar A. The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacol. [DOI: 10.1007/s10787-022-01053-4] [Reference Citation Analysis]
19 Rossini E, Biscetti F, Rando MM, Nardella E, Cecchini AL, Nicolazzi MA, Covino M, Gasbarrini A, Massetti M, Flex A. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? IJMS 2022;23:9326. [DOI: 10.3390/ijms23169326] [Reference Citation Analysis]
20 Fernandes Silva L, Ravi R, Vangipurapu J, Laakso M. Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways. Metabolites 2022;12:753. [DOI: 10.3390/metabo12080753] [Reference Citation Analysis]
21 Meng H, Ruan J, Yan Z, Chen Y, Liu J, Li X, Meng F. New Progress in Early Diagnosis of Atherosclerosis. IJMS 2022;23:8939. [DOI: 10.3390/ijms23168939] [Reference Citation Analysis]
22 Li Q, Peng H, Liu H, Zou Y, Li D, Ge J, Yue Z, Liu M, Chang X. Hypercholesterolemia treated with medicinal pad-separated moxibustion: A randomized clinical trial隔药饼灸治疗高胆固醇血症-随机临床试验. World Journal of Acupuncture - Moxibustion 2022. [DOI: 10.1016/j.wjam.2022.08.001] [Reference Citation Analysis]
23 Byrne P, DuBroff R. Emphasizing Study Selection in a Review of Statin Treatment Effects and Low-Density Lipoprotein Cholesterol-Reply. JAMA Intern Med 2022;182:891. [PMID: 35759256 DOI: 10.1001/jamainternmed.2022.2217] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jensen JC, Miedema MD. Coronary Artery Calcium to Guide Treatment in Primary Prevention - Can We Afford Not to? Eur J Prev Cardiol 2022:zwac142. [PMID: 35881522 DOI: 10.1093/eurjpc/zwac142] [Reference Citation Analysis]
25 Citarella A, Cammarota S, Bernardi FF, Caliendo L, D'Andrea A, Fimiani B, Fogliasecca M, Pacella D, Pagnotta R, Trama U, Zito GB, Cillo M, Vercellone A. Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy. J Clin Med 2022;11:4344. [PMID: 35893434 DOI: 10.3390/jcm11154344] [Reference Citation Analysis]
26 Rachas A, Gastaldi-Ménager C, Denis P, Barthélémy P, Constantinou P, Drouin J, Lastier D, Lesuffleur T, Mette C, Nicolas M, Pestel L, Rivière S, Tajahmady A, Gissot C, Fagot-Campagna A. The Economic Burden of Disease in France From the National Health Insurance Perspective: The Healthcare Expenditures and Conditions Mapping Used to Prepare the French Social Security Funding Act and the Public Health Act. Med Care 2022. [PMID: 35880776 DOI: 10.1097/MLR.0000000000001745] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hsieh SS, Budoff MJ. Estimating the accuracy of dual energy chest radiography for coronary calcium detection with lateral or anteroposterior orientations. Med Phys 2022. [PMID: 35848231 DOI: 10.1002/mp.15855] [Reference Citation Analysis]
28 Horton AE, Martin AC, Srinivasan S, Justo RN, Poplawski NK, Sullivan D, Brett T, Chow CK, Nicholls SJ, Pang J, Watts GF; FH Australasia Network Consensus Working Group. Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician. J Paediatr Child Health 2022. [PMID: 35837752 DOI: 10.1111/jpc.16096] [Reference Citation Analysis]
29 Mortensen MB, Tybjærg-Hansen A, Nordestgaard BG. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines. JAMA Cardiol 2022. [PMID: 35793078 DOI: 10.1001/jamacardio.2022.1876] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Acevedo F, Ip T, Orellana M, Martínez G, Gabrielli L, Andia M, Besa C, Pinto MP, Sánchez C, Merino T. Oncological Benefit versus Cardiovascular Risk in Breast Cancer Patients Treated with Modern Radiotherapy. JCM 2022;11:3889. [DOI: 10.3390/jcm11133889] [Reference Citation Analysis]
31 Kaolawanich Y, Boonyasirinant T. Prognostic Value of Adenosine Stress Perfusion Cardiac Magnetic Resonance Imaging in Older Adults with Known or Suspected Coronary Artery Disease. Arq Bras Cardiol 2022;119:97-106. [PMID: 35830106 DOI: 10.36660/abc.20210530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Al-Kindi S, Tashtish N, Rashid I, Gupta A, AnsariGilani K, Gilkeson R, Cainzos-Achirica M, Nasir K, Pronovost P, Simon DI, Rajagopalan S. Effect of No-Charge Coronary Artery Calcium Scoring on Cardiovascular Prevention. Am J Cardiol 2022;174:40-7. [PMID: 35487777 DOI: 10.1016/j.amjcard.2022.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Gupta A, Bera K, Kikano E, Pierce JD, Gan J, Rajdev M, Ciancibello LM, Gupta A, Rajagopalan S, Gilkeson RC. Coronary Artery Calcium Scoring: Current Status and Future Directions. Radiographics 2022;42:947-67. [PMID: 35657766 DOI: 10.1148/rg.210122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Al-musharaf S. Changes in Sleep Patterns during Pregnancy and Predictive Factors: A Longitudinal Study in Saudi Women. Nutrients 2022;14:2633. [DOI: 10.3390/nu14132633] [Reference Citation Analysis]
35 Insani WN, Whittlesea C, Ju C, Man KKC, Alwafi H, Alsharif A, Chapman S, Wei L. Statin-related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality. Br J Clin Pharmacol 2022. [PMID: 35695656 DOI: 10.1111/bcp.15438] [Reference Citation Analysis]
36 Valério RS, Generoso G, Fernandes JL, Nasir K, Hong JC, Bittencourt MS. Custo-Efetividade do Emprego do Escore de Cálcio Coronariano na Orientação para a Decisão Terapêutica na Prevenção Primária, na População Brasileira. Arquivos Brasileiros de Cardiologia 2022;118:1126-31. [DOI: 10.36660/abc.20210347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Chobufo MD, Regner SR, Zeb I, Lacoste JL, Virani SS, Balla S. Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: From the National Health and Nutrition Examination Survey 2017-2020. Eur J Prev Cardiol 2022:zwac103. [PMID: 35653373 DOI: 10.1093/eurjpc/zwac103] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Levintow SN, Reading SR, Noshad S, Mayer SE, Wiener C, Eledath B, Exter J, Brookhart MA. Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008–2019. CLEP 2022;Volume 14:737-48. [DOI: 10.2147/clep.s361258] [Reference Citation Analysis]
39 Berzinji B, Dizaye K. Investigating the effect of Fenofibrate on biomarkers of vascular inflammation in L-NAME induced hypertensive rats. PHAR 2022;69:459-65. [DOI: 10.3897/pharmacia.69.e81078] [Reference Citation Analysis]
40 Fonseca A, Lima TM, Fernandez-Llimos F, Castel-Branco MM, Figueiredo IV. Evaluation of Cardiovascular Pharmacotherapy Guideline Adherence and Risk Factor Control in Portuguese Community Pharmacy Patients. Int J Environ Res Public Health 2022;19:6170. [PMID: 35627707 DOI: 10.3390/ijerph19106170] [Reference Citation Analysis]
41 Imai K, Sugiyama T, Ohsugi M, Kakei M, Hara K. Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States: Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study. Int J Environ Res Public Health 2022;19:6099. [PMID: 35627634 DOI: 10.3390/ijerph19106099] [Reference Citation Analysis]
42 Nelson AJ, Haynes K, Shambhu S, Eapen Z, Cziraky MJ, Nanna MG, Calvert SB, Gallagher K, Pagidipati NJ, Granger CB. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. J Am Coll Cardiol 2022;79:1802-13. [PMID: 35512860 DOI: 10.1016/j.jacc.2022.02.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Bao R, Wang W, Chen B, Pan J, Chen Q, Liu M, Wang D, Wu Y, Yu H, Han L, Zhang Y, Wang T. Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway. Nutrients 2022;14:1983. [PMID: 35565954 DOI: 10.3390/nu14091983] [Reference Citation Analysis]
44 Ling C, Bacos K, Rönn T. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine? Nat Rev Endocrinol 2022. [PMID: 35513492 DOI: 10.1038/s41574-022-00671-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Nie G, Yang X, Wang Y, Liang W, Li X, Luo Q, Yang H, Liu J, Wang J, Guo Q, Yu Q, Liang X. The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:850815. [PMID: 35496275 DOI: 10.3389/fphar.2022.850815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Barge-caballero E, Marcos-rodríguez PJ, Domenech-garcía N, Bou-arévalo G, Cid-fernández J, Iglesias-reinoso R, López-vázquez P, Muñiz J, Vázquez-rodríguez JM, Crespo-leiro MG. IMPACTO DEL TRATAMIENTO PREVIO CON ESTATINAS SOBRE LA SUPERVIVENCIA DE LOS PACIENTES HOSPITALIZADOS CON COVID-19. Medicina Clínica 2022. [DOI: 10.1016/j.medcli.2022.03.015] [Reference Citation Analysis]
47 Tran C, Vo V, Taylor P, Koehn DA, Virani SS, Dixon DL. Adherence to Lipid Monitoring and Its Impact on Treat Intensification of LDL-C Lowering Therapies at an Urban Academic Medical Center. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.05.003] [Reference Citation Analysis]
48 Grundy SM, Vega GL. Statin Therapy for Primary Prevention in Women: What is the Role for Coronary Artery Calcium? Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Axon DR, Kloster J, Eckert B, Morales S, Riggs S, Kilungo A, Ehiri J, Grieser M, Turner-warren T, Aseret-manygoats T, Bingham JM, Scovis N, Warholak T. Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice. Clinics and Practice 2022;12:243-52. [DOI: 10.3390/clinpract12030029] [Reference Citation Analysis]
50 Enriquez R, Ssekubugu R, Ndyanabo A, Marrone G, Gigante B, Chang LW, Reynolds SJ, Nalugoda F, Ekstrom AM, Sewankambo NK, Serwadda DM, Nordenstedt H. Prevalence of cardiovascular risk factors by HIV status in a population-based cohort in South Central Uganda: a cross-sectional survey. J Int AIDS Soc 2022;25:e25901. [PMID: 35419976 DOI: 10.1002/jia2.25901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Lu B, Posner D, Vassy JL, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF. Prediction of Cardiovascular and All-Cause Mortality After Myocardial Infarction in US Veterans. Am J Cardiol 2022;169:10-7. [PMID: 35063273 DOI: 10.1016/j.amjcard.2021.12.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Peng L, Liu L, Ma N, Yang F, Nie C, Yang T, Zeng Q, Wang Z, Xu D, Ma L, Xu Y, Hong F. The dose-response relationship of serum uric acid with Dyslipidaemia and its components: a cross-sectional study of a Chinese multi-ethnic cohort. Lipids Health Dis 2022;21. [DOI: 10.1186/s12944-022-01647-5] [Reference Citation Analysis]
53 Achila OO, Fessahye N, Mengistu ST, Habtemikael NT, Werke WY, Zemichael FT, Leghese HN, Weldegegish TA, Tekeste TH, Garoy EY. A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09446-9] [Reference Citation Analysis]
54 Borden WB, Wang J, Jones P, Tang Y, Contreras J, Daugherty SL, Desai NR, Virani SS, Wasfy JH, Maddox TM. Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circ Cardiovasc Qual Outcomes 2022;15:e007908. [PMID: 35272505 DOI: 10.1161/CIRCOUTCOMES.121.007908] [Reference Citation Analysis]
55 Gouws CA, Mckune A, Tee N, Somerset S, Mortazavi R. Prickly pear juice consumption after fat intake affects postprandial heart rate variability but not traditional risk factors of cardiovascular disease in healthy men. Nutrition 2022;96:111555. [DOI: 10.1016/j.nut.2021.111555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Kim JH, Chang IB, Kim YH, Kwon MJ, Kim JH, Choi HG. Association between statin use and Parkinson's disease in Korean patients with hyperlipidemia. Parkinsonism Relat Disord 2022;97:15-24. [PMID: 35276584 DOI: 10.1016/j.parkreldis.2022.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 47.0] [Reference Citation Analysis]
58 Schwier NC, Cornelio CK, Boylan PM. A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies. Pharmacotherapy 2022;42:320-33. [PMID: 35175631 DOI: 10.1002/phar.2674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tomo S, Sankanagoudar S, Shukla R, Sharma P. Validation of a novel method for determination of low-density lipoprotein cholesterol levels in Indian patients with type 2 diabetes. Diabetes Metab Syndr 2022;16:102448. [PMID: 35313205 DOI: 10.1016/j.dsx.2022.102448] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, Thakkar A, Rifai MA, Mehta A, Thobani A, Al-saiegh Y, Nelson AJ, Sheth S, Toth PP. Ten Things to Know About Ten Cardiovascular Disease Risk Factors – 2022. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100342] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Petrazzini BO, Chaudhary K, Márquez-Luna C, Forrest IS, Rocheleau G, Cho J, Narula J, Nadkarni G, Do R. Coronary Risk Estimation Based on Clinical Data in Electronic Health Records. J Am Coll Cardiol 2022;79:1155-66. [PMID: 35331410 DOI: 10.1016/j.jacc.2022.01.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Maitra NS, Mahtta D, Navaneethan S, Vaughan EM, Kochar A, Gulati M, Levine GN, Petersen LA, Virani SS. A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep 2022. [PMID: 35352278 DOI: 10.1007/s11886-022-01694-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Li M, Wang A, Ren S, Wang Z, Wang Q, Gou C, Zhao W, Zhang L, Li N. Factors associated with acute pancreatitis in patients with impacted duodenal papillary stones: a retrospective cohort study. Scand J Gastroenterol 2022;:1-8. [PMID: 35297730 DOI: 10.1080/00365521.2022.2050294] [Reference Citation Analysis]
64 Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis. JAMA Intern Med 2022. [PMID: 35285850 DOI: 10.1001/jamainternmed.2022.0134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
65 Fan H, Wang Y, Liu T, Zhang K, Ren J, Li Y, Li J, Wu X, Li X, Niu X. Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization. Ann Clin Transl Neurol. [DOI: 10.1002/acn3.51541] [Reference Citation Analysis]
66 Bernardi A, Olandoski M, Erbano LO, Guarita-souza LC, Baena CP, Faria-neto JR. Alcance das Metas de Colesterol LDL após Infarto Agudo do Miocárdio: Dados Reais do Sistema Público de Saúde da Cidade de Curitiba. Arquivos Brasileiros de Cardiologia 2022. [DOI: 10.36660/abc.20210328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Bideberi AT, Mutagaywa R. Statin Prescription Patterns and Associated Factors Among Patients with Type 2 Diabetes Mellitus Attending Diabetic Clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Diabetes Metab Syndr Obes 2022;15:633-46. [PMID: 35250285 DOI: 10.2147/DMSO.S347765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Husain MJ, Spencer G, Nugent R, Kostova D, Richter P. The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review. gh 2022;17:18. [DOI: 10.5334/gh.1097] [Reference Citation Analysis]
69 Kim MJ, Kim IW. Self-rated health may be a predictor for metabolic syndrome and high hs-CRP prevalences in healthy adults in South Korea: Based on the 2015 Korea National Health and Nutrition Examination Survey. Nutrition Research 2022. [DOI: 10.1016/j.nutres.2022.03.003] [Reference Citation Analysis]
70 Short L, La VT, Patel M, Pai RG. Primary and Secondary Prevention of CAD: A Review. Int J Angiol 2022;31:16-26. [PMID: 35221848 DOI: 10.1055/s-0041-1729925] [Reference Citation Analysis]
71 Chi CL, Wang J, Ying Yew P, Lenskaia T, Loth M, Mani Pradhan P, Liang Y, Kurella P, Mehta R, Robinson JG, Tonellato PJ, Adam TJ. Producing personalized statin treatment plans to optimize clinical outcomes using big data and machine learning. J Biomed Inform 2022;:104029. [PMID: 35182785 DOI: 10.1016/j.jbi.2022.104029] [Reference Citation Analysis]
72 Jin X, Yang S, Lu J, Wu M. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies. Front Cardiovasc Med 2022;8:804214. [DOI: 10.3389/fcvm.2021.804214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Han KT, Kim S. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea. BMC Cancer 2022;22:156. [PMID: 35135497 DOI: 10.1186/s12885-022-09250-8] [Reference Citation Analysis]
74 Sharma A, Christodorescu R, Agbariah A, Duda-Seiman D, Dahdal D, Man D, Kundnani NR, Cretu OM, Dragan S. Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases. Healthcare (Basel) 2022;10:312. [PMID: 35206926 DOI: 10.3390/healthcare10020312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Horne BD, Muhlestein JB, Lappé DL, May HT, Le VT, Bair TL, Babcock D, Bride D, Knowlton KU, Anderson JL. Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial. Am Heart J 2022;244:125-34. [PMID: 34798073 DOI: 10.1016/j.ahj.2021.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
76 Mayo NL, Russell HA, Holt K, Williams GC. Implementation of a self-determination based clinical program to reduce cardiovascular disease risk. J Health Psychol 2022;:13591053211068124. [PMID: 35086378 DOI: 10.1177/13591053211068124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Song M, Cho H, Lee S, Lee KH, Kim W. Daeshiho-tang Attenuates Atherosclerosis by Regulating Cholesterol Metabolism and Inducing M2 Macrophage Polarization. Life 2022;12:197. [DOI: 10.3390/life12020197] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Chang H, Fang H, Huang C, Chiang C, Chuang S, Hsu C, Cheng H, Chen T, Yao W, Pan W. Developing and Validating Risk Scores for Predicting Major Cardiovascular Events Using Population Surveys Linked with Electronic Health Insurance Records. IJERPH 2022;19:1319. [DOI: 10.3390/ijerph19031319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Guo X, Chen X, Chen J, Tan Z, Yang Y, Zhang H. Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases. Evid Based Complement Alternat Med 2022;2022:6181862. [PMID: 35069763 DOI: 10.1155/2022/6181862] [Reference Citation Analysis]
80 Al-Karaghouli M, Fuentes S, Davyduke T, Ma M, Abraldes JG. Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD. BMJ Open Gastroenterol 2022;9:e000798. [PMID: 34992072 DOI: 10.1136/bmjgast-2021-000798] [Reference Citation Analysis]
81 Wang H, Tang C, Gao Z, Huang Y, Zhang B, Wei J, Zhao L, Tong X. Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus. J Diabetes Res 2021;2021:1655336. [PMID: 34988228 DOI: 10.1155/2021/1655336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Luo X, Cai WY, Wu XK. Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome. Front Cardiovasc Med 2021;8:790454. [PMID: 34977197 DOI: 10.3389/fcvm.2021.790454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Tummalapalli SL, Estrella MM, Jannat-Khah DP, Keyhani S, Ibrahim S. Capitated versus fee-for-service reimbursement and quality of care for chronic disease: a US cross-sectional analysis. BMC Health Serv Res 2022;22:19. [PMID: 34980111 DOI: 10.1186/s12913-021-07313-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Plutzky J, Benson MD, Chaney K, Bui TV, Kraft M, Matta L, McPartlin M, Zelle D, Cannon CP, Dodek A, Gaziano TA, Desai AS, MacRae CA, Scirica BM. Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program. Am Heart J 2022;243:15-27. [PMID: 34481756 DOI: 10.1016/j.ahj.2021.08.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Noh S, Mai K, Shaver M, Yong S, Mostaghimi M, Oh G, Radwan MM. Emerging Cholesterol Modulators for Atherosclerotic Cardiovascular Disease. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.011] [Reference Citation Analysis]
86 Sciattella P, Maggioni AP, Arcangeli E, Sidelnikov E, Kahangire DA, Mennini FS. Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy. Adv Ther 2022;39:314-27. [PMID: 34718949 DOI: 10.1007/s12325-021-01960-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Wagner JR, Fitzpatrick JK, Yang J, Sung SH, Allen AR, Philip S, Granowitz C, Abrahamson D, Ambrosy AP, Go AS. Global Assessment Improves Risk Stratification for Major Adverse Cardiac Events Across a Wide Range of Triglyceride Levels: Insights from the KP REACH Study. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100319] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Hua R, Li Y, Li W, Wei Z, Yuan Z, Zhou J. Apolipoprotein B/A1 Ratio Is Associated with Severity of Coronary Artery Stenosis in CAD Patients but Not in Non-CAD Patients Undergoing Percutaneous Coronary Intervention. Dis Markers 2021;2021:8959019. [PMID: 34961824 DOI: 10.1155/2021/8959019] [Reference Citation Analysis]
89 Ellimuttil TM, Harrison K, Rollins AT, Feurer ID, Rega SA, Gray J, Menachem JN. Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy. Card Fail Rev 2021;7:e15. [PMID: 34950505 DOI: 10.15420/cfr.2021.07] [Reference Citation Analysis]
90 Buchanan CH, Brown EA, Bishu KG, Weeda E, Axon RN, Taber DJ, Gebregziabher M. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues 2021:S1049-3867(21)00156-0. [PMID: 34949527 DOI: 10.1016/j.whi.2021.10.003] [Reference Citation Analysis]
91 Zapatero-Belinchón FJ, Moeller R, Lasswitz L, van Ham M, Becker M, Brogden G, Rosendal E, Bi W, Carriquí-Madroñal B, Islam K, Lenman A, Gunesch AP, Kirui J, Pietschmann T, Överby AK, Jänsch L, Gerold G. Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience 2021;24:103469. [PMID: 34812415 DOI: 10.1016/j.isci.2021.103469] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
92 Fahimfar N, Malekzadeh R, Fotouhi A, Mansournia MA, Sarrafzadegan N, Azizi F, Sepanlou SG, Mansourian M, Hadaegh F, Emamian MH, Poustchi H, Talaei M, Pourshams A, Roohafza H, Sharafkhah M, Samavat T, Lotfaliany M, Steyerberg EW, Khalili D. An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country: Developing and validating an office-based model to predict cardiovascular mortality using cohorts of a middle-income country. J Clin Epidemiol 2021:S0895-4356(21)00420-0. [PMID: 34920114 DOI: 10.1016/j.jclinepi.2021.12.017] [Reference Citation Analysis]
93 Muhlestein JB, Knowlton KU, Le VT, Lappe DL, May HT, Min DB, Johnson KM, Cripps ST, Schwab LH, Braun SB, Bair TL, Anderson JL. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial. JACC Cardiovasc Imaging 2021:S1936-878X(21)00833-0. [PMID: 34922872 DOI: 10.1016/j.jcmg.2021.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
94 Vega GL, Wang J, Grundy SM. Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease: Risk Enhancing Factors in Intermediate Risk for ASCVD. J Clin Lipidol 2021:S1933-2874(21)00289-0. [PMID: 34922882 DOI: 10.1016/j.jacl.2021.11.009] [Reference Citation Analysis]
95 Fiedorowicz JG, Merranko JA, Iyengar S, Hower H, Gill MK, Yen S, Goldstein TR, Strober M, Hafeman D, Keller MB, Goldstein BI, Diler RS, Hunt JI, Birmaher BB. Validation of the youth mood recurrences risk calculator in an adult sample with bipolar disorder. J Affect Disord 2021;295:1482-8. [PMID: 34563392 DOI: 10.1016/j.jad.2021.09.037] [Reference Citation Analysis]
96 Chang JC, Chen YJ, Chen IC, Lin WS, Chen YM, Lin CH. Perinatal Outcomes After Statin Exposure During Pregnancy. JAMA Netw Open 2021;4:e2141321. [PMID: 34967881 DOI: 10.1001/jamanetworkopen.2021.41321] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Mansi IA, Chansard M, Lingvay I, Zhang S, Halm EA, Alvarez CA. Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Intern Med 2021;181:1562-74. [PMID: 34605849 DOI: 10.1001/jamainternmed.2021.5714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
98 Rana JS, Virani SS, Moffet HH, Liu JY, Coghlan LA, Vasadia J, Ballantyne CM, Karter AJ. Association of Low-Density Lipoprotein Testing after an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification. Am J Med 2021:S0002-9343(21)00794-4. [PMID: 34861203 DOI: 10.1016/j.amjmed.2021.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Liu L, Zhao Y, Ming J, Chen J, Zhao G, Chen ZY, Wang Y, Lei L. Polyphenol extract and essential oil of Amomum tsao-ko equally alleviate hypercholesterolemia and modulate gut microbiota. Food Funct 2021;12:12008-21. [PMID: 34755750 DOI: 10.1039/d1fo03082e] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
100 Shafter AM, Shaikh K, Johanis A, Budoff MJ. De-risking primary prevention: role of imaging. Ther Adv Cardiovasc Dis 2021;15:17539447211051248. [PMID: 34821189 DOI: 10.1177/17539447211051248] [Reference Citation Analysis]
101 Walsh CG, McKillop MM, Lee P, Harris JW, Simpson C, Novak LL. Risky business: a scoping review for communicating results of predictive models between providers and patients. JAMIA Open 2021;4:ooab092. [PMID: 34805776 DOI: 10.1093/jamiaopen/ooab092] [Reference Citation Analysis]
102 Eslami SM, Khorshidi L, Ghasemi M, Rashidian A, Mirghazanfari M, Nezhadi A, Chamanara M, Mirjani R. Protective effects of atorvastatin and rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-induced spatial learning and memory impairment. Inflammopharmacology 2021;29:1807-18. [PMID: 34780009 DOI: 10.1007/s10787-021-00891-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Pereira-Manfro WF, Lima GR, Nogueira Neto JF, Portugal MRC, Milagres LG, Bezerra FF, Faerstein E, Koury JC. Association between visceral/subcutaneous adipose tissue ratio and plasma inflammatory markers and score for cardiovascular risk prediction in a Brazilian cohort: Pró-Saúde Study. Braz J Med Biol Res 2021;54:e11521. [PMID: 34730680 DOI: 10.1590/1414-431X2021e11521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Lee SH, Jang MU, Kim Y, Park SY, Kim C, Kim YJ, Sohn JH. Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment. J Clin Med 2021;10:5147. [PMID: 34768673 DOI: 10.3390/jcm10215147] [Reference Citation Analysis]
105 Grundy SM, Vega GL. Statin Intolerance and Noncompliance: An Empiric Approach. Am J Med 2021:S0002-9343(21)00644-6. [PMID: 34717898 DOI: 10.1016/j.amjmed.2021.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Qasem Surrati AM, Mohammedsaeed W, Shikieri ABE. Cardiovascular Risk Awareness and Calculated 10-Year Risk Among Female Employees at Taibah University 2019. Front Public Health 2021;9:658243. [PMID: 34671586 DOI: 10.3389/fpubh.2021.658243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Olson KL, Stine JM, Stadler SL, Angleson J, Campbell SM, Friesleben C, Schimmer JJ. Using pharmacy technicians and electronic health record capabilities to improve outcomes for patients with cardiovascular disease. J Am Pharm Assoc (2003) 2021:S1544-3191(21)00433-7. [PMID: 34753672 DOI: 10.1016/j.japh.2021.10.014] [Reference Citation Analysis]
108 Jin H, He J, Dong C, Li B, Ma Z, Li B, Huang T, Fan J, He G, Zhao X. Altered Lipid Profile Is a Risk Factor for the Poor Progression of COVID-19: From Two Retrospective Cohorts. Front Cell Infect Microbiol 2021;11:712530. [PMID: 34660338 DOI: 10.3389/fcimb.2021.712530] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
109 Zhang MW, Wang XH, Shi J, Yu JG. Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences. Front Cardiovasc Med 2021;8:749113. [PMID: 34660748 DOI: 10.3389/fcvm.2021.749113] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
110 Naqvi TZ, Polonsky TS. Finding the Right Age for CAC Testing: How Low Should You Go? J Am Coll Cardiol 2021;78:1584-6. [PMID: 34649695 DOI: 10.1016/j.jacc.2021.08.027] [Reference Citation Analysis]
111 Wong ND, Puri R, Mehta V, Duell PB. When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL? Am J Cardiol 2021;157:142-4. [PMID: 34344510 DOI: 10.1016/j.amjcard.2021.06.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Lewis ACF, Green RC, Vassy JL. Polygenic risk scores in the clinic: Translating risk into action. HGG Adv 2021;2:100047. [PMID: 35047839 DOI: 10.1016/j.xhgg.2021.100047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Denova-Gutiérrez E, Lara-Castor L, Hernández-Alcaraz C, Hernández-Ávila M, Aguilar-Salinas C, Kershenobich D, Barquera S. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. Ann Hepatol 2021;:100562. [PMID: 34653686 DOI: 10.1016/j.aohep.2021.100562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Liu J, Wu YP, Qi JJ, Yue ZP, Hu CD. Effect of Statin Therapy on Diabetes Retinopathy in People With Type 2 Diabetes Mellitus: A Meta-Analysis. Clin Appl Thromb Hemost 2021;27:10760296211040109. [PMID: 34617462 DOI: 10.1177/10760296211040109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites 2021;11:690. [PMID: 34677405 DOI: 10.3390/metabo11100690] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
116 Zhang J, Zhang J, Wu H, Wang R. Sleep duration and risk of hyperlipidemia: a systematic review and meta-analysis of prospective studies. Sleep Breath 2021. [PMID: 34618292 DOI: 10.1007/s11325-021-02504-y] [Reference Citation Analysis]
117 Whelton SP, Marshall CH, Cainzos-Achirica M, Dzaye O, Blumenthal RS, Nasir K, McClelland RL, Blaha MJ. Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis. Am J Prev Cardiol 2021;7:100212. [PMID: 34611644 DOI: 10.1016/j.ajpc.2021.100212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Li J, Liu FH, Guo J, Yu YF, Li CQ. Retrospective analysis of renal prognosis in elderly coronary artery disease patients complicated with renal insufficiency. Aging (Albany NY) 2021;13:22856-66. [PMID: 34606471 DOI: 10.18632/aging.203579] [Reference Citation Analysis]
119 Jia X, Lee MT, Ramsey DJ, Mahtta D, Akeroyd JM, Turchin A, Navar AM, Matheny ME, Gobbel G, Stone NJ, Nambi V, Ballantyne CM, Petersen LA, Virani SS. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the veteran's affairs healthcare system. J Clin Lipidol 2021:S1933-2874(21)00249-X. [PMID: 34666951 DOI: 10.1016/j.jacl.2021.09.050] [Reference Citation Analysis]
120 Zhang X, Chen X, Liang Z, Nie M, Yan Y, Zhao Q. Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study. J Cardiovasc Pharmacol 2021;78:544-50. [PMID: 34651601 DOI: 10.1097/FJC.0000000000001088] [Reference Citation Analysis]
121 Reese PP, Barankay I, Putt M, Russell LB, Yan J, Zhu J, Huang Q, Loewenstein G, Andersen R, Testa H, Mussell AS, Pagnotti D, Wesby LE, Hoffer K, Volpp KG. Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial. JAMA Netw Open 2021;4:e2121908. [PMID: 34605920 DOI: 10.1001/jamanetworkopen.2021.21908] [Reference Citation Analysis]
122 Russell N, Grossmann M. Management of bone and metabolic effects of androgen deprivation therapy. Urologic Oncology: Seminars and Original Investigations 2021;39:704-12. [DOI: 10.1016/j.urolonc.2018.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
123 Lanzolla G, Sabini E, Leo M, Menconi F, Rocchi R, Sframeli A, Piaggi P, Nardi M, Marcocci C, Marinò M. Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial. Lancet Diabetes Endocrinol 2021;9:733-42. [PMID: 34592164 DOI: 10.1016/S2213-8587(21)00238-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
124 Zingel R, Bohlken J, Riedel-Heller S, Barth S, Kostev K. Association Between Low-Density Lipoprotein Cholesterol Levels, Statin Use, and Dementia in Patients followed in German General Practices. J Alzheimers Dis 2021;79:37-46. [PMID: 33216039 DOI: 10.3233/JAD-201176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
125 Zhu Y, Chiang CW, Wang L, Brock G, Milks MW, Cao W, Zhang P, Zeng D, Donneyong M, Li L. A multistate transition model for statin-induced myopathy and statin discontinuation. CPT Pharmacometrics Syst Pharmacol 2021;10:1236-44. [PMID: 34562311 DOI: 10.1002/psp4.12691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Brunet L, Mallon P, Fusco JS, Wohlfeiler MB, Prajapati G, Beyer A, Fusco GP. Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clin Drug Investig 2021;41:955-65. [PMID: 34546533 DOI: 10.1007/s40261-021-01081-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Kim YM, Kim JD, Jung H. A Cross-Sectional Study of the Effects of Physical Activity and Nutrient Intakes on Blood Glucose Control Rates in Middle-Aged and Elderly Diabetes Patients: Korean National Health and Nutrition Examination Survey 2015-2017. Inquiry 2021;58:469580211035727. [PMID: 34541956 DOI: 10.1177/00469580211035727] [Reference Citation Analysis]
128 Ioffe M, Kremer A, Nachimov I, Swartzon M, Justo D. Mortality associated with stopping statins in the oldest-old - with and without ischemic heart disease. Medicine (Baltimore) 2021;100:e26966. [PMID: 34664827 DOI: 10.1097/MD.0000000000026966] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
129 Pan M, Li S, Tu R, Li R, Liu X, Chen R, Yu S, Mao Z, Huo W, Yin S, Hu K, Bo Chen G, Guo Y, Hou J, Wang C. Associations of solid fuel use and ambient air pollution with estimated 10-year atherosclerotic cardiovascular disease risk. Environ Int 2021;157:106865. [PMID: 34509046 DOI: 10.1016/j.envint.2021.106865] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
130 Nakamae H, Yamamoto M, Sakaida E, Kanda Y, Ohmine K, Ono T, Matsumura I, Ishikawa M, Aoki M, Maki A, Shibayama H. Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. Int J Hematol 2021. [PMID: 34508295 DOI: 10.1007/s12185-021-03216-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Sarraju A, Spencer-Bonilla G, Chung S, Gomez S, Li J, Heidenreich P, Palaniappan L, Rodriguez F. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk. J Gen Intern Med 2021. [PMID: 34505981 DOI: 10.1007/s11606-021-07107-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Boettiger DC, Chattranukulchai P, Avihingsanon A, Chaiwarith R, Khusuwan S, Law MG, Ross J, Kiertiburanakul S. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis. PLoS One 2021;16:e0256926. [PMID: 34499685 DOI: 10.1371/journal.pone.0256926] [Reference Citation Analysis]
133 Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J. Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. Nutrients 2021;13:3138. [PMID: 34579015 DOI: 10.3390/nu13093138] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
134 Fernandez KA, Allen P, Campbell M, Page B, Townes T, Li CM, Cheng H, Garrett J, Mulquin M, Clements A, Mulford D, Ortiz C, Brewer C, Dubno JR, Newlands S, Schmitt NC, Cunningham LL. Atorvastatin is associated with reduced cisplatin-induced hearing loss. J Clin Invest 2021;131:142616. [PMID: 33393488 DOI: 10.1172/JCI142616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
135 Eid WE, Sapp EH, Flerlage E, Nolan JR. Lower-Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia. J Am Heart Assoc 2021;10:e020800. [PMID: 34465130 DOI: 10.1161/JAHA.121.020800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
136 Jun JE, Choi MS, Park SW, Kim G, Jin SM, Kim K, Hwang YC, Ahn KJ, Chung HY, Jeong IK, Kang M, Kim JH. Low Skeletal Muscle Mass Is Associated With the Presence, Incidence, and Progression of Coronary Artery Calcification. Can J Cardiol 2021:S0828-282X(21)00178-1. [PMID: 33845138 DOI: 10.1016/j.cjca.2021.04.002] [Reference Citation Analysis]
137 Sidebottom AC, Miedema MD, Benson G, Vacquier M, VanWormer JJ, Sillah A, Lindberg R, Boucher JL, Bradley SM. The impact of a population-based prevention program on cardiovascular events: Findings from the heart of new Ulm project. Am Heart J 2021;239:38-51. [PMID: 33957104 DOI: 10.1016/j.ahj.2021.04.010] [Reference Citation Analysis]
138 Oh PC, Jang AY, Ha K, Kim M, Moon J, Suh SY, Lee K, Han SH, Kang WC. Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis. Am J Cardiol 2021;154:22-8. [PMID: 34238445 DOI: 10.1016/j.amjcard.2021.05.039] [Reference Citation Analysis]
139 Campos-Staffico AM, Cordwin D, Murthy VL, Dorsch MP, Luzum JA. Comparative performance of the two pooled cohort equations for predicting atherosclerotic cardiovascular disease. Atherosclerosis 2021;334:23-9. [PMID: 34461391 DOI: 10.1016/j.atherosclerosis.2021.08.034] [Reference Citation Analysis]
140 Marco-Benedí V, Cenarro A, Laclaustra M, Larrea-Sebal A, Jarauta E, Lamiquiz-Moneo I, Calmarza P, Bea AM, Plana N, Pintó X, Martín C, Civeira F. Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation. Atherosclerosis 2021:S0021-9150(21)01270-3. [PMID: 34456049 DOI: 10.1016/j.atherosclerosis.2021.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Björnsson E, Thorgeirsson G, Helgadóttir A, Thorleifsson G, Sveinbjörnsson G, Kristmundsdóttir S, Jónsson H, Jónasdóttir A, Jónasdóttir Á, Sigurðsson Á, Guðnason T, Ólafsson Í, Sigurðsson EL, Sigurðardóttir Ó, Viðarsson B, Baldvinsson M, Bjarnason R, Danielsen R, Matthíasson SE, Thórarinsson BL, Grétarsdóttir S, Steinthórsdóttir V, Halldórsson BV, Andersen K, Arnar DO, Jónsdóttir I, Guðbjartsson DF, Hólm H, Thorsteinsdóttir U, Sulem P, Stefánsson K. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland. Arterioscler Thromb Vasc Biol 2021;41:2616-28. [PMID: 34407635 DOI: 10.1161/ATVBAHA.120.315904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
142 Ekor M, Owusu Agyei PE, Obese E, Biney RP, Henneh IT, Antwi-Adjei M, Yahaya ES, Amoakohene G, Akakpo PK. Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia. PLoS One 2021;16:e0247735. [PMID: 34403420 DOI: 10.1371/journal.pone.0247735] [Reference Citation Analysis]
143 Tang PC, Miller S, Stavropoulos H, Kartoun U, Zambrano J, Ng K. Precision population analytics: population management at the point-of-care. J Am Med Inform Assoc 2021;28:588-95. [PMID: 33180897 DOI: 10.1093/jamia/ocaa247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
144 Vaughan EM, Naik AD, Amspoker AB, Johnston CA, Landrum JD, Balasubramanyam A, Virani SS, Ballantyne CM, Foreyt JP. Mentored implementation to initiate a diabetes program in an underserved community: a pilot study. BMJ Open Diabetes Res Care 2021;9:e002320. [PMID: 34385148 DOI: 10.1136/bmjdrc-2021-002320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Tanz LJ, Stuart JJ, Williams PL, Rimm EB, Missmer SA, Mukamal KJ, Rexrode KM, Rich-Edwards JW. Contributions of Preterm Delivery to Cardiovascular Disease Risk Prediction in Women. J Womens Health (Larchmt) 2021. [PMID: 34388032 DOI: 10.1089/jwh.2021.0166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Sofat S, Chen X, Chowdhury MM, Coughlin PA. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg 2021;62:450-61. [PMID: 34389230 DOI: 10.1016/j.ejvs.2021.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Dai W, Lund H, Chen Y, Zhang J, Osinski K, Jones SZ, Kreuziger LB, López JA, Benjamin IJ, Silverstein RL, Zheng Z. Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19. J Clin Lipidol 2021:S1933-2874(21)00122-7. [PMID: 34470719 DOI: 10.1016/j.jacl.2021.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SS. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis 2021:S0033-0620(21)00089-X. [PMID: 34371083 DOI: 10.1016/j.pcad.2021.08.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
149 Alfaifi AA, Lai L, Althemery AU. Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework. PLoS One 2021;16:e0255729. [PMID: 34352007 DOI: 10.1371/journal.pone.0255729] [Reference Citation Analysis]
150 Khandelwal A, Bakir M, Bezaire M, Costello B, Gomez JMD, Hoover V, Nazir NT, Nichols K, Reisenberg A, Rao A, Sanghani R, Tracy M, Volgman AS. Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center. Curr Atheroscler Rep 2021;23:56. [PMID: 34345945 DOI: 10.1007/s11883-021-00956-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
151 Díaz-Zagoya JC, Marín-Medina A, Zetina-Esquivel AM, Blé-Castillo JL, Castell-Rodríguez AE, Juárez-Rojop IE, Miranda-Zamora R. Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice. Sci Rep 2021;11:15809. [PMID: 34349148 DOI: 10.1038/s41598-021-95140-1] [Reference Citation Analysis]
152 Toreyhi H, Asgari S, Khalili D, Pishgahi M, Azizi F, Hadaegh F. Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study. Sci Rep 2021;11:15720. [PMID: 34344986 DOI: 10.1038/s41598-021-95210-4] [Reference Citation Analysis]
153 Davidson J, Rotondo D. The potential role of the lipid phosphate phosphatase 3 (Plpp3) gene in cardiovascular disease. Curr Opin Lipidol 2020;31:258-9. [PMID: 32692036 DOI: 10.1097/MOL.0000000000000695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. Br J Haematol 2021. [PMID: 34331461 DOI: 10.1111/bjh.17733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Wang J, Wang YS, Huang YP, Jiang CH, Gao M, Zheng X, Yin ZQ, Zhang J. Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression. Phytomedicine 2021;91:153688. [PMID: 34380071 DOI: 10.1016/j.phymed.2021.153688] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
156 Virani SS, Morris PB, Agarwala A, Ballantyne CM, Birtcher KK, Kris-Etherton PM, Ladden-Stirling AB, Miller M, Orringer CE, Stone NJ. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021;78:960-93. [PMID: 34332805 DOI: 10.1016/j.jacc.2021.06.011] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
157 Deshotels MR, Virani SS, Ballantyne CM. Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Curr Cardiol Rep 2021;23:116. [PMID: 34269897 DOI: 10.1007/s11886-021-01545-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
158 Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, Nierenberg AA, Maes M, Fernandes BS, Dean OM, Williams LJ, Eyre HA, Kim SW, Zoungas S, Carvalho AF, Berk M. Statins: Neurobiological underpinnings and mechanisms in mood disorders. Neurosci Biobehav Rev 2021;128:693-708. [PMID: 34265321 DOI: 10.1016/j.neubiorev.2021.07.012] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
159 Nardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJ. Retrospective cohort study of statin prescribing for primary prevention among people living with HIV. JRSM Cardiovasc Dis 2021;10:20480040211031068. [PMID: 34290861 DOI: 10.1177/20480040211031068] [Reference Citation Analysis]
160 Lohia P, Kapur S, Benjaram S, Cantor Z, Mahabadi N, Mir T, Badr MS. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching. Cardiovasc Diabetol 2021;20:140. [PMID: 34246277 DOI: 10.1186/s12933-021-01336-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
161 Miller BF, Thyfault JP. Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan. Physiology (Bethesda) 2020;35:338-47. [PMID: 32783612 DOI: 10.1152/physiol.00013.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
162 Franchi C, Lancellotti G, Bertolotti M, Di Salvatore S, Nobili A, Mannucci PM, Mussi C, Ardoino I; REPOSI (REgistro POliterapie SIMI, Società Italiana di Medicina Interna) Study Group. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients. Clin Interv Aging 2021;16:1251-64. [PMID: 34239298 DOI: 10.2147/CIA.S305933] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
163 Liu J, Zhang B, Chen M, Zheng B. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials. Medicine (Baltimore) 2021;100:e26278. [PMID: 34160392 DOI: 10.1097/MD.0000000000026278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 de Beer R, Outhoff K, Phulukdaree A, Soma P. Prevalence of SLCO1B1 single nucleotide variations and their association with hypercholesterolaemia in hypercholesterolemic patients in Gauteng, South Africa. Xenobiotica 2021;51:949-59. [PMID: 34154510 DOI: 10.1080/00498254.2021.1945165] [Reference Citation Analysis]
165 García-Ulloa AC, Lechuga-Fonseca C, Del Razo-Olvera FM, Aguilar-Salinas CA, Galaviz KI, Narayan KMV, Hernández-Jiménez S; Group of Study CAIPaDi. Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2021;9:e001891. [PMID: 33568360 DOI: 10.1136/bmjdrc-2020-001891] [Reference Citation Analysis]
166 Allar BG, Swerdlow NJ, de Guerre LEVM, Dansey KD, Li C, Wang GJ, Patel VI, Schermerhorn ML. Preoperative statin therapy is associated with higher 5-year survival after thoracic endovascular aortic repair. J Vasc Surg 2021:S0741-5214(21)01012-0. [PMID: 34182025 DOI: 10.1016/j.jvs.2021.05.057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Younis NK, Ghoubaira JA, Bassil EP, Tantawi HN, Eid AH. Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine 2021;36:102433. [PMID: 34171467 DOI: 10.1016/j.nano.2021.102433] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
168 Akoumianakis I, Badi I, Douglas G, Chuaiphichai S, Herdman L, Akawi N, Margaritis M, Antonopoulos AS, Oikonomou EK, Psarros C, Galiatsatos N, Tousoulis D, Kardos A, Sayeed R, Krasopoulos G, Petrou M, Schwahn U, Wohlfart P, Tennagels N, Channon KM, Antoniades C. Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition. Sci Transl Med 2020;12:eaav8824. [PMID: 32350133 DOI: 10.1126/scitranslmed.aav8824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
169 Wang MC, Lloyd-Jones DM. Cardiovascular Risk Assessment in Hypertensive Patients. Am J Hypertens 2021;34:569-77. [PMID: 33503227 DOI: 10.1093/ajh/hpab021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Lioutas VA, Beiser AS, Aparicio HJ, Himali JJ, Selim MH, Romero JR, Seshadri S. Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016. JAMA Neurol 2020;77:1252-60. [PMID: 32511690 DOI: 10.1001/jamaneurol.2020.1512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
171 Wang C, Zhang Y, Xing D, Zhang R. PROTACs technology for targeting non-oncoproteins: Advances and perspectives. Bioorg Chem 2021;114:105109. [PMID: 34175722 DOI: 10.1016/j.bioorg.2021.105109] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
172 Mortensen MB, Blaha MJ. Is There a Role of Coronary CTA in Primary Prevention? Current State and Future Directions. Curr Atheroscler Rep 2021;23:44. [PMID: 34146160 DOI: 10.1007/s11883-021-00943-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Zhou R, Stouffer GA, Smith SC Jr. Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes? J Cardiovasc Pharmacol Ther 2021;:10742484211023632. [PMID: 34138676 DOI: 10.1177/10742484211023632] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
174 Föhse FK, Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Hisdal J, Semb AG. Degree of arterial stiffness is comparable across inflammatory joint disease entities. Scand J Rheumatol 2021;:1-10. [PMID: 34132621 DOI: 10.1080/03009742.2021.1920169] [Reference Citation Analysis]
175 Wu Z, Huang Z, Lichtenstein AH, Liu Y, Chen S, Jin Y, Na M, Bao L, Wu S, Gao X. The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL. BMC Med 2021;19:142. [PMID: 34130689 DOI: 10.1186/s12916-021-02014-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Delshad Aghdam S, Siassi F, Nasli Esfahani E, Qorbani M, Rajab A, Sajjadpour Z, Bashiri A, Aghayan M, Sotoudeh G. Dietary phytochemical index associated with cardiovascular risk factor in patients with type 1 diabetes mellitus. BMC Cardiovasc Disord 2021;21:293. [PMID: 34118879 DOI: 10.1186/s12872-021-02106-2] [Reference Citation Analysis]
177 Lari A, Sohouli MH, Fatahi S, Cerqueira HS, Santos HO, Pourrajab B, Rezaei M, Saneie S, Rahideh ST. The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00253-2. [PMID: 34353704 DOI: 10.1016/j.numecd.2021.05.030] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
178 Chowdhury MZI, Turin TC. Precision health through prediction modelling: factors to consider before implementing a prediction model in clinical practice. J Prim Health Care 2020;12:3-9. [PMID: 32223844 DOI: 10.1071/HC19087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
179 Kim NH, Kim SG. Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction. Diabetes Metab J 2020;44:213-21. [PMID: 32347023 DOI: 10.4093/dmj.2020.0001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
180 Talic S, Marquina C, Ofori-Asenso R, Petrova M, Liew D, Owen AJ, Lybrand S, Thomson D, Ilomaki J, Zomer E, Ademi Z. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data. Cardiovasc Drugs Ther 2021. [PMID: 34097194 DOI: 10.1007/s10557-021-07199-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
181 Cho Y, Jeong Y, Seo DH, Ahn SH, Hong S, Suh YJ, Kim SH. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study. Atherosclerosis 2021;328:92-9. [PMID: 34126505 DOI: 10.1016/j.atherosclerosis.2021.05.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Huang R, Demarco JK, Ota H, Macedo TA, Abdelmoneim SS, Huston J, Pellikka PA, Mulvagh SL. Prognostic Value of Intraplaque Neovascularization Detected by Carotid Contrast-Enhanced Ultrasound in Patients Undergoing Stress Echocardiography. Journal of the American Society of Echocardiography 2021;34:614-24. [DOI: 10.1016/j.echo.2020.12.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
183 Malecki EA. Bile Acid Sequestrants Are Contraindicated for Patients With Hypertrigly-ceridemia: A Case Report. Am J Gastroenterol 2021;116:1352. [PMID: 33491957 DOI: 10.14309/ajg.0000000000001161] [Reference Citation Analysis]
184 Hess CN, Cannon CP, Beckman JA, Goodney PP, Patel MR, Hiatt WR, Mues KE, Orroth KK, Shannon E, Bonaca MP. Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. J Am Coll Cardiol 2021;77:3016-27. [PMID: 34140105 DOI: 10.1016/j.jacc.2021.04.060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
185 Gopaul VS, Pieterman EJ, Princen HMG, Bergenholm L, Lundborg E, Cavallin A, Johansson MJ, Hawthorne G, Björkbom A, Hammarberg M, Li X, Jarke A, Bright J, Svensson L, Jansson-Löfmark R, Abrahamsson B, Agrawal R, Hurt-Camejo E. Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs. Eur J Pharm Sci 2021;161:105776. [PMID: 33667667 DOI: 10.1016/j.ejps.2021.105776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Kocyigit D, Scanameo A, Xu B. Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond. Cardiovasc Diagn Ther 2021;11:840-58. [PMID: 34295709 DOI: 10.21037/cdt-19-654] [Reference Citation Analysis]
187 Li X, Wang G, Yan K, Yin S, Wang H, Wang Y, Bai X, Shen Y. The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound. Cancer Manag Res 2021;13:4329-40. [PMID: 34103988 DOI: 10.2147/CMAR.S301458] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
188 Khan AA, Sundar P, Natarajan B, Gupta V, Arige V, Reddy SS, Barthwal MK, Mahapatra NR. An evolutionarily-conserved promoter allele governs HMG-CoA reductase expression in spontaneously hypertensive rat. J Mol Cell Cardiol 2021;158:140-52. [PMID: 34081950 DOI: 10.1016/j.yjmcc.2021.05.017] [Reference Citation Analysis]
189 Smith MP. Cardioprotective effects of resistance training add to those of total activity in Americans. Ann Epidemiol 2021;62:13-8. [PMID: 34052437 DOI: 10.1016/j.annepidem.2021.05.007] [Reference Citation Analysis]
190 Chang CY, Lin FJ, Hong JL, Wu CH. Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia. Inquiry 2021;58:469580211019201. [PMID: 34036836 DOI: 10.1177/00469580211019201] [Reference Citation Analysis]
191 Schulz CA, Mavarani L, Reinsch N, Albayrak-Rena S, Potthoff A, Brockmeyer N, Hower M, Erbel R, Jöckel KH, Schmidt B, Esser S; HIV HEART Aging Study Group and Heinz Nixdorf Recall Investigative Group. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population. HIV Med 2021;22:732-41. [PMID: 34028959 DOI: 10.1111/hiv.13124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Santos RD, Pereira C, Cesena F, Laurinavicius AG, Tabone V, Bittencourt MS. Cardiovascular Risk Misperception and Low Awareness of Familial Hypercholesterolemia in Individuals with Severe Hypercholesterolemia. Arq Bras Cardiol 2021;116:706-12. [PMID: 33566934 DOI: 10.36660/abc.20190516] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
193 Prasongsukarn K, Dechkhajorn W, Benjathummarak S, Maneerat Y. TRPM2, PDLIM5, BCL3, CD14, GBA Genes as Feasible Markers for Premature Coronary Heart Disease Risk. Front Genet 2021;12:598296. [PMID: 34093636 DOI: 10.3389/fgene.2021.598296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Lloyd-Jones DM. Incorporating Coronary Calcium Scoring Into Risk Assessment For Primary Prevention. JACC Cardiovasc Imaging 2021;14:422-5. [PMID: 33541530 DOI: 10.1016/j.jcmg.2020.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Mortensen MB, Nordestgaard BG. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease. Eur Heart J 2020;41:3005-15. [PMID: 32227172 DOI: 10.1093/eurheartj/ehaa150] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
196 You A, Li Y, Tomlinson B, Yue L, Zhao K, Fan H, Liu Z, Zhang Y, Zheng L. Association Between Renal Dysfunction and Low HDL Cholesterol Among the Elderly in China. Front Cardiovasc Med 2021;8:644208. [PMID: 34055931 DOI: 10.3389/fcvm.2021.644208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Chun M, Clarke R, Cairns BJ, Clifton D, Bennett D, Chen Y, Guo Y, Pei P, Lv J, Yu C, Yang L, Li L, Chen Z, Zhu T; China Kadoorie Biobank Collaborative Group. Stroke risk prediction using machine learning: a prospective cohort study of 0.5 million Chinese adults. J Am Med Inform Assoc 2021;28:1719-27. [PMID: 33969418 DOI: 10.1093/jamia/ocab068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Talic S, Marquina Hernandez C, Ofori-Asenso R, Liew D, Owen A, Petrova M, Lybrand S, Thomson D, Ilomaki J, Ademi Z, Zomer E. Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data. Curr Probl Cardiol 2021;:100880. [PMID: 34108083 DOI: 10.1016/j.cpcardiol.2021.100880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
199 Golub I, Lakshmanan S, Dahal S, Budoff MJ. Utilizing coronary artery calcium to guide statin use. Atherosclerosis 2021;326:17-24. [PMID: 34000565 DOI: 10.1016/j.atherosclerosis.2021.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Tani S, Matsuo R, Imatake K, Suzuki Y, Yagi T, Takahashi A, Matsumoto N, Okumura Y. Gender differences in the associations among fish intake, lifestyle, and non-HDL-C level in Japanese subjects over the age of 50 years: Anti-atherosclerotic effect of fish consumption. Nutr Metab Cardiovasc Dis 2021;31:1434-44. [PMID: 33744037 DOI: 10.1016/j.numecd.2020.12.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
201 Schrader S, Perfilyev A, Martinell M, García-Calzón S, Ling C. Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes. Epigenomics 2021;13:919-25. [PMID: 33947200 DOI: 10.2217/epi-2020-0442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
202 Nasir K, Cainzos-Achirica M. Role of coronary artery calcium score in the primary prevention of cardiovascular disease. BMJ 2021;373:n776. [PMID: 33947652 DOI: 10.1136/bmj.n776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
203 Lee E, Lee MS, Chang E, Kim CT, Choi AJ, Kim IH, Kim Y. High hydrostatic pressure extract of mulberry leaves ameliorates hypercholesterolemia via modulating hepatic microRNA-33 expression and AMPK activity in high cholesterol diet fed rats. Food Nutr Res 2021;65. [PMID: 33994909 DOI: 10.29219/fnr.v65.7587] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
204 Wild RA, Hovey KM, Andrews C, Robinson JG, Kaunitz AM, Manson JE, Crandall CJ, Paragallo R, Shufelt C, Merz CNB. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause 2021;28:610-8. [PMID: 33950030 DOI: 10.1097/GME.0000000000001753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Noubiap JJ. Clustering of cardiometabolic risk factors in sub-Saharan Africans. Pan Afr Med J 2021;38:112. [PMID: 33912282 DOI: 10.11604/pamj.2021.38.112.28180] [Reference Citation Analysis]
206 Yadav HM, Park J, Kang H, Lee J. Recent Development in Nanomaterial-Based Electrochemical Sensors for Cholesterol Detection. Chemosensors 2021;9:98. [DOI: 10.3390/chemosensors9050098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
207 Manita D, Yoshida H, Koyama I, Nakamura M, Hirowatari Y. Verification of Low-Density Lipoprotein Cholesterol Levels Measured by Anion-Exchange High-Performance Liquid Chromatography in Comparison with Beta Quantification Reference Measurement Procedure. J Appl Lab Med 2021;6:654-67. [PMID: 33147343 DOI: 10.1093/jalm/jfaa144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Nikparvar M, Khaladeh M, Yousefi H, Vahidi Farashah M, Moayedi B, Kheirandish M. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci Rep 2021;11:9125. [PMID: 33911149 DOI: 10.1038/s41598-021-88680-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
209 Ünlütürk U, Savaş M, Oğuz SH, Samadi A, Fırlatan B, Yüce D, Lay İ, Gürlek A. Oxysterol species generated by auto-oxidation in subclinical hypothyroidism. Clin Biochem 2021;93:73-9. [PMID: 33861988 DOI: 10.1016/j.clinbiochem.2021.04.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Giannopoulos S, Armstrong EJ. Clinical considerations after endovascular therapy of peripheral artery disease. Expert Rev Cardiovasc Ther 2021;19:369-78. [PMID: 33870848 DOI: 10.1080/14779072.2021.1914590] [Reference Citation Analysis]
211 Haj S, Chodick G, Goren S, Na'amnih W, Shalev V, Muhsen K. Differences in glycated hemoglobin levels and cholesterol levels in individuals with diabetes according to Helicobacter pylori infection. Sci Rep 2021;11:8416. [PMID: 33875700 DOI: 10.1038/s41598-021-87808-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Flores VA, Pal L, Manson JE. Recommended Hormone Therapy in Menopause: Concepts, Controversies and Approach to Treatment. Endocr Rev 2021:bnab011. [PMID: 33858012 DOI: 10.1210/endrev/bnab011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
213 Idrizovic K, Ahmeti GB, Sekulic D, Zevrnja A, Ostojic L, Versic S, Zenic N. Indices of Cardiovascular Health, Body Composition and Aerobic Endurance in Young Women; Differential Effects of Two Endurance-Based Training Modalities. Healthcare (Basel) 2021;9:449. [PMID: 33920449 DOI: 10.3390/healthcare9040449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
214 Taron J, Foldyna B, Mayrhofer T, Osborne MT, Meyersohn N, Bittner DO, Puchner SB, Emami H, Lu MT, Ferencik M, Pagidipati NJ, Douglas PS, Hoffmann U. Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease. JACC Cardiovasc Imaging 2021:S1936-878X(21)00285-0. [PMID: 33865792 DOI: 10.1016/j.jcmg.2021.03.019] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
215 Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci 2021;22:3850. [PMID: 33917744 DOI: 10.3390/ijms22083850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
216 Ryou IS, Chang J, Son JS, Ko A, Choi S, Kim K, Kim SM, Park SM. Association between CVDs and initiation and adherence to statin treatment in patients with newly diagnosed hypercholesterolaemia: a retrospective cohort study. BMJ Open 2021;11:e045375. [PMID: 33827840 DOI: 10.1136/bmjopen-2020-045375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
217 Feldman DI, Wu KC, Hays AG, Marvel FA, Martin SS, Blumenthal RS, Sharma G. The Johns Hopkins Ciccarone Center's expanded 'ABC's approach to highlight 2020 updates in cardiovascular disease prevention. Am J Prev Cardiol 2021;6:100181. [PMID: 34327502 DOI: 10.1016/j.ajpc.2021.100181] [Reference Citation Analysis]
218 Kondo-Kawai A, Sakai T, Terao J, Mukai R. Suppressive effects of quercetin on hydrogen peroxide-induced caveolin-1 phosphorylation in endothelial cells. J Clin Biochem Nutr 2021;69:28-36. [PMID: 34376911 DOI: 10.3164/jcbn.20-190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Agha AM, Virani SS, Ballantyne CM. Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes 2021;28:114-21. [PMID: 33395089 DOI: 10.1097/MED.0000000000000608] [Reference Citation Analysis]
220 Guo LL, Chen YQ, Lin QZ, Tian F, Xiang QY, Zhu LY, Xu J, Wen T, Liu L. Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients. Front Cardiovasc Med 2021;8:649181. [PMID: 33869310 DOI: 10.3389/fcvm.2021.649181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Brotons C, Moral I, Fernández D, Puig M, Vilella MT, Puig T, Cuixart L, Férriz G, Pedro AM, Codinachs R, Rodríguez M, Fuentes R, On Behalf Of Inforisk Study Investigators. Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial. Int J Environ Res Public Health 2021;18:3621. [PMID: 33807285 DOI: 10.3390/ijerph18073621] [Reference Citation Analysis]
222 Thomson MJ, Serper M, Khungar V, Weiss LM, Trinh H, Firpi-Morell R, Roden M, Loomba R, Barritt AS 4th, Gazis D, Mospan AR, Fried MW, Reddy KR, Lok AS. Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00341-4. [PMID: 33775894 DOI: 10.1016/j.cgh.2021.03.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
223 Ducharme-smith K, Caulfield LE, Brady TM, Rosenstock S, Mueller NT, Garcia-larsen V. Higher Diet Quality in African-American Adolescents Is Associated with Lower Odds of Metabolic Syndrome: Evidence from the NHANES. The Journal of Nutrition 2021;151:1609-17. [DOI: 10.1093/jn/nxab027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Kaplan DE, Mehta R, Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G, Bajaj J, Hernaez R, Hunt K, Ioannou G, Johnson K, Kanwal F, Lee TH, Monto A, Pandya P, Schaubel D, Taddei TH. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation. Contemp Clin Trials 2021;104:106367. [PMID: 33771685 DOI: 10.1016/j.cct.2021.106367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
225 Boettiger DC, Newall AT, Chattranukulchai P, Chaiwarith R, Khusuwan S, Avihingsanon A, Phillips A, Bendavid E, Law MG, Kahn JG, Ross J, Bautista-Arredondo S, Kiertiburanakul S. Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis. J Int AIDS Soc 2020;23 Suppl 1:e25494. [PMID: 32562359 DOI: 10.1002/jia2.25494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
226 Karimi Galougahi K, Chadban S, Mehran R, Bangalore S, Chertow GM, Ali ZA. Invasive Management of Coronary Artery Disease in Advanced Renal Disease. Kidney Int Rep 2021;6:1513-24. [PMID: 34169192 DOI: 10.1016/j.ekir.2021.02.041] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
227 Axon DR, Johnson M, Abeln B, Forbes S, Anderson EJ, Taylor AM, Aseret-Manygoats T, Warholak T, Hall-Lipsy E. An Academic-Community Collaboration to Deliver Medication Therapy Management (MTM) Services to Patients Living in Rural Counties of a Southwestern State in the United States. J Pharm Pract 2021;:8971900211000219. [PMID: 33759609 DOI: 10.1177/08971900211000219] [Reference Citation Analysis]
228 Mehta RS, Kochar BD, Kennelty K, Ernst ME, Chan AT. Emerging approaches to polypharmacy among older adults. Nat Aging 2021;1:347-56. [DOI: 10.1038/s43587-021-00045-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
229 Oh JH, Lee JH, Cho MS, Kim H, Chun J, Lee JH, Yoon Y, Kang W. Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. Nutrients 2021;13:1013. [PMID: 33801023 DOI: 10.3390/nu13031013] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
230 Wu T, Ye J, Gong X, Li X, Shao C, Li F, Lin Y, Ma Q, Mai W, Wang W, Feng ST, Zhong B. Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Dig Liver Dis 2021:S1590-8658(21)00055-4. [PMID: 33744170 DOI: 10.1016/j.dld.2021.02.003] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
231 Mack DS, Hume AL, Tjia J, Lapane KL. National Trends in Statin Use among the United States Nursing Home Population (2011-2016). Drugs Aging 2021;38:427-39. [PMID: 33694105 DOI: 10.1007/s40266-021-00844-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Motawea A, Ahmed DAM, Eladl AS, El-Mansy AAE, Saleh NM. Appraisal of amiodarone-loaded PLGA nanoparticles for prospective safety and toxicity in a rat model. Life Sci 2021;274:119344. [PMID: 33716062 DOI: 10.1016/j.lfs.2021.119344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Lohia P, Kapur S, Benjaram S, Mir T. Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching. J Clin Lipidol 2021;15:451-9. [PMID: 33726984 DOI: 10.1016/j.jacl.2021.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
234 Burén J, Ericsson M, Damasceno NRT, Sjödin A. A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial. Nutrients 2021;13:814. [PMID: 33801247 DOI: 10.3390/nu13030814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
235 Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, Gouni-Berthold I, Heiman ML, Kautzky-Willer A, Klein SL, Murphy A, Regitz-Zagrosek V, Reue K, Rubin JB. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacol Rev 2021;73:730-62. [PMID: 33653873 DOI: 10.1124/pharmrev.120.000206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
236 Shipe ME, Maiga AW, Deppen SA, Edwards GC, Marmor HN, Pinkerman R, Smith GT, Lio E, Wright JL, Shah C, Nesbitt JC, Grogan EL. Preoperative coronary artery calcifications in veterans predict higher all-cause mortality in early-stage lung cancer: a cohort study. J Thorac Dis 2021;13:1427-33. [PMID: 33841935 DOI: 10.21037/jtd-20-2102] [Reference Citation Analysis]
237 Oh TK, Song IA. Drug-specific and dosage effects of statins and the risk of cancer: a population-based cohort study in South Korea. Eur J Cancer Prev 2021;30:188-94. [PMID: 32483011 DOI: 10.1097/CEJ.0000000000000600] [Reference Citation Analysis]
238 Black JA, Campbell JA, Parker S, Sharman JE, Nelson MR, Otahal P, Hamilton G, Marwick TH. Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinic. Med J Aust 2021;214:266-71. [PMID: 33622026 DOI: 10.5694/mja2.50960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
239 Mohottige D, Diamantidis CJ, Norris KC, Boulware LE. Racism and Kidney Health: Turning Equity Into a Reality. Am J Kidney Dis 2021;77:951-62. [PMID: 33639186 DOI: 10.1053/j.ajkd.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
240 Knudsen AD, Krebs-Demmer L, Bjørge NID, Elming MB, Gelpi M, Sigvardsen PE, Lebech AM, Fuchs A, Kühl JT, Køber L, Lundgren J, Nordestgaard BG, Kofoed KF, Nielsen SD. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. J Infect Dis 2020;222:54-61. [PMID: 32027374 DOI: 10.1093/infdis/jiaa057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
241 Skajaa N, Schønfeldt Troelsen F, Pedersen L, Ekholm O, Strate LL, Erichsen R, Sørensen HT. Statins and risk of diverticular disease: Nested case-control study. Pharmacoepidemiol Drug Saf 2021;30:770-8. [PMID: 33583126 DOI: 10.1002/pds.5205] [Reference Citation Analysis]
242 Zhao X, Chen Y, Li L, Zhai J, Yu B, Wang H, Yang D, Wang Q, Chang Y, Li J, Zhang P, Zhang H, Li Y. Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota. J Cardiovasc Pharmacol 2021;77:458-69. [PMID: 33657052 DOI: 10.1097/FJC.0000000000000970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
243 Cavero-Redondo I, Deeks JJ, Alvarez-Bueno C, Jolly K, Saz-Lara A, Price M, Pascual-Morena C, Martínez-Vizcaíno V. Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis. PLoS Med 2021;18:e1003543. [PMID: 33591983 DOI: 10.1371/journal.pmed.1003543] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
244 Giannopoulos S, Armstrong EJ. Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia. Vasc Med 2021;26:210-24. [PMID: 33587692 DOI: 10.1177/1358863X20987612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Lou J, Wang Y, Li L, Zeng D. Learning latent heterogeneity for type 2 diabetes patients using longitudinal health markers in electronic health records. Stat Med 2021;40:1930-46. [PMID: 33586187 DOI: 10.1002/sim.8880] [Reference Citation Analysis]
246 Naghipour M, Joukar F, Salari A, Asgharnezhad M, Hassanipour S, Mansour-Ghanaei F. Epidemiologic Profile of Hypertension in Northern Iranian Population: The PERSIAN Guilan Cohort Study (PGCS). Ann Glob Health 2021;87:14. [PMID: 33614420 DOI: 10.5334/aogh.3027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Zeitouni M, Nanna MG, Sun JL, Chiswell K, Peterson ED, Navar AM. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults. J Am Coll Cardiol 2020;76:653-64. [PMID: 32762899 DOI: 10.1016/j.jacc.2020.06.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
248 Hiremath S, Velez JCQ. Preventing a nonexistent entity: the curious case of contrast and acute kidney injury. Curr Opin Nephrol Hypertens 2020;29:152-60. [PMID: 31725007 DOI: 10.1097/MNH.0000000000000562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
249 Tiarukkitsagul J, Sungkanuparph S. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting. Int J STD AIDS 2021;32:421-6. [PMID: 33533302 DOI: 10.1177/0956462420972855] [Reference Citation Analysis]
250 Mack DS, Baek J, Tjia J, Lapane KL. Geographic Variation of Statin Use Among US Nursing Home Residents With Life-limiting Illness. Med Care 2021;59:425-36. [PMID: 33560713 DOI: 10.1097/MLR.0000000000001505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Zhao X, Wang D, Qin L. Lipid profile and prognosis in patients with coronary heart disease: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord 2021;21:69. [PMID: 33535982 DOI: 10.1186/s12872-020-01835-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
252 Sud M, Han L, Koh M, Abdel-Qadir H, Austin PC, Farkouh ME, Godoy LC, Lawler PR, Udell JA, Wijeysundera HC, Ko DT. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention. J Am Coll Cardiol 2020;76:1440-50. [PMID: 32943162 DOI: 10.1016/j.jacc.2020.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
253 Scott FI, Vajravelu RK, Mamtani R, Bianchina N, Mahmoud N, Hou JK, Wu Q, Wang X, Haynes K, Lewis JD. Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction. JAMA Netw Open 2021;4:e2036315. [PMID: 33533930 DOI: 10.1001/jamanetworkopen.2020.36315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
254 Sun L, Parikh RB, Hubbard RA, Cashy J, Takvorian SU, Vaughn DJ, Robinson KW, Narayan V, Ky B. Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer. JAMA Netw Open 2021;4:e210070. [PMID: 33625512 DOI: 10.1001/jamanetworkopen.2021.0070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
255 Alsuhibani A, Albogami Y, Diaby V, Friedman J, Vouri SM. Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort study. Surg Obes Relat Dis 2021;17:939-46. [PMID: 33648887 DOI: 10.1016/j.soard.2021.01.025] [Reference Citation Analysis]
256 Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol 2021;5:100149. [PMID: 34327491 DOI: 10.1016/j.ajpc.2021.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
257 Liang W, Zhang P, Liu M. Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease. BMC Geriatr 2021;21:75. [PMID: 33482738 DOI: 10.1186/s12877-021-02018-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
258 Zhao Y, Yang YY, Yang BL, Du YW, Ren DW, Zhou HM, Wang J, Yang HM, Wang YX, Zhang YY, Wu SX. Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial. Trials 2021;22:85. [PMID: 33482853 DOI: 10.1186/s13063-021-05028-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Shawish MI, Bagheri B, Musini VM, Adams SP, Wright JM. Effect of atorvastatin on testosterone levels. Cochrane Database Syst Rev 2021;1:CD013211. [PMID: 33482034 DOI: 10.1002/14651858.CD013211.pub2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
260 Ko DT, Sivaswamy A, Sud M, Kotrri G, Azizi P, Koh M, Austin PC, Lee DS, Roifman I, Thanassoulis G, Tu K, Udell JA, Wijeysundera HC, Anderson TJ. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations. CMAJ 2020;192:E442-9. [PMID: 32392491 DOI: 10.1503/cmaj.190848] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
261 Park J, Lee SH, Han S, Oh AR, Lee SK, Choi GS, Park MS, Carriere K, Ahn J, Kim GS. An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure. Sci Rep 2021;11:959. [PMID: 33441656 DOI: 10.1038/s41598-020-79673-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Jarrah MI, Ababneh MJ, Tawalbeh LI, Hammoudeh AJ, Barukba HM, Othman A. Statin eligibility based on the ACC/AHA guidelines among Middle Eastern patients with diabetes mellitus presenting with acute myocardial infarction. Ann Med Surg (Lond) 2021;61:148-54. [PMID: 33425348 DOI: 10.1016/j.amsu.2020.12.036] [Reference Citation Analysis]
263 Aguilar-Ballester M, Hurtado-Genovés G, Taberner-Cortés A, Herrero-Cervera A, Martínez-Hervás S, González-Navarro H. Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia. Int J Mol Sci 2021;22:E660. [PMID: 33440821 DOI: 10.3390/ijms22020660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
264 Trivedi LU, Femnou Mbuntum L, Halm EA, Mansi I. Is Statin Use Associated With Risk of Thyroid Diseases? Results of a Retrospective Cohort Study. Ann Pharmacother 2021;55:1110-9. [PMID: 33412925 DOI: 10.1177/1060028020986552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Zhang H, Zhang Y, Chen X, Li J, Zhang Z, Yu H. Effects of statins on cytokines levels in gingival crevicular fluid and saliva and on clinical periodontal parameters of middle-aged and elderly patients with type 2 diabetes mellitus. PLoS One 2021;16:e0244806. [PMID: 33417619 DOI: 10.1371/journal.pone.0244806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020;31:171-90. [PMID: 31959335 DOI: 10.1016/j.annonc.2019.10.023] [Cited by in Crossref: 164] [Cited by in F6Publishing: 239] [Article Influence: 164.0] [Reference Citation Analysis]
267 Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther 2021. [PMID: 33400053 DOI: 10.1007/s10557-020-07125-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
268 Li R, Yuan M, Yu S, Fu W, Yu W, Ling S, Sun J, Chen Y. Effect of statins on the risk of recurrent venous thromboembolism: A systematic review and meta-analysis. Pharmacol Res 2021;165:105413. [PMID: 33412275 DOI: 10.1016/j.phrs.2020.105413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
269 Hirano M, Berardo A, Barca E, Emmanuele V, Quinzii C, Simpson CV, Engelstad K, Rosales XQ, Thompson JLP. Regulatory environment for novel therapeutic development in mitochondrial diseases. J Inherit Metab Dis 2021;44:292-300. [PMID: 33368420 DOI: 10.1002/jimd.12353] [Reference Citation Analysis]
270 Chang Y, Liu Q, Zhou Z, Ding Y, Yang M, Xu W, Chen K, Zhang Q, Wang Z, Li H. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis. Technol Cancer Res Treat 2020;19:1533033820934881. [PMID: 32552476 DOI: 10.1177/1533033820934881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
271 Hinerman AS, El Khoudary SR, Wahed AS, Courcoulas AP, Barinas-Mitchell EJM, King WC. Predictors of change in cardiovascular disease risk and events following gastric bypass: a 7-year prospective multicenter study. Surg Obes Relat Dis 2021;17:910-8. [PMID: 33582036 DOI: 10.1016/j.soard.2020.12.013] [Reference Citation Analysis]
272 Levin MG, Klarin D, Assimes TL, Freiberg MS, Ingelsson E, Lynch J, Natarajan P, O'Donnell C, Rader DJ, Tsao PS, Chang KM, Voight BF, Damrauer SM; VA Million Veteran Program. Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study. JAMA Netw Open 2021;4:e2034461. [PMID: 33464320 DOI: 10.1001/jamanetworkopen.2020.34461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
273 Lenze EJ, Nicol GE, Barbour DL, Kannampallil T, Wong AWK, Piccirillo J, Drysdale AT, Sylvester CM, Haddad R, Miller JP, Low CA, Lenze SN, Freedland KE, Rodebaugh TL. Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders. J Psychiatry Neurosci 2021;46:E97-E110. [PMID: 33206039 DOI: 10.1503/jpn.200042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
274 Meng H, Wang Y, Zhou F, Ruan J, Duan M, Wang X, Yu Q, Yang P, Chen W, Meng F. Reduced Serum Zinc Ion Concentration Is Associated with Coronary Heart Disease. Biol Trace Elem Res 2021. [PMID: 33387273 DOI: 10.1007/s12011-020-02551-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
275 Hsiao Y, Wu C. Dyslipidemia and Cardiometabolic Syndrome. Cardiometab Syndr J 2021;1:18. [DOI: 10.51789/cmsj.2021.1.e2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
276 Pawlos A, Broncel M, Wlazłowska E, Jabłonowska E, Gorzelak-Pabiś P. Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations. PLoS One 2020;15:e0244675. [PMID: 33373417 DOI: 10.1371/journal.pone.0244675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
277 López-Melgar B, Fernández-Friera L, Oliva B, García-Ruiz JM, Sánchez-Cabo F, Bueno H, Mendiguren JM, Lara-Pezzi E, Andrés V, Ibáñez B, Fernández-Ortiz A, Sanz J, Fuster V. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis. J Am Coll Cardiol 2020;75:1617-27. [PMID: 32273027 DOI: 10.1016/j.jacc.2020.02.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
278 Li YH, Tseng WK, Yin WH, Lin FJ, Wu YW, Hsieh IC, Lin TH, Sheu WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment. Sci Rep 2020;10:21835. [PMID: 33318590 DOI: 10.1038/s41598-020-78828-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Orban M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, Schramm R, Tippmann K, Hein-Rothweiler R, Strüven A, Lehner A, Braun D, Hausleiter J, Jakob A, Fischer M, Hagl C, Haas N, Massberg S, Mehilli J, Robert DP. Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography. Int J Cardiol 2021;328:227-34. [PMID: 33316256 DOI: 10.1016/j.ijcard.2020.12.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
280 Joseph T, Hale G, Moreau C, Rosario ED, Logan N, Perez A. Evaluating a Pharmacist-Led Intervention on Cardiovascular- and Diabetes-Related Quality Measures in a Primary Care-Based Accountable Care Organization. J Pharm Pract 2020;:897190020977740. [PMID: 33302778 DOI: 10.1177/0897190020977740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
281 Cho YA, Han JM, Kang SY, Kim DC, Youn YJ, Choi KH, Gwak HS. Analysis of Risk Factors for Hepatotoxicity Induced by Immune Checkpoint Inhibitors. J Immunother 2021;44:16-21. [PMID: 33290362 DOI: 10.1097/CJI.0000000000000347] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
282 Curtis JR, Xie F, Crowson CS, Sasso EH, Hitraya E, Chin CL, Bamford RD, Ben-Shachar R, Gutin A, Flake DD 2nd, Mabey B, Lanchbury JS. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients. Arthritis Res Ther 2020;22:282. [PMID: 33276814 DOI: 10.1186/s13075-020-02355-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
283 Mack DS, Baek J, Tjia J, Lapane KL. Statin Discontinuation and Life-Limiting Illness in Non-Skilled Stay Nursing Homes at Admission. J Am Geriatr Soc 2020;68:2787-96. [PMID: 33270223 DOI: 10.1111/jgs.16777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
284 Jeong IK, Kim SR. Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study). Endocrinol Metab (Seoul) 2020;35:882-91. [PMID: 33261312 DOI: 10.3803/EnM.2020.723] [Reference Citation Analysis]
285 Huang Z, Shui X, Ling Y, Zhou L, Shi W, Luo Y, Li S, Zhu J, Yu S, Liu J. Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention. Clin Cardiol 2020. [PMID: 33289114 DOI: 10.1002/clc.23520] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
286 Rajan T, Rozanski A, Cainzos-Achirica M, Grandhi GR, Dardari ZA, Al-Mallah MH, Blankstein R, Miedema MD, Shaw LJ, Rumberger JA, Budoff MJ, Blaha MJ, Berman D, Nasir K. Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk Among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines. Am J Cardiol 2020;136:49-55. [PMID: 32941817 DOI: 10.1016/j.amjcard.2020.08.050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Guo L, Zheng J, Zeng H, Zhang Z, Shao G. Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1. Oncol Lett 2021;21:82. [PMID: 33363619 DOI: 10.3892/ol.2020.12343] [Reference Citation Analysis]
288 Sadeghi C, Khan HA, Gudleski G, Reynolds JL, Bakhai SY. Multifaceted strategies to improve blood pressure control in a primary care clinic: A quality improvement project. Int J Cardiol Hypertens 2020;7:100060. [PMID: 33447781 DOI: 10.1016/j.ijchy.2020.100060] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Langslet G, Hovingh GK, Guyton JR, Baccara-Dinet MT, Letierce A, Manvelian G, Farnier M. Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study. Cardiovasc Drugs Ther 2020;34:515-23. [PMID: 32363493 DOI: 10.1007/s10557-020-06984-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
290 Bhagavathula AS, Clark C, Rahmani J. Statin use and new-onset of inflammatory bowel disease: A systematic review and meta-analysis of over ten million participants. Eur J Pharmacol 2021;891:173750. [PMID: 33245900 DOI: 10.1016/j.ejphar.2020.173750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
291 Sotos-Prieto M, Ruiz-Canela M, Song Y, Christophi C, Mofatt S, Rodriguez-Artalejo F, Kales SN. The Effects of a Mediterranean Diet Intervention on Targeted Plasma Metabolic Biomarkers among US Firefighters: A Pilot Cluster-Randomized Trial. Nutrients 2020;12:E3610. [PMID: 33255353 DOI: 10.3390/nu12123610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
292 Gaudet D, López-sendón JL, Averna M, Bigot G, Banach M, Letierce A, Loy M, Samuel R, Manvelian G, Batsu I, Henry P. Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study. European Journal of Preventive Cardiology 2020. [DOI: 10.1093/eurjpc/zwaa097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
293 Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, Reges O. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality. Am J Med 2021;134:643-52. [PMID: 33217370 DOI: 10.1016/j.amjmed.2020.09.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
294 Forcadell Drago E, Dalmau Llorca MR, Aguilar Martín C, Ferreira-González I, Hernández Rojas Z, Gonçalves AQ, López-Pablo C. Impact of Implementing a Dyslipidemia Management Guideline on Cholesterol Control for Secondary Prevention of Ischemic Heart Disease in Primary Care. Int J Environ Res Public Health 2020;17:E8590. [PMID: 33228008 DOI: 10.3390/ijerph17228590] [Reference Citation Analysis]
295 Rachamin Y, Markun S, Grischott T, Rosemann T, Meier R. Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study. J Clin Med 2020;9:E3719. [PMID: 33228169 DOI: 10.3390/jcm9113719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Stiekema LCA, Stroes ESG, Verweij SL, Kassahun H, Chen L, Wasserman SM, Sabatine MS, Mani V, Fayad ZA. Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment. Eur Heart J 2019;40:2775-81. [PMID: 30561610 DOI: 10.1093/eurheartj/ehy862] [Cited by in Crossref: 51] [Cited by in F6Publishing: 62] [Article Influence: 25.5] [Reference Citation Analysis]
297 Shaik Alavudeen S, Alshahrani SM, Vigneshwaran E, Abdulla Khan N, Mir JI, Hussein ATM. Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non-interventional comparative study. Int J Clin Pract 2021;75:e13802. [PMID: 33112452 DOI: 10.1111/ijcp.13802] [Reference Citation Analysis]
298 Kim HL, Lim WH, Seo JB, Kim SH, Zo JH, Kim MA. Prognostic value of arterial stiffness according to the cardiovascular risk profiles. J Hum Hypertens 2021;35:978-84. [PMID: 33184487 DOI: 10.1038/s41371-020-00441-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
299 Rababa'h AM, Mustafa R, Rabab'ah M, Khasawneh M, Ababneh M, Khraisha S, Altarabsheh SE. Evaluation of physician's knowledge in Jordan about the ACC/AHA blood cholesterol guidelines. Int J Clin Pract 2021;75:e13784. [PMID: 33095960 DOI: 10.1111/ijcp.13784] [Reference Citation Analysis]
300 Sitasuwan T, Lertwattanarak R. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand. BMJ Open 2020;10:e041269. [PMID: 33172945 DOI: 10.1136/bmjopen-2020-041269] [Reference Citation Analysis]
301 Ahmed ST, Akeroyd JM, Mahtta D, Street R, Slagle J, Navar AM, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects. J Am Heart Assoc 2020;9:e017915. [PMID: 33170055 DOI: 10.1161/JAHA.120.017915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
302 Moon J, Cohen Sedgh R, Jackevicius CA. Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System. Circ Cardiovasc Qual Outcomes 2021;14:e007480. [PMID: 33161769 DOI: 10.1161/CIRCOUTCOMES.120.007480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
303 Orlando LA, Wu RR, Myers RA, Neuner J, McCarty C, Haller IV, Harry M, Fulda KG, Dimmock D, Rakhra-Burris T, Buchanan A, Ginsburg GS. At the intersection of precision medicine and population health: an implementation-effectiveness study of family health history based systematic risk assessment in primary care. BMC Health Serv Res 2020;20:1015. [PMID: 33160339 DOI: 10.1186/s12913-020-05868-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
304 Wu DF, Lin D, Lu F, Liao QC, Wu YJ, Wang Z, Yu K, Li WJ, Deng JL. Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Pharmgenomics Pers Med 2020;13:553-61. [PMID: 33154658 DOI: 10.2147/PGPM.S273346] [Reference Citation Analysis]
305 Saadati H, Baradaran HR, Danaei G, Ostovar A, Hadaegh F, Janani L, Steyerberg EW, Khalili D. Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease. BMC Med Inform Decis Mak 2020;20:288. [PMID: 33148227 DOI: 10.1186/s12911-020-01304-w] [Reference Citation Analysis]
306 Bavishi A, Lloyd-Jones DM, Ning H, Vu THT, Yancy CW, Shah SJ, Carnethon M, Khan SS. Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure. PLoS One 2020;15:e0240567. [PMID: 33141828 DOI: 10.1371/journal.pone.0240567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
307 Yao X, Shah ND, Gersh BJ, Lopez-Jimenez F, Noseworthy PA. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016. JAMA Netw Open 2020;3:e2025505. [PMID: 33216139 DOI: 10.1001/jamanetworkopen.2020.25505] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
308 Chinthammit C, Axon DR, Anderson S, Lott B, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ. A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans. Journal of Clinical Lipidology 2020;14:791-8. [DOI: 10.1016/j.jacl.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Vega GL, Wang J, Grundy SM. Chronic kidney disease and statin eligibility. J Clin Lipidol 2021;15:173-80. [PMID: 33191195 DOI: 10.1016/j.jacl.2020.10.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
310 Ahmed MAA, Almirall J, Ngangue P, Poitras ME, Fortin M. A bibliometric analysis of multimorbidity from 2005 to 2019. J Comorb 2020;10:2235042X20965283. [PMID: 33110764 DOI: 10.1177/2235042X20965283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Menon V, Kumar A, Patel DR, St John J, Riesmeyer J, Weerakkody G, Ruotolo G, Wolski KE, McErlean E, Cremer PC, Nicholls SJ, Lincoff AM, Nissen SE. Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial. BMJ Open Diabetes Res Care 2020;8:e000943. [PMID: 32179516 DOI: 10.1136/bmjdrc-2019-000943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
312 Zhao Y, Xiang P, Coll B, López JAG, Wong ND. Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease. J Diabetes Complications 2021;35:107767. [PMID: 33168394 DOI: 10.1016/j.jdiacomp.2020.107767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Ding QY, Tian JX, Li M, Lian FM, Zhao LH, Wei XX, Han L, Zheng YJ, Gao ZZ, Yang HY, Fang XY, Tong XL. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Front Cell Infect Microbiol 2020;10:530160. [PMID: 33194785 DOI: 10.3389/fcimb.2020.530160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
314 Waheed N, Elias-Smale S, Malas W, Maas AH, Sedlak TL, Tremmel J, Mehta PK. Sex differences in non-obstructive coronary artery disease. Cardiovasc Res 2020;116:829-40. [PMID: 31958135 DOI: 10.1093/cvr/cvaa001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
315 DeWitt CM, Ponce RB, Bry H, Wali S, Sedlander E, Ladapo JA. Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy. J Clin Med 2020;9:E3337. [PMID: 33080939 DOI: 10.3390/jcm9103337] [Reference Citation Analysis]
316 García-Sánchez E, Rubio-Arias JÁ, Ávila-Gandía V, López-Román FJ, Menarguez-Puche JF. Effects of Two Community-Based Exercise Programs on Adherence, Cardiometabolic Markers, and Body Composition in Older People with Cardiovascular Risk Factors: A Prospective Observational Cohort Study. J Pers Med 2020;10:E176. [PMID: 33081361 DOI: 10.3390/jpm10040176] [Reference Citation Analysis]
317 Camargo A, Vals-Delgado C, Alcala-Diaz JF, Villasanta-Gonzalez A, Gomez-Delgado F, Haro C, Leon-Acuña A, Cardelo MP, Torres-Peña JD, Guler I, Malagon MM, Ordovas JM, Perez-Martinez P, Delgado-Lista J, Lopez-Miranda J. A Diet-Dependent Microbiota Profile Associated with Incident Type 2 Diabetes: From the CORDIOPREV Study. Mol Nutr Food Res 2020;:e2000730. [PMID: 33064356 DOI: 10.1002/mnfr.202000730] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
318 Ko SH, Lee JS, Kim SK, Jeong KY. Serum cholesterol as a predictor of mortality among the elderly patients with pneumonia in the emergency department. Am J Emerg Med 2021;45:404-9. [PMID: 33039214 DOI: 10.1016/j.ajem.2020.09.012] [Reference Citation Analysis]
319 Muñoz AE, Pollarsky F, Marino M, Cartier M, Míguez C, Vázquez H, Álvarez D, Salgado P, Romero G. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury. Dig Dis Sci 2021;66:3199-208. [DOI: 10.1007/s10620-020-06630-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
320 Płatek T, Polus A, Góralska J, Raźny U, Gruca A, Kieć-Wilk B, Zabielski P, Kapusta M, Słowińska-Solnica K, Solnica B, Malczewska-Malec M, Dembińska-Kieć A. DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia. Mol Med 2020;26:93. [PMID: 33028190 DOI: 10.1186/s10020-020-00220-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
321 Bengaluru Jayanna M, Robinson JG. The extent to which statins have improved cardiovascular outcomes: Lessons from randomized trials and observational studies of "real world" practice in people with diabetes. Diabetes Obes Metab 2019;21 Suppl 1:17-27. [PMID: 31002457 DOI: 10.1111/dom.13701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
322 Kaolawanich Y, Boonyasirinant T. Impact of aortic stiffness by velocity-encoded magnetic resonance imaging on late gadolinium enhancement to predict cardiovascular events. Int J Cardiol Heart Vasc 2020;30:100635. [PMID: 33015313 DOI: 10.1016/j.ijcha.2020.100635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
323 Darwesh AM, Bassiouni W, Sosnowski DK, Seubert JM. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol Ther 2021;219:107703. [PMID: 33031856 DOI: 10.1016/j.pharmthera.2020.107703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
324 Nesti L, Mengozzi A, Natali A. Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective. Am J Cardiovasc Drugs 2020;20:405-12. [PMID: 31840213 DOI: 10.1007/s40256-019-00391-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Zhang P, Su Q, Ye X, Guan P, Chen C, Hang Y, Dong J, Xu Z, Hu W. Trends in LDL-C and Non-HDL-C Levels with Age. Aging Dis 2020;11:1046-57. [PMID: 33014521 DOI: 10.14336/AD.2019.1025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
326 Lavu S, Therneau TM, Harmsen WS, Mara KC, Wongjarupong N, Hassan M, Ali HA, Antwi S, Giama NH, Miyabe K, Roberts LR. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma. Hepatology 2020;72:1298-309. [PMID: 32119126 DOI: 10.1002/hep.31146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
327 Eid WE, Sapp EH, McCreless T, Nolan JR, Flerlage E. Prevalence and Characteristics of Patients With Primary Severe Hypercholesterolemia in a Multidisciplinary Healthcare System. Am J Cardiol 2020;132:59-65. [PMID: 32773228 DOI: 10.1016/j.amjcard.2020.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
328 Giglio RV, Nikolic D, Volti GL, Stoian AP, Banerjee Y, Magan-Fernandez A, Castellino G, Patti AM, Chianetta R, Castracani CC, Montalto G, Rizvi AA, Sesti G, Rizzo M. Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites 2020;10:E391. [PMID: 33008044 DOI: 10.3390/metabo10100391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
329 Shehab A, Bhagavathula AS, Elnour AA, Al-Rasadi K, Al-Shamsi S. The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study. Curr Vasc Pharmacol 2020;18:193-9. [PMID: 30963975 DOI: 10.2174/1570161117666190408164908] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
330 Tunoa JA, Billups SJ, Lowe RN, Saseen JJ. Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation. J Clin Lipidol 2020;14:784-90. [PMID: 32978094 DOI: 10.1016/j.jacl.2020.09.001] [Reference Citation Analysis]
331 Suruga K, Miyoshi T, Kotani K, Ichikawa K, Miki T, Osawa K, Ejiri K, Toda H, Nakamura K, Morita H, Ito H. Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography. Int J Cardiol 2021;324:193-8. [PMID: 32987049 DOI: 10.1016/j.ijcard.2020.09.060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
332 Oktora MP, Kerr KP, Hak E, Denig P. Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review. Diabet Med 2021;38:e14408. [PMID: 32969063 DOI: 10.1111/dme.14408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
333 Siniscalchi C, Suriñach JM, Visonà A, Fernández-Reyes JL, Gómez-Cuervo C, Verhamme P, Marchena PJ, Farge-Bancel D, Moisés J, Monreal M; and the RIETE Investigators . Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry. TH Open 2020;4:e236-44. [PMID: 32964178 DOI: 10.1055/s-0040-1716734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Yebyo HG, Zappacosta S, Aschmann HE, Haile SR, Puhan MA. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study. BMC Cardiovasc Disord 2020;20:418. [PMID: 32942999 DOI: 10.1186/s12872-020-01697-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Güner A, Zehir R, Kalçik M, Uslu A, Ösken A, Kalkan AK, Güner EG. Eosinophil percentage as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. IMAS 2020;11:146-53. [DOI: 10.1556/1646.11.2019.17] [Reference Citation Analysis]
336 Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020;313:126-36. [PMID: 33045618 DOI: 10.1016/j.atherosclerosis.2020.09.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
337 Lee HW, Kang WY, Jung W, Gwon MR, Cho K, Yang DH, Yoon YR, Seong SJ. Evaluation of the Pharmacokinetic Drug-Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers. Pharmaceutics 2020;12:E869. [PMID: 32932576 DOI: 10.3390/pharmaceutics12090869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
338 Adamson PD, Newby DE. Non-invasive imaging of the coronary arteries. Eur Heart J 2019;40:2444-54. [PMID: 30388261 DOI: 10.1093/eurheartj/ehy670] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
339 Yaghooti-Khorasani M, Ghazizadeh H, Bijari M, Mohammadi-Bajgiran M, Oladi MR, Zare-Feizabadi R, Timar A, Nazarpour S, Khedmatgozar H, Rohban M, Hasanzadeh E, Javandoost A, Banpoor H, Sheikh Andalibi MS, Moazedi S, Mosalman-Zadeh N, Aghasizadeh M, Ferns GA, Esmaily H, Ghayour-Mobarhan M. Evaluation of ABO blood group in subjects with CVD risk factors in a population sample from northeastern Iran. Diabetes Metab Syndr 2020;14:1689-95. [PMID: 32905941 DOI: 10.1016/j.dsx.2020.08.031] [Reference Citation Analysis]
340 Singh M, McEvoy JW, Khan SU, Wood DA, Graham IM, Blumenthal RS, Mishra AK, Michos ED. Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines. Mayo Clin Proc 2020;95:998-1014. [PMID: 32370858 DOI: 10.1016/j.mayocp.2020.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
341 Lee KA, Park TS, Jin HY. Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy. Endocrine 2020;70:465-78. [PMID: 32895875 DOI: 10.1007/s12020-020-02473-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
342 Naresh S, Bitla AR, Rao PVLNS, Sachan A, Amancharla YL. Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus. Endocrine 2021;71:76-86. [PMID: 32895874 DOI: 10.1007/s12020-020-02472-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
343 Fleming ML, Rege S, Johnson ML, Serna O, Esse T, Choi J, Abughosh SM. Examination of physicians' adherence to the 2013 ACC/AHA statin/cholesterol guidelines using a framework of awareness to adherence: A cross-sectional study. JRSM Cardiovasc Dis 2020;9:2048004020947298. [PMID: 32874555 DOI: 10.1177/2048004020947298] [Reference Citation Analysis]
344 Tangelloju S, Little BB, Esterhay RJ, Brock G, LaJoie S. Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years. Diabetes Metab Res Rev 2020;36:e3310. [PMID: 32162770 DOI: 10.1002/dmrr.3310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
345 Du J, Du J, She Q, Deng S. Spontaneous Coronary Artery Dissection with Iliac Artery Dissection: A Case Report and Literature Review. Cardiovascular Innovations and Applications 2020;5:57-61. [DOI: 10.15212/cvia.2019.0583] [Reference Citation Analysis]
346 Niu J, Deng C, Zheng R, Xu M, Lu J, Wang T, Zhao Z, Chen Y, Wang S, Dai M, Xu Y, Wang W, Ning G, Bi Y, Li M. The Association and Predictive Ability of ECG Abnormalities with Cardiovascular Diseases: A Prospective Analysis. Glob Heart 2020;15:59. [PMID: 32923352 DOI: 10.5334/gh.790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
347 Fiolet ATL, Silvis MJM, Opstal TSJ, Bax WA, van der Horst FAL, Mosterd A, de Kleijn D, Cornel JH. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein. PLoS One 2020;15:e0237665. [PMID: 32866166 DOI: 10.1371/journal.pone.0237665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
348 Ferrières J, Lautsch D, Bramlage P, Horack M, Baxter CA, Ambegaonkar B, Toth PP, Poh KK, De Ferrari GM, Gitt AK. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome. Arch Cardiovasc Dis 2020;113:617-29. [PMID: 32873522 DOI: 10.1016/j.acvd.2020.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Tomita Y, Lee D, Miwa Y, Jiang X, Ohta M, Tsubota K, Kurihara T. Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy. Int J Mol Sci 2020;21:E6243. [PMID: 32872333 DOI: 10.3390/ijms21176243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
350 Cassagnol M, Hai O, Sherali SA, D’Angelo K, Bass D, Zeltser R, Makaryus AN. Impact of cardiologist intervention on guideline-directed use of statin therapy. World J Cardiol 2020; 12(8): 419-426 [PMID: 32879704 DOI: 10.4330/wjc.v12.i8.419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
351 Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, Michos ED, Itchhaporia D, Nasir K, Alam M, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther 2020;34:745-54. [PMID: 32840709 DOI: 10.1007/s10557-020-07057-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
352 Engeda JC, Lhachimi SK, Rosamond WD, Lund JL, Keyserling TC, Safford MM, Colantonio LD, Muntner P, Avery CL, Aminde L. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study. PLoS Med 2020;17:e1003280. [DOI: 10.1371/journal.pmed.1003280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
353 Levintow SN, Reading SR, Saul BC, Yu Y, Reams D, McGrath LJ, Philip K, Dluzniewski PJ, Brookhart MA. Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines. Clin Epidemiol 2020;12:835-45. [PMID: 32801921 DOI: 10.2147/CLEP.S259757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
354 Jørstad HT, Snaterse M, Ter Hoeve N, Sunamura M, Brouwers R, Kemps H, Scholte Op Reimer WJM, Peters RJG. The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands. Neth Heart J 2020;28:136-40. [PMID: 32780344 DOI: 10.1007/s12471-020-01450-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
355 Al-Musharaf S, Aljuraiban GS, Danish Hussain S, Alnaami AM, Saravanan P, Al-Daghri N. Low Serum Vitamin B12 Levels Are Associated with Adverse Lipid Profiles in Apparently Healthy Young Saudi Women. Nutrients 2020;12:E2395. [PMID: 32785129 DOI: 10.3390/nu12082395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
356 Silverio A, Benvenga RM, Piscione F, Gulizia MM, Meessen JMTA, Colivicchi F, Nardi F, Baldi C, Galasso G, Vecchione C, Di Lenarda A, Gabrielli D, De Luca L. Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry. J Cardiovasc Pharmacol Ther 2021;26:149-57. [PMID: 32757779 DOI: 10.1177/1074248420947633] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
357 Schindler TH, Bateman TM, Berman DS, Chareonthaitawee P, De Blanche LE, Dilsizian V, Dorbala S, Gropler RJ, Shaw L, Soman P, Winchester DE, Verberne H, Ahuja S, Beanlands RS, Di Carli MF, Murthy VL, Ruddy TD, Schwartz RG. Appropriate Use Criteria for PET Myocardial Perfusion Imaging. J Nucl Med 2020;61:1221-65. [PMID: 32747510 DOI: 10.2967/jnumed.120.246280] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
358 German CA, Shapiro MD. Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science. Eur Cardiol 2020;15:e56. [PMID: 32742310 DOI: 10.15420/ecr.2019.18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
359 Chbat J, Ezzat S, Papi G. Subclinical hypothyroidism. Minerva Endocrinol (Torino) 2021;46:238-42. [PMID: 32744440 DOI: 10.23736/S2724-6507.20.03176-4] [Reference Citation Analysis]
360 Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Netw Open 2020;3:e2011051. [PMID: 32816031 DOI: 10.1001/jamanetworkopen.2020.11051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
361 Sahebkar A, Cicero AFG, Di Giosia P, Pomilio I, Stamerra CA, Giorgini P, Ferri C, von Haehling S, Banach M, Jamialahmadi T. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. J Cachexia Sarcopenia Muscle 2020;11:1177-86. [PMID: 32743965 DOI: 10.1002/jcsm.12579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
362 Blankstein R, Singh A. Cholesterol Guidelines. Journal of the American College of Cardiology 2020;76:665-8. [DOI: 10.1016/j.jacc.2020.06.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
363 Hamad R, Penko J, Kazi DS, Coxson P, Guzman D, Wei PC, Mason A, Wang EA, Goldman L, Fiscella K, Bibbins-Domingo K. Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults. JAMA Cardiol 2020;5:899-908. [PMID: 32459344 DOI: 10.1001/jamacardio.2020.1458] [Cited by in Crossref: 17] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
364 Su ZL, Hang PZ, Hu J, Zheng YY, Sun HQ, Guo J, Liu KY, Du ZM. Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats. Acta Pharmacol Sin 2020;41:1085-92. [PMID: 32203084 DOI: 10.1038/s41401-020-0392-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
365 Dong S, Pei B, Xie W, Wang J, Zeng Q. Anticardiolipin antibody and anti-β2 glycoprotein I antibody are potential risk markers of ischaemic stroke in Chinese adults. Rheumatology (Oxford) 2020;59:1834-41. [PMID: 31722435 DOI: 10.1093/rheumatology/kez551] [Reference Citation Analysis]
366 Daghem M, Newby DE. Innovation in medical imaging to improve disease staging, therapeutic intervention, and clinical outcomes. Atherosclerosis 2020;306:75-84. [DOI: 10.1016/j.atherosclerosis.2020.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
367 Asgedom SW, Gidey K, Gidey K, Niriayo YL, Desta DM, Atey TM. Medical complications and mortality of hospitalized stroke patients. Journal of Stroke and Cerebrovascular Diseases 2020;29:104990. [DOI: 10.1016/j.jstrokecerebrovasdis.2020.104990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
368 Dai L, Liu A, Zhang H, Wu H, Zhang T, Su B, Shao Y, Li J, Ye J, Scott SR, Mahajan SD, Schwartz SA, Yu H, Sun L. Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study. Curr HIV Res 2019;17:324-34. [PMID: 31654514 DOI: 10.2174/1570162X17666191025115508] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
369 Chu CS, Law SH, Lenzen D, Tan YH, Weng SF, Ito E, Wu JC, Chen CH, Chan HC, Ke LY. Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis. Biomedicines 2020;8:E254. [PMID: 32751498 DOI: 10.3390/biomedicines8080254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
370 Thomas LE, Yang S, Wojdyla D, Schaubel DE. Matching with time-dependent treatments: A review and look forward. Stat Med 2020;39:2350-70. [PMID: 32242973 DOI: 10.1002/sim.8533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
371 Vattimo ACA, Fonseca FAH, Morais DC, Generoso LF, Herrera R, Barbosa CM, de Oliveira Izar MC, Cardoso RA, Zung S. Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial. Curr Ther Res Clin Exp 2020;93:100595. [PMID: 32904162 DOI: 10.1016/j.curtheres.2020.100595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
372 Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev 2020;159:4-33. [PMID: 32730849 DOI: 10.1016/j.addr.2020.07.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
373 Vaughan EM, Hyman DJ, Naik AD, Samson SL, Razjouyan J, Foreyt JP. A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial. J Gen Intern Med 2021;36:455-63. [PMID: 32700217 DOI: 10.1007/s11606-020-06017-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
374 Minetti G. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections. Med Hypotheses 2020;144:110128. [PMID: 32758903 DOI: 10.1016/j.mehy.2020.110128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
375 Khan SU, Rahman H, Okunrintemi V, Riaz H, Khan MS, Sattur S, Kaluski E, Lincoff AM, Martin SS, Blaha MJ. Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2019;8:e011581. [PMID: 30898075 DOI: 10.1161/JAHA.118.011581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
376 Liu CJ, Huang HS. Statins significantly alter urinary stone-related urine biochemistry in calcium kidney stone patients with dyslipidemia. Int J Urol 2020;27:839-44. [PMID: 32681579 DOI: 10.1111/iju.14312] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
377 Seo DY, Heo JW, No MH, Yoo SZ, Ko JR, Park DH, Kang JH, Kim CJ, Jung SJ, Han J, Kwak HB. Exercise Training Protects against Atorvastatin-Induced Skeletal Muscle Dysfunction and Mitochondrial Dysfunction in the Skeletal Muscle of Rats. J Clin Med 2020;9:E2292. [PMID: 32707695 DOI: 10.3390/jcm9072292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
378 Ostermann J, Mühlbacher A, Brown DS, Regier DA, Hobbie A, Weinhold A, Alshareef N, Derrick C, Thielman NM. Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment. Value Health 2020;23:851-61. [PMID: 32762986 DOI: 10.1016/j.jval.2020.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
379 Bach RG, Cannon CP, Giugliano RP, White JA, Lokhnygina Y, Bohula EA, Califf RM, Braunwald E, Blazing MA. Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.JAMA Cardiol. 2019;4:846-854. [PMID: 31314050 DOI: 10.1001/jamacardio.2019.2306] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
380 Udhaya Kumar S, Thirumal Kumar D, Bithia R, Sankar S, Magesh R, Sidenna M, George Priya Doss C, Zayed H. Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach. Front Genet 2020;11:734. [PMID: 32760426 DOI: 10.3389/fgene.2020.00734] [Cited by in Crossref: 23] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
381 Cho JM, Chae J, Jeong SR, Moon MJ, Ha KC, Kim S, Lee JH. The cholesterol-lowering effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline-high cholesterol levels: a randomized controlled trial. Lipids Health Dis 2020;19:166. [PMID: 32646501 DOI: 10.1186/s12944-020-01338-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
382 Meier R, Rachamin Y, Rosemann T, Markun S. The Impact of the 2019 European Guideline for Cardiovascular Risk Management: A Cross-Sectional Study in General Practice. J Clin Med 2020;9:E2140. [PMID: 32645925 DOI: 10.3390/jcm9072140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
383 Yang YS, Lee SY, Kim JS, Choi KM, Lee KW, Lee SC, Cho JR, Oh SJ, Kim JH, Choi SH. Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments. Endocrinol Metab (Seoul) 2020;35:367-76. [PMID: 32615721 DOI: 10.3803/EnM.2020.35.2.367] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
384 Liew JW, Reveille JD, Castillo M, Sawhney H, Naovarat BS, Heckbert SR, Gensler LS. Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study. J Rheumatol 2021;48:361-6. [PMID: 32611668 DOI: 10.3899/jrheum.200188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
385 Tu R, Hou J, Liu X, Li R, Dong X, Pan M, Mao Z, Huo W, Chen G, Guo Y, Li S, Wang C. Physical activity attenuated association of air pollution with estimated 10-year atherosclerotic cardiovascular disease risk in a large rural Chinese adult population: A cross-sectional study. Environment International 2020;140:105819. [DOI: 10.1016/j.envint.2020.105819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
386 Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System. JAMA Netw Open 2020;3:e208236. [PMID: 32662843 DOI: 10.1001/jamanetworkopen.2020.8236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
387 Velz J, Esposito G, Wegener S, Kulcsar Z, Luft A, Regli L. Diagnostisches und therapeutisches Handeln bei Karotisstenose. Praxis 2020;109:705-23. [DOI: 10.1024/1661-8157/a003475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
388 Gitto S, De Maria N, Marzi L, Magistri P, Falcini M, Vitale G, Olivieri T, Guerrini GP, Serra V, Forte P, Carrai P, De Simone P, Mega A, Zoller H, Piai G, Schepis F, Marocchi M, Villa E, Marra F, Andreone P, Di Benedetto F; other members of MEDITRA research group. Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study. Eur J Intern Med 2020;79:70-5. [PMID: 32616342 DOI: 10.1016/j.ejim.2020.05.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
389 Abbasnezhad A, Hasanavand A, Falahi E, Kashkooli S, Asbaghi O, Choghakhori R. Effect of L-Carnitine Supplementation on Lipid Profiles of Patients with Liver Disease: A Systematic Review and Meta-Analysis. Prev Nutr Food Sci 2020;25:124-32. [PMID: 32676462 DOI: 10.3746/pnf.2020.25.2.124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
390 Seo J, Choi SI, Kim YK. Subclinical Coronary Atherosclerosis: Implication of Coronary Computed Tomography Angiography Findings among Statin Candidates according to the 2013 ACC/AHA Cholesterol Management Guidelines. Korean J Radiol 2019;20:1156-66. [PMID: 31270979 DOI: 10.3348/kjr.2018.0016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
391 Kim S, Choi H, Won CW. Effects of Statin Use for Primary Prevention among Adults Aged 75 Years and Older in the National Health Insurance Service Senior Cohort (2002-2015). Ann Geriatr Med Res 2020;24:91-8. [PMID: 32743329 DOI: 10.4235/agmr.20.0028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
392 Hyun MH, Jang JW, Lee E, An H, Seog Seo H. Baseline, delta, and achieved low-density lipoprotein cholesterol levels and cardiovascular risk in patients on statin therapy: A post-hoc resampling mediation analysis of treating new targets [TNT] trial. Clin Exp Pharmacol Physiol 2020;47:1649-58. [PMID: 32583886 DOI: 10.1111/1440-1681.13367] [Reference Citation Analysis]
393 Wang KN, Bell JS, Tan EC, Gilmartin-Thomas JF, Dooley MJ, Ilomäki J. Statin use and fall-related hospitalizations among residents of long-term care facilities: A case-control study. J Clin Lipidol 2020;14:507-14. [PMID: 32571729 DOI: 10.1016/j.jacl.2020.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
394 Shakoor H, Khan MI, Sahar A, Khan MKI, Faiz F, Basheer Ahmad H. Development of omega-3 rich eggs through dietary flaxseed and bio-evaluation in metabolic syndrome. Food Sci Nutr 2020;8:2619-26. [PMID: 32566179 DOI: 10.1002/fsn3.1522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
395 Gupta VA, Alnabelsi TS, Shringi S, Leung SW, Sorrell VL. Cardiovascular Risk After Sepsis: Understanding the Role of Statin Indications and the Impact of Clinical Inertia on Prescribing Patterns. J Cardiovasc Pharmacol Ther 2020;25:541-7. [PMID: 32551836 DOI: 10.1177/1074248420933395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
396 Tanner RM, Colantonio LD, Kilgore ML, Mefford MT, Chachappan DT, Mues KE, Safford MM, Rosenson RS, Muntner P. Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Clin Lipidol 2020;14:720-9. [PMID: 32680814 DOI: 10.1016/j.jacl.2020.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
397 Mathew RO, Rosenson RS, Lyubarova R, Chaudhry R, Costa SP, Bangalore S, Sidhu MS. Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease. Cardiovasc Drugs Ther 2021;35:479-89. [PMID: 32556851 DOI: 10.1007/s10557-020-07020-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
398 Szoeke C, Goodwill AM, Gorelik A, Dennerstein L, Caeyenberghs K, Simpson S, Hill E, Campbell S. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women. J Alzheimers Dis 2019;68:105-14. [PMID: 30689578 DOI: 10.3233/JAD-180815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
399 Mo J, Chen Z, Xu J, Wang A, Meng X, Zhao X, Li H, Wu S, Wang Y. The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study. Aging (Albany NY) 2020;12:11990-2001. [PMID: 32544081 DOI: 10.18632/aging.103365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
400 Irawati S, Prayudeni S, Rachmawati R, Wita IW, Willfert B, Hak E, Taxis K. Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia. BMJ Open 2020;10:e035098. [PMID: 32540888 DOI: 10.1136/bmjopen-2019-035098] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
401 Altamimi M, Zidan S, Badrasawi M. Effect of Tree Nuts Consumption on Serum Lipid Profile in Hyperlipidemic Individuals: A Systematic Review. Nutr Metab Insights 2020;13:1178638820926521. [PMID: 32595280 DOI: 10.1177/1178638820926521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
402 Yousufuddin M, Young N. Aging and ischemic stroke. Aging (Albany NY) 2019;11:2542-4. [PMID: 31043575 DOI: 10.18632/aging.101931] [Cited by in F6Publishing: 67] [Reference Citation Analysis]
403 Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study. J Natl Cancer Inst 2019;111:854-62. [PMID: 30715404 DOI: 10.1093/jnci/djy218] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
404 Bødtker H, Gunnersen S, Adelborg K, Kulenovic I, Kanstrup H, Falk E, Bruun JM, Mortensen MB. Association between lipid fractions and age of first myocardial infarction. Scand Cardiovasc J 2020;54:346-51. [PMID: 32483990 DOI: 10.1080/14017431.2020.1770850] [Reference Citation Analysis]
405 Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Whitbourn R, Zirlik A, Zeller T, Stawowy P, Cohen SA, Fahy M, Böhm M. Renal Denervation in High-Risk Patients With Hypertension. Journal of the American College of Cardiology 2020;75:2879-88. [DOI: 10.1016/j.jacc.2020.04.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 11.5] [Reference Citation Analysis]
406 Mourikis P, Zako S, Dannenberg L, Nia AM, Heinen Y, Busch L, Richter H, Hohlfeld T, Zeus T, Kelm M, Polzin A. Lipid lowering therapy in cardiovascular disease: From myth to molecular reality. Pharmacol Ther 2020;213:107592. [PMID: 32492513 DOI: 10.1016/j.pharmthera.2020.107592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
407 Hwang YC. Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9). Diabetes Metab J 2019;43:915-6. [PMID: 31902151 DOI: 10.4093/dmj.2019.0213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
408 Tiniakou E. Statin-Associated Autoimmune Myopathy: Current Perspectives. Ther Clin Risk Manag 2020;16:483-92. [PMID: 32581543 DOI: 10.2147/TCRM.S197941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
409 Kolovou GD, Watts GF, Mikhailidis DP, Pérez-Martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text. Curr Vasc Pharmacol 2019;17:498-514. [PMID: 31060488 DOI: 10.2174/1570161117666190507110519] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
410 Meah MN, Dweck MR, Newby DE. Cardiovascular imaging to guide primary prevention. Heart 2020;106:1267-75. [PMID: 32451365 DOI: 10.1136/heartjnl-2019-316217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
411 Patel N, Bhargava A, Kalra R, Parcha V, Arora G, Muntner P, Arora P. Trends in Lipid, Lipoproteins, and Statin Use Among U.S. Adults: Impact of 2013 Cholesterol Guidelines. J Am Coll Cardiol. 2019;74:2525-2528. [PMID: 31727291 DOI: 10.1016/j.jacc.2019.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
412 Salerno AG, van Solingen C, Scotti E, Wanschel ACBA, Afonso MS, Oldebeken SR, Spiro W, Tontonoz P, Rayner KJ, Moore KJ. LDL Receptor Pathway Regulation by miR-224 and miR-520d. Front Cardiovasc Med 2020;7:81. [PMID: 32528976 DOI: 10.3389/fcvm.2020.00081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
413 Doneen AL, Bale BF, Vigerust DJ, Leimgruber PP. Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification. Front Cardiovasc Med 2020;7:92. [PMID: 32528979 DOI: 10.3389/fcvm.2020.00092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
414 Kohlman-Trigoboff D, Rich K, Foley A, Fitzgerald K, Arizmendi D, Robinson C, Brown R, Treat-Jacobson D; Society for Vascular Nursing Practice and Research Committee. Society for Vascular Nursing endovascular repair of abdominal aortic aneurysm updated nursing clinical practice guideline. J Vasc Nurs 2020;38:36-65. [PMID: 32534654 DOI: 10.1016/j.jvn.2020.01.004] [Reference Citation Analysis]
415 Lee S, Lee MS, Chang E, Lee Y, Lee J, Kim J, Kim CT, Kim IH, Kim Y. Mulberry Fruit Extract Promotes Serum HDL-Cholesterol Levels and Suppresses Hepatic microRNA-33 Expression in Rats Fed High Cholesterol/Cholic Acid Diet. Nutrients 2020;12:E1499. [PMID: 32455724 DOI: 10.3390/nu12051499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
416 Bae SS, Oganesian B, Golub I, Charles-Schoeman C. Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study. Clin Cardiol 2020;43:732-42. [PMID: 32432360 DOI: 10.1002/clc.23375] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
417 Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH;  Conference Participants. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;74:1823-1838. [PMID: 31582143 DOI: 10.1016/j.jacc.2019.08.1017] [Cited by in Crossref: 116] [Cited by in F6Publishing: 168] [Article Influence: 58.0] [Reference Citation Analysis]
418 Chiu SW, Pratt CM, Feinn R, Chatterjee S. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled Trials. J Cardiovasc Pharmacol Ther 2020;25:409-17. [DOI: 10.1177/1074248420924983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
419 Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, Situ S, Shadmehr M, Hashemzadeh M. State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications. Cardiovasc Drugs Ther 2019;33:625-39. [PMID: 31773344 DOI: 10.1007/s10557-019-06904-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
420 Wu Z, Wu D, Jiang J, Chen A, Zheng DD, Li J, Dong Y, Chen Y. Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study. BMJ Open 2020;10:e034585. [PMID: 32423930 DOI: 10.1136/bmjopen-2019-034585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
421 Feldman DI, Pacor JM, Blumenthal RS, Nasir K. 2019 clinical trials in lipid lowering. Curr Opin Cardiol 2020;35:319-24. [PMID: 32412963 DOI: 10.1097/HCO.0000000000000757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Verdoia M, Galasso G, Filardi PP, De Luca G. Statins and Elderly: From Clinical Trials to Daily Practice. Curr Vasc Pharmacol 2019;17:233-8. [PMID: 29956633 DOI: 10.2174/1570161116666180628145723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
423 Fitch KV. Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV. Curr HIV/AIDS Rep 2019;16:482-91. [PMID: 31776973 DOI: 10.1007/s11904-019-00467-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
424 Zhang D, Ding Y, Wang X, Xin W, Du W, Chen W, Zhang X, Li P. Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin. Eur J Clin Pharmacol 2020;76:939-46. [PMID: 32361904 DOI: 10.1007/s00228-020-02882-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
425 Zhu Y, Hu H, Yang J, Yao Q, Xu H, Yu Y, Liu T, Lin S. The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis. Bosn J Basic Med Sci 2020;20:169-82. [PMID: 31668143 DOI: 10.17305/bjbms.2019.4437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
426 Wang K, Feng C, Wu Y, Huang J, Xiao W, Xia S. Statin Pretreatment Might Be Associated with Decreased Myocardial Injury After Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 2020;29:104697. [DOI: 10.1016/j.jstrokecerebrovasdis.2020.104697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
427 Klimchak AC, Patel MY, Iorga ŞR, Kulkarni N, Wong ND. Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States. Am J Prev Cardiol 2020;1:100010. [PMID: 34327452 DOI: 10.1016/j.ajpc.2020.100010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
428 Cannon CP. Low-Density Lipoprotein Cholesterol. Journal of the American College of Cardiology 2020;75:2119-21. [DOI: 10.1016/j.jacc.2020.03.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
429 Wong ND. Cardiovascular risk assessment: The foundation of preventive cardiology. Am J Prev Cardiol 2020;1:100008. [PMID: 34327451 DOI: 10.1016/j.ajpc.2020.100008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
430 Phan BAP, Ma Y, Scherzer R, Deeks SG, Hsue PY. Association between statin use, atherosclerosis, and mortality in HIV-infected adults. PLoS One 2020;15:e0232636. [PMID: 32353062 DOI: 10.1371/journal.pone.0232636] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
431 Eltonsy S, Doiron MD, Simard P, Jose C, Sénéchal M, Bouchard DR, LeBlanc R, Bélanger M. Comparing the Effect of Combining Exercise with Rosuvastatin versus Atorvastatin on Lipid Profile and Functional Capacity: A Retrospective Cohort Study. Biomed Res Int 2020;2020:7026530. [PMID: 32420363 DOI: 10.1155/2020/7026530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
432 Kwon TG, Jang AY, Kim SW, Hong YJ, Bae JH, Lee SY, Kim SH, Han SH. Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study. Trials 2020;21:353. [PMID: 32321551 DOI: 10.1186/s13063-020-04291-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
433 Li M, Yang Y, Zhao Q, Wu Y, Song L, Yang H, He M, Gao H, Song B, Luo J, Rao Y. Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase. J Med Chem 2020;63:4908-28. [DOI: 10.1021/acs.jmedchem.0c00339] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
434 Caimmi C, De Marchi S, Bosello SL, Giuggioli D, Caramaschi P, Di Giorgio A, Spinella A, Astorino G, Canestrari G, Cocchiara E, Gremese E, Viapiana O, Rossini M. Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients. Int J Rheum Dis 2020;23:681-92. [DOI: 10.1111/1756-185x.13824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
435 Hinerman AS, Barinas-Mitchell EJM, El Khoudary SR, Courcoulas AP, Wahed AS, King WC. Change in predicted 10-year and lifetime cardiovascular disease risk after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2020;16:1011-21. [PMID: 32475754 DOI: 10.1016/j.soard.2020.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
436 Zhong G, Huang S, Peng Y, Wan L, Wu Y, Hu T, Hu J, Hao F. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies. Eur J Prev Cardiolog 2020;27:1187-203. [DOI: 10.1177/2047487320914756] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
437 Olivieri C. The current state of heart disease: statins, cholesterol, fat and sugar. Int J Evid Based Healthc 2019;17:179-86. [PMID: 31318717 DOI: 10.1097/XEB.0000000000000197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
438 Khan AA, Agarwal H, Reddy SS, Arige V, Natarajan B, Gupta V, Kalyani A, Barthwal MK, Mahapatra NR. MicroRNA 27a Is a Key Modulator of Cholesterol Biosynthesis. Mol Cell Biol 2020;40:e00470-19. [PMID: 32071155 DOI: 10.1128/MCB.00470-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
439 Smolenski S, George NM. Management of ketosis-prone type 2 diabetes mellitus. J Am Assoc Nurse Pract 2019;31:430-6. [PMID: 30829978 DOI: 10.1097/JXX.0000000000000183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
440 Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts HJWL, Mak RH. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. J Am Coll Cardiol 2019;73:2976-87. [PMID: 31196455 DOI: 10.1016/j.jacc.2019.03.500] [Cited by in Crossref: 54] [Cited by in F6Publishing: 86] [Article Influence: 27.0] [Reference Citation Analysis]
441 Sedlak T, Herscovici R, Cook-Wiens G, Handberg E, Wei J, Shufelt C, Bittner V, Reis SE, Reichek N, Pepine C, Bairey Merz CN. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation). J Am Heart Assoc 2020;9:e013234. [PMID: 32268814 DOI: 10.1161/JAHA.119.013234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
442 Laukkanen JA, Voutilainen A, Kurl S, Araujo CGS, Jae SY, Kunutsor SK. Handgrip strength is inversely associated with fatal cardiovascular and all-cause mortality events. Ann Med 2020;52:109-19. [PMID: 32223654 DOI: 10.1080/07853890.2020.1748220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
443 Park H, Lee JS, Hong K, Cho Y, Park J, Kang K, Lee SJ, Kim JG, Cha J, Kim D, Nah H, Han M, Kim BJ, Park TH, Park S, Lee KB, Lee J, Lee B, Yu K, Oh MS, Kim J, Choi K, Kim D, Ryu W, Choi JC, Kwon J, Kim W, Shin D, Sohn SI, Hong J, Lee J, Gorelick PB, Bae H. Statin therapy in acute cardioembolic stroke with no guidance-based indication. Neurology 2020;94:e1984-95. [DOI: 10.1212/wnl.0000000000009397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
444 Zimmer DP, Shea CM, Tobin JV, Tchernychev B, Germano P, Sykes K, Banijamali AR, Jacobson S, Bernier SG, Sarno R, Carvalho A, Chien YT, Graul R, Buys ES, Jones JE, Wakefield JD, Price GM, Chickering JG, Milne GT, Currie MG, Masferrer JL. Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease. Front Pharmacol 2020;11:419. [PMID: 32322204 DOI: 10.3389/fphar.2020.00419] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
445 Annemans L, Azuri J, Al-Rasadi K, Al-Zakwani I, Daclin V, Mercier F, Danchin N. Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS). Lipids Health Dis 2020;19:64. [PMID: 32264883 DOI: 10.1186/s12944-020-01235-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
446 Jeong HY, Lee SY, Kim SH, Kim J. Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study. Patient Prefer Adherence 2020;14:717-24. [PMID: 32308376 DOI: 10.2147/PPA.S245324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
447 Villette R, Kc P, Beliard S, Salas Tapia MF, Rainteau D, Guerin M, Lesnik P. Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels. Front Pharmacol 2020;11:278. [PMID: 32308619 DOI: 10.3389/fphar.2020.00278] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
448 Vitali F, Li Q, Schissler AG, Berghout J, Kenost C, Lussier YA. Developing a 'personalome' for precision medicine: emerging methods that compute interpretable effect sizes from single-subject transcriptomes. Brief Bioinform 2019;20:789-805. [PMID: 29272327 DOI: 10.1093/bib/bbx149] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
449 Liu F, Du GL, Song N, Ma YT, Li XM, Gao XM, Yang YN. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012). Lipids Health Dis 2020;19:58. [PMID: 32238146 DOI: 10.1186/s12944-020-01211-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
450 Kokkinidis DG, Armstrong EJ. Current developments in endovascular therapy of peripheral vascular disease. J Thorac Dis 2020;12:1681-94. [PMID: 32395311 DOI: 10.21037/jtd.2019.12.130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
451 Shehab A, Bhagavathula AS. Statin Therapy and Low-Density Lipoprotein Cholesterol Reduction after Acute Coronary Syndrome: Insights from the United Arab Emirates. Heart Views 2020;21:80-7. [PMID: 33014300 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_115_19] [Reference Citation Analysis]
452 Jhee JH, Joo YS, Park JT, Yoo TH, Park SK, Jung JY, Kim SW, Oh YK, Oh KH, Kang SW, Choi KH, Ahn C, Han SH. Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease. Kidney Res Clin Pract 2020;39:93-102. [PMID: 32182639 DOI: 10.23876/j.krcp.20.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
453 Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, De Leeuw P, Fendrikova-Mahlay N, Froehlich J, Ganesh SK, Gray BH, Jamison C, Januszewicz A, Jeunemaitre X, Kadian-Dodov D, Kim ESH, Kovacic JC, Mace P, Morganti A, Sharma A, Southerland AM, Touzé E, Van der Niepen P, Wang J, Weinberg I, Wilson S, Olin JW, Plouin PF; Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). First international consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 2019;37:229-52. [PMID: 30640867 DOI: 10.1097/HJH.0000000000002019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 21.0] [Reference Citation Analysis]
454 Koutroumpakis E, Gosmanova EO, Stahura H, Jou S, Alreshq R, Ata A, Sidhu MS, Philbin E, Boden WE, Lyubarova R. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease. Cardiovasc Drugs Ther 2019;33:443-51. [PMID: 31123935 DOI: 10.1007/s10557-019-06883-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
455 Chen PS, Lin SH, Lee CH, Lin HW, Li YH. Efficacy and Safety of High-intensity Statins in Patients With Acute Myocardial Infarction: An Asian Perspective. Can J Cardiol 2020;36:886-92. [PMID: 32204951 DOI: 10.1016/j.cjca.2019.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Feng L, Nian S, Tong Z, Zhu Y, Li Y, Zhang C, Bai X, Luo X, Wu M, Yan Z. Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ Open 2020;10:e034226. [PMID: 32193266 DOI: 10.1136/bmjopen-2019-034226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
457 Liu J, Yang W, Li Y, Wei Z, Dan X. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population. BMC Med Genet 2020;21:54. [PMID: 32183743 DOI: 10.1186/s12881-020-0987-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
458 Yousufuddin M, Zhu Y, Al Ward R, Peters J, Doyle T, Jensen KL, Wang Z, Murad MH. Association of hyperlipidaemia with 5-year survival after hospitalisation for acute myocardial infarction: a propensity score matched analysis. Open Heart 2020;7:e001163. [PMID: 32206316 DOI: 10.1136/openhrt-2019-001163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
459 Zaric B, Obradovic M, Trpkovic A, Banach M, Mikhailidis DP, Isenovic ER. Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications. CMC 2020;27:1021-40. [DOI: 10.2174/0929867326666190903112146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
460 Jia X, Ramsey DJ, Rifai MA, Ahmed ST, Akeroyd JM, Dixon DL, Gluckman TJ, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol 2020;125:874-9. [PMID: 31952841 DOI: 10.1016/j.amjcard.2019.12.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
461 Bae J, Hong N, Lee BW, Kang ES, Cha BS, Lee YH. Comparison of Renal Effects of Ezetimibe-Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis. J Clin Med 2020;9:E798. [PMID: 32183405 DOI: 10.3390/jcm9030798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
462 Solomon MD, Leong TK, Levin E, Rana JS, Jaffe MG, Sidney S, Sung SH, Lee C, DeMaria A, Go AS. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc 2020;9:e014415. [PMID: 32131689 DOI: 10.1161/JAHA.119.014415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
463 Modolo R, Chichareon P, Kogame N, Dressler O, Crowley A, Ben-Yehuda O, Puskas J, Banning A, Taggart DP, Kappetein AP, Sabik JA, Onuma Y, Stone GW, Serruys PW. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease. J Am Coll Cardiol 2019;73:1877-86. [PMID: 30999989 DOI: 10.1016/j.jacc.2018.12.090] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
464 Kalra R, Parcha V, Patel N, Bhargava A, Booker KS, Arora G, Arora P. Increased awareness, inadequate treatment, and poor control of cardiovascular risk factors in American young adults: 2005-2016. Eur J Prev Cardiol 2021;28:304-12. [PMID: 33891685 DOI: 10.1177/2047487320905190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
465 Wongsalap Y, Jedsadayanmata A. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome. Journal of Cardiology 2020;75:275-81. [DOI: 10.1016/j.jjcc.2019.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
466 Patel T, Baydoun H, Patel NK, Tripathi B, Nanavaty S, Savani S, Mojadidi MK, Agarwal N, Patel G, Patel S, Pancholy S. Peripheral Arterial Disease in Women: The Gender Effect. Cardiovascular Revascularization Medicine 2020;21:404-8. [DOI: 10.1016/j.carrev.2019.05.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
467 Spann N, Hamper J, Griffith R, Cleveland K, Flynn T, Jindrich K. Independent pharmacist prescribing of statins for patients with type 2 diabetes: An analysis of enhanced pharmacist prescriptive authority in Idaho. J Am Pharm Assoc (2003) 2020;60:S108-S114.e1. [PMID: 32127253 DOI: 10.1016/j.japh.2019.12.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
468 Miao B, Hernandez AV, Roman YM, Alberts MJ, Coleman CI, Baker WL. Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation. Clin Cardiol 2020;43:524-31. [PMID: 32106334 DOI: 10.1002/clc.23344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
469 Sidebottom AC, Vacquier MC, Jensen JC, Bradley SM, Knickelbine T, Strauss C, Miedema MD. Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system. Clin Cardiol 2020;43:560-7. [PMID: 32104922 DOI: 10.1002/clc.23347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
470 Rhodes JM, LoRe VA 3rd, Mato AR, Chong EA, Barrientos JC, Gerson JN, Barta SK, Landsburg DJ, Nasta SD, Svoboda J, Loren AW, Schuster SJ. Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes. Clin Lymphoma Myeloma Leuk 2020;20:438-444.e1. [PMID: 32197990 DOI: 10.1016/j.clml.2020.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
471 Nicolas X, Djebli N, Rauch C, Brunet A, Hurbin F, Martinez JM, Fabre D. Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II. Clin Pharmacokinet 2019;58:115-30. [PMID: 29725997 DOI: 10.1007/s40262-018-0670-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
472 Edmonston DL, Pun PH. Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2020;97:642-4. [PMID: 32093916 DOI: 10.1016/j.kint.2019.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
473 Levin MG, Rader DJ. Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time? Circulation 2020;141:637-40. [DOI: 10.1161/circulationaha.119.044770] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
474 Bair TL, May HT, Knowlton KU, Anderson JL, Lappe DL, Muhlestein JB. Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES Study. J Cardiovasc Pharmacol 2020;75:426-31. [PMID: 32079856 DOI: 10.1097/FJC.0000000000000808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
475 Weijers JM, Semb AG, Rollefstad S, Kitas GD, van Riel PLCM; ATrans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers. Rheumatol Int 2020;40:523-7. [PMID: 32088752 DOI: 10.1007/s00296-020-04533-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
476 Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2018 Update on Medical Overuse. JAMA Intern Med 2019;179:240-6. [PMID: 30508032 DOI: 10.1001/jamainternmed.2018.5748] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
477 Kunutsor SK, Laukkanen JA. Heart Failure Risk Reduction: Hydrophilic or Lipophilic Statins? Cardiology 2020;145:384-6. [PMID: 32074601 DOI: 10.1159/000506151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
478 Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S. Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Metab Syndr Obes 2020;13:423-31. [PMID: 32110075 DOI: 10.2147/DMSO.S219496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
479 Lin FJ, Shyu KG, Hsieh IC, Huey-Herng Sheu W, Tu ST, Yeh SJ, Chen CI, Lu KC, Wu CC, Shau WY, Inocencio TJ, Wen YC, Yeh HI. Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan. J Formos Med Assoc 2020;119:907-16. [PMID: 32081563 DOI: 10.1016/j.jfma.2020.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
480 Lee J, Hwang YC, Lee WJ, Won JC, Song KH, Park CY, Ahn KJ, Park JY. Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study. Diabetes Ther 2020;11:859-71. [PMID: 32065359 DOI: 10.1007/s13300-020-00778-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
481 Ahmed S, Capric V, Khan M, Koneru P. A Rapidly Progressive Case of Statin-induced Necrotizing Autoimmune Myopathy. Cureus 2020;12:e7021. [PMID: 32211257 DOI: 10.7759/cureus.7021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
482 Go AS, Ambrosy AP, Kheder K, Fan D, Sung SH, Inveiss AI, Romo-LeTourneau V, Thomas SM, Koren A, Lo JC; Kaiser Permanente Cholesterol-Lowering Therapy in High-Risk Adults: Management and Patient Risks (KP CHAMP) Study. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol 2020;125:534-41. [PMID: 31848029 DOI: 10.1016/j.amjcard.2019.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
483 Wang S, Liu M, Yang S, Wang J, Jia W, Cao W, Han K, He Y. Higher Normal Levels of Triglyceride and Low and High-Density Lipoprotein Cholesterol Might Have a Protective Effect Against Activities of Daily Living Disability Within Chinese Female Centenarians: A Cross-Sectional, Complete Sample Study. Clin Interv Aging 2020;15:225-37. [PMID: 32110002 DOI: 10.2147/CIA.S237505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
484 Beqa Ahmeti G, Idrizovic K, Elezi A, Zenic N, Ostojic L. Endurance Training vs. Circuit Resistance Training: Effects on Lipid Profile and Anthropometric/Body Composition Status in Healthy Young Adult Women. Int J Environ Res Public Health 2020;17:E1222. [PMID: 32074953 DOI: 10.3390/ijerph17041222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
485 Mack DS, Tjia J, Hume AL, Lapane KL. Prevalent Statin Use in Long-Stay Nursing Home Residents with Life-Limiting Illness. J Am Geriatr Soc 2020;68:708-16. [PMID: 32057091 DOI: 10.1111/jgs.16336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
486 De La Cruz JA, Mihos CG, Horvath SA, Santana O. The Pleiotropic Effects of Statins in Endocrine Disorders. Endocr Metab Immune Disord Drug Targets 2019;19:787-93. [PMID: 30924424 DOI: 10.2174/1871530319666190329115003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
487 Raghunathan NJ, Zabor EC, Anderson N, Oeffinger K, Tonorezos ES, Korenstein D. Communicating cardiovascular risk to high-risk cancer survivors: a mixed-methods pilot study of a statin risk communication tool. J Cancer Surviv 2020;14:417-23. [PMID: 32043205 DOI: 10.1007/s11764-020-00860-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
488 Atallah B, Khaddage R, Sadik ZG, Mallah SI, Lee-St John TJ, Alfardan S, Traina MI, Almahmeed W. Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort. Glob Heart 2020;15:12. [PMID: 32489785 DOI: 10.5334/gh.530] [Reference Citation Analysis]
489 Krishnapillai V, Nair S, T N A, T P S, Soman B. Quality of medical prescriptions in diabetes and hypertension management in Kerala and its associated factors. BMC Public Health 2020;20:193. [PMID: 32028918 DOI: 10.1186/s12889-020-8214-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Hansson L, Lind T, Öhlund I, Wiklund U, Rydberg A. Increased abdominal fat mass and high fat consumption in young school children with congenital heart disease: results from a case‐control study. J Hum Nutr Diet 2020;33:566-73. [DOI: 10.1111/jhn.12739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Shah VS, Kreatsoulas D, Dornbos D 3rd, Cua S, Powers CJ. The impact of pre-operative symptoms on carotid endarterectomy Outcomes: Analysis of the ACS-NSQIP carotid endarterectomy database. J Clin Neurosci 2020;73:51-6. [PMID: 32019726 DOI: 10.1016/j.jocn.2020.01.077] [Reference Citation Analysis]
492 Mandraffino G, Scicali R, Rodríguez-Carrio J, Savarino F, Mamone F, Scuruchi M, Cinquegrani M, Imbalzano E, Di Pino A, Piro S, Rabuazzo AM, Squadrito G, Purrello F, Saitta A. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience. J Clin Lipidol 2020;14:231-40. [PMID: 32111581 DOI: 10.1016/j.jacl.2020.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
493 Lee H, Park J, Hwang I, Yoon YE, Park HE, Choi S, Kim Y, Cho G, Han K, Kim H. Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study. Eur J Prev Cardiolog 2020;27:870-81. [DOI: 10.1177/2047487319898571] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
494 Escobar C, Anguita M, Arrarte V, Barrios V, Cequier Á, Cosín-sales J, Egocheaga I, López de Sa E, Masana L, Pallarés V, Pérez de Isla L, Pintó X, González Juanatey JR, Zamorano JL. Recomendaciones para mejorar el control lipídico. Documento de consenso de la Sociedad Española de Cardiología. Revista Española de Cardiología 2020;73:161-7. [DOI: 10.1016/j.recesp.2019.07.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 11.5] [Reference Citation Analysis]
495 Wong ND, Amsterdam EA, Ballantyne C, Khera A, Nasir K, Toth PP; American Society for Preventive Cardiology. Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. Am J Cardiovasc Drugs 2020;20:1-9. [PMID: 31286451 DOI: 10.1007/s40256-019-00358-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
496 Rana JS, Liu JY, Moffet HH, Sanchez RJ, Khan I, Karter AJ. Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease. Am J Med 2020;133:200-6. [PMID: 31344341 DOI: 10.1016/j.amjmed.2019.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
497 Al-salameh A, Danchin N, Verstuyft C, Kotti S, Puymirat E, Ferrières J, Schiele F, Coste P, Lemesle G, Cayla G, Becquemont L, Simon T. Association between rs4149056 variant in SLCO1B1 and early discontinuation of statin after acute myocardial infarction. Pharmacogenomics 2020;21:163-72. [DOI: 10.2217/pgs-2019-0109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
498 Schreinlechner M, Noflatscher M, Reinstadler SJ, Sommer P, Lener D, Reiser E, Theurl M, Kirchmair R, Bauer A, Marschang P. Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression. Atherosclerosis 2020;297:25-31. [PMID: 32062136 DOI: 10.1016/j.atherosclerosis.2020.01.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
499 Yang X, Hidru TH, Wang B, Han X, Li H, Wu S, Xia Y. The link between elevated long-term resting heart rate and SBP variability for all-cause mortality. J Hypertens 2019;37:84-91. [PMID: 30005029 DOI: 10.1097/HJH.0000000000001857] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
500 Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol 2019;4:206-13. [PMID: 30758506 DOI: 10.1001/jamacardio.2018.4936] [Cited by in Crossref: 81] [Cited by in F6Publishing: 96] [Article Influence: 40.5] [Reference Citation Analysis]
501 Suzuki K, Oikawa T, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Takahashi J, Miyata S, Sakata Y, Shimokawa H. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment. Arterioscler Thromb Vasc Biol 2019;39:934-44. [PMID: 30866657 DOI: 10.1161/ATVBAHA.119.312336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
502 Tanguturi VK, Kennedy KF, Virani SS, Maddox TM, Armstrong K, Wasfy JH. Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med 2020;21:1016-21. [PMID: 31992531 DOI: 10.1016/j.carrev.2019.12.026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
503 Persell SD, Lee JY, Lipiszko D, Peprah YA, Ruderman EM, Schachter M, Majka DS. Outreach to Promote Management of Cardiovascular Risk in Primary Care Among Patients With Rheumatoid Arthritis Seen in Rheumatology Practice. ACR Open Rheumatol 2020;2:131-7. [PMID: 31989787 DOI: 10.1002/acr2.11116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
504 Pan SW, Yen YF, Feng JY, Chuang PH, Su VY, Kou YR, Su WJ, Chan YJ. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study. Br J Clin Pharmacol 2020;86:569-79. [PMID: 31633826 DOI: 10.1111/bcp.14142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
505 Henein MY, Vancheri S, Bajraktari G, Vancheri F. Coronary Atherosclerosis Imaging. Diagnostics (Basel) 2020;10:E65. [PMID: 31991633 DOI: 10.3390/diagnostics10020065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
506 Patel N, Miller DP Jr, Snavely AC, Bellinger C, Foley KL, Case D, McDonald ML, Masmoudi YR, Dharod A. A Comparison of Smoking History in the Electronic Health Record With Self-Report. Am J Prev Med 2020;58:591-5. [PMID: 31982229 DOI: 10.1016/j.amepre.2019.10.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
507 Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73:948-963. [PMID: 30819364 DOI: 10.1016/j.jacc.2018.11.050] [Cited by in Crossref: 80] [Cited by in F6Publishing: 130] [Article Influence: 40.0] [Reference Citation Analysis]
508 Kokkinidis DG, Arfaras-melainis A, Giannopoulos S, Katsaros I, Jawaid O, Jonnalagadda AK, Parikh SA, Secemsky EA, Giri J, Kumbhani DJ, Armstrong EJ. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis. Vasc Med 2020;25:106-17. [DOI: 10.1177/1358863x19894055] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
509 Hull RA, Berger JM, Boster JM, Williams MU, Sharp AJ, Fentanes E, Maroules CD, Cury RC, Thomas DM. Adoption of coronary artery disease - Reporting and Data System (CAD-RADS™) and observed impact on medical therapy and systolic blood pressure control. J Cardiovasc Comput Tomogr 2020;14:421-7. [PMID: 32005447 DOI: 10.1016/j.jcct.2020.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
510 Climent E, Benaiges D, Goday A, Villatoro M, Julià H, Ramón JM, Flores JA, Pedro-Botet J. Morbid obesity and dyslipidaemia: The impact of bariatric surgery. Clin Investig Arterioscler 2020;32:79-86. [PMID: 31973950 DOI: 10.1016/j.arteri.2019.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
511 El Rouby N, Alrwisan A, Langaee T, Lipori G, Angiolillo DJ, Franchi F, Riva A, Elsey A, Johnson JA, Cavallari LH, Winterstein AG. Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention. Clin Transl Sci 2020;13:473-81. [PMID: 31758664 DOI: 10.1111/cts.12729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
512 Wokhlu A, Wymer D, Taasan V, Winchester DE. Effect of Elevated Calcium Score on Normal Myocardial Perfusion Study on Clinician Management of Coronary Artery Disease Risk Factors. Crit Pathw Cardiol 2020;19:58-61. [PMID: 31939754 DOI: 10.1097/HPC.0000000000000209] [Reference Citation Analysis]
513 Ballout RA, Bianconi S, Livinski A, Fu YP, Remaley AT, Porter FD. Statins for Smith-Lemli-Opitz syndrome. Cochrane Database Syst Rev 2020;2020. [PMID: 32132878 DOI: 10.1002/14651858.cd013521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
514 Liu A, Xu P, Gong C, Zhu Y, Zhang H, Nie W, Zhou X, Liang X, Xu Y, Huang C, Liu XL, Zhou JC. High serum concentration of selenium, but not calcium, cobalt, copper, iron, and magnesium, increased the risk of both hyperglycemia and dyslipidemia in adults: A health examination center based cross-sectional study. J Trace Elem Med Biol 2020;59:126470. [PMID: 31958698 DOI: 10.1016/j.jtemb.2020.126470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
515 Maile MD, Sigakis MJ, Stringer KA, Jewell ES, Engoren MC. Impact of the pre-illness lipid profile on sepsis mortality. J Crit Care 2020;57:197-202. [PMID: 32182565 DOI: 10.1016/j.jcrc.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
516 Dun Y, Thomas RJ, Medina-Inojosa JR, Squires RW, Huang H, Smith JR, Liu S, Olson TP. High-Intensity Interval Training in Cardiac Rehabilitation: Impact on Fat Mass in Patients With Myocardial Infarction. Mayo Clin Proc 2019;94:1718-30. [PMID: 31486378 DOI: 10.1016/j.mayocp.2019.04.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
517 Yang YS, Yang BR, Kim MS, Hwang Y, Choi SH. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study. Lipids Health Dis 2020;19:5. [PMID: 31926562 DOI: 10.1186/s12944-019-1158-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
518 Tsujimoto T, Kajio H. Use of Nitrates and Risk of Cardiovascular Events in Patients With Heart Failure With Preserved Ejection Fraction. Mayo Clin Proc 2019;94:1210-20. [PMID: 31272569 DOI: 10.1016/j.mayocp.2018.11.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
519 Zijlstra LE, Trompet S, Mooijaart SP, van Buren M, Jukema JW. Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran. Mayo Clin Proc 2020;95:12-4. [PMID: 31902406 DOI: 10.1016/j.mayocp.2019.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
520 Carrillo-Larco RM, Altez-Fernandez C, Pacheco-Barrios N, Bambs C, Irazola V, Miranda JJ, Danaei G, Perel P. Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review. Glob Heart 2019;14:81-93. [PMID: 31036306 DOI: 10.1016/j.gheart.2019.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
521 Miedema MD, Nauffal VD, Singh A, Blankstein R. Statin therapy for young adults: A long-term investment worth considering. Trends in Cardiovascular Medicine 2020;30:48-53. [DOI: 10.1016/j.tcm.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
522 Rodrigues DF, Couto ROD, Sinisterra RD, Jensen CEDM. Novel Eudragit® -based polymeric nanoparticles for sustained release of simvastatin. Braz J Pharm Sci 2020;56:e18363. [DOI: 10.1590/s2175-97902019000418363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
523 Ding F, Ma B, Nazary-vannani A, Kord-varkaneh H, Fatahi S, Papageorgiou M, Rahmani J, Poursoleiman F, Júnior Borges do Nascimento I, Li H, Han D, Wang D. The effects of green coffee bean extract supplementation on lipid profile in humans: A systematic review and meta-analysis of randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases 2020;30:1-10. [DOI: 10.1016/j.numecd.2019.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
524 Malaki M. Statins: A distant hope and thousand dangers in near. J Pharm Negative Results 2020;11:77. [DOI: 10.4103/jpnr.jpnr_20_18] [Reference Citation Analysis]
525 Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J 2020;219:21-30. [PMID: 31710841 DOI: 10.1016/j.ahj.2019.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
526 Jamil A, Tajrishi FZ, Kahe F, Najafi H, Montazerin SM, Shojaei F, Chitsazan M, Chitsazan M, Liu Y, Chi G. Spontaneous coronary artery dissection managed with a conservative or revascularization approach: a meta-analysis. Journal of Cardiovascular Medicine 2020;21:42-50. [DOI: 10.2459/jcm.0000000000000891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
527 Rasheed H, Hussien N, Al-naimi M, Al-kuraishy H, Al-gareeb A. Fenofibrate and Crataegus oxyacantha is an effectual combo for mixed dyslipidemia. Biomed Biotechnol Res J 2020;4:259. [DOI: 10.4103/bbrj.bbrj_26_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
528 Sandesara PB, Mehta A, O'neal WT, Kelli HM, Sathiyakumar V, Martin SS, Blaha MJ, Blumenthal RS, Sperling LS. Clinical significance of zero coronary artery calcium in individuals with LDL cholesterol ≥190 mg/dL: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2020;292:224-9. [DOI: 10.1016/j.atherosclerosis.2019.09.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
529 Kim HK, Ahn Y, Chang K, Jeong YH, Hahn JY, Choo EH, Kim MC, Kim HS, Kim W, Cho MC, Jang Y, Kim CJ, Jeong MH, Chae SC; Task Force on Expert Consensus Document of the Korean Society of Myocardial Infarction (KSMI). 2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction. Korean Circ J 2020;50:845-66. [PMID: 32969206 DOI: 10.4070/kcj.2020.0196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
530 Wright RS, Collins MG, Stoekenbroek RM, Robson R, Wijngaard PL, Landmesser U, Leiter LA, Kastelein JJ, Ray KK, Kallend D. Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies. Mayo Clinic Proceedings 2020;95:77-89. [DOI: 10.1016/j.mayocp.2019.08.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 42] [Article Influence: 11.5] [Reference Citation Analysis]
531 Anderson EJ, Axon DR, Taylor AM, Towers V, Warholak T, Johnson M, Forbes S, Manygoats T. Impact evaluation of a four-year academic-community partnership in provision of medication management and tertiary prevention services for rural patients with diabetes and/or hypertension. Prev Med Rep 2020;17:101038. [PMID: 31956473 DOI: 10.1016/j.pmedr.2019.101038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
532 Scicali R, Di Pino A, Pavanello C, Ossoli A, Strazzella A, Alberti A, Di Mauro S, Scamporrino A, Urbano F, Filippello A, Piro S, Rabuazzo AM, Calabresi L, Purrello F. Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation. Sci Rep 2019;9:20354. [PMID: 31889114 DOI: 10.1038/s41598-019-56857-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
533 Blackman AL, Pandit NS, Pincus KJ. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients. HIV Med 2020;21:135-41. [PMID: 31876122 DOI: 10.1111/hiv.12794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
534 Drexel H, Coats AJS, Spoletini I, Bilato C, Mollace V, Perrone Filardi P, Rosano GMC. An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome. European Heart Journal - Cardiovascular Pharmacotherapy 2020;6:115-21. [DOI: 10.1093/ehjcvp/pvz079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
535 Al Amri T, Bahijri S, Al-Raddadi R, Ajabnoor G, Al Ahmadi J, Jambi H, Borai A, Tuomilehto J. The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia. Diabetes Metab Syndr Obes 2019;12:2735-43. [PMID: 31920353 DOI: 10.2147/DMSO.S233717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
536 Kakadiaris IA, Vrigkas M, Yen AA, Kuznetsova T, Budoff M, Naghavi M. Machine Learning Outperforms ACC / AHA CVD Risk Calculator in MESA. J Am Heart Assoc 2018;7:e009476. [PMID: 30571498 DOI: 10.1161/JAHA.118.009476] [Cited by in Crossref: 47] [Cited by in F6Publishing: 60] [Article Influence: 15.7] [Reference Citation Analysis]
537 Christensen JL, Yu W, Tan S, Chu A, Vargas F, Assali M, Shah NR, Reginato AM, Wu WC, Choudhary G, Morrison AR. Gout Is Associated With Increased Coronary Artery Calcification and Adverse Cardiovascular Outcomes. JACC Cardiovasc Imaging 2020;13:884-6. [PMID: 31864984 DOI: 10.1016/j.jcmg.2019.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
538 Ulven SM, Christensen JJ, Nygård O, Svardal A, Leder L, Ottestad I, Lysne V, Laupsa-Borge J, Ueland PM, Midttun Ø, Meyer K, McCann A, Andersen LF, Holven KB. Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat-a randomized controlled dietary intervention study. Am J Clin Nutr 2019;109:1239-50. [PMID: 31051508 DOI: 10.1093/ajcn/nqy356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
539 Solache-Berrocal G, Barral-Varela AM, Areces-Rodríguez S, Junco-Vicente A, Vallina-Álvarez A, Corte-Torres MD, Valdivielso JM, Llosa JC, Morís C, Martín M, Rodríguez I. Correlation of Micro-Computed Tomography Assessment of Valvular Mineralisation with Histopathological and Immunohistochemical Features of Calcific Aortic Valve Disease. J Clin Med 2019;9:E29. [PMID: 31877754 DOI: 10.3390/jcm9010029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
540 Kastelein JJ, Kereiakes DJ, Cannon CP, Bays HE, Minini P, Lee LV, Maroni J, Farnier M. Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia. Coron Artery Dis 2017;28:190-7. [PMID: 27740972 DOI: 10.1097/MCA.0000000000000438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
541 Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H. Comprehensive efforts to increase adherence to statin therapy. Eur Heart J 2017;38:2473-9. [PMID: 28077470 DOI: 10.1093/eurheartj/ehw628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
542 Mortensen MB, Falk E. Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention. Eur Heart J 2017;38:2259-63. [PMID: 27941016 DOI: 10.1093/eurheartj/ehw568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
543 Sperl-Hillen JM, Crain AL, Margolis KL, Ekstrom HL, Appana D, Amundson G, Sharma R, Desai JR, O'Connor PJ. Clinical decision support directed to primary care patients and providers reduces cardiovascular risk: a randomized trial. J Am Med Inform Assoc 2018;25:1137-46. [PMID: 29982627 DOI: 10.1093/jamia/ocy085] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
544 AlTurki A, Marafi M, Dawas A, Dube MP, Vieira L, Sherman MH, Gregoire J, Thanassoulis G, Tardif JC, Huynh T. Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes. Am J Cardiol 2019;124:1869-75. [PMID: 31679643 DOI: 10.1016/j.amjcard.2019.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
545 Robinson JG. The next treatment paradigm in cardiovascular prevention? Lancet 2019;394:2129-31. [PMID: 31810608 DOI: 10.1016/S0140-6736(19)32949-6] [Reference Citation Analysis]
546 Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J 2018;39:2401-8. [PMID: 29688297 DOI: 10.1093/eurheartj/ehy217] [Cited by in Crossref: 175] [Cited by in F6Publishing: 207] [Article Influence: 58.3] [Reference Citation Analysis]
547 Su B, Wang Y, Zhou R, Jiang T, Zhang H, Li Z, Liu A, Shao Y, Hua W, Zhang T, Wu H, He S, Dai L, Sun L. Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China. Front Pharmacol. 2019;10:1472. [PMID: 31920659 DOI: 10.3389/fphar.2019.01472] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
548 Monti CB, Codari M, De Cecco CN, Secchi F, Sardanelli F, Stillman AE. Novel imaging biomarkers: epicardial adipose tissue evaluation. Br J Radiol 2020;93:20190770. [PMID: 31782934 DOI: 10.1259/bjr.20190770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
549 Heigl F, Pflederer T, Klingel R, Hettich R, Lotz N, Reeg H, Schettler VJJ, Roeseler E, Grützmacher P, Hohenstein B, Julius U. Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy? Atheroscler Suppl 2019;40:23-9. [PMID: 31818446 DOI: 10.1016/j.atherosclerosissup.2019.08.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
550 Perez-Calahorra S, Laclaustra M, Marco-Benedi V, Pinto X, Sanchez-Hernandez RM, Plana N, Ortega E, Fuentes F, Civeira F. Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence. Lipids Health Dis 2019;18:216. [PMID: 31829197 DOI: 10.1186/s12944-019-1153-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
551 Escobar C, Anguita M, Arrarte V, Barrios V, Cequier Á, Cosín-Sales J, Egocheaga I, López de Sa E, Masana L, Pallarés V, Pérez de Isla L, Pintó X; Expert reviewers. Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) 2020;73:161-7. [PMID: 31818706 DOI: 10.1016/j.rec.2019.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
552 Wong ND, Toth PP, Amsterdam EA; American Society for Preventive Cardiology. Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology. Trends Cardiovasc Med 2021;31:49-56. [PMID: 31882264 DOI: 10.1016/j.tcm.2019.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
553 Rhee M, Kim K, Kim S, Yoon YW, Rha S, Hong SJ, Kwak C, Kim W, Nam C, Park T, Hong T, Park S, Ahn Y, Lee N, Jeon H, Jeon DW, Han K, Moon K, Chae I, Kim H, Kim H. Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy. Clinical Therapeutics 2019;41:2571-92. [DOI: 10.1016/j.clinthera.2019.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
554 Milinkovic A, Berger F, Arenas-Pinto A, Mauss S. Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back. AIDS 2019;33:2387-91. [PMID: 31764103 DOI: 10.1097/QAD.0000000000002350] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
555 Cegla J, Neely RG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H. HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis 2019;291:62-70. [DOI: 10.1016/j.atherosclerosis.2019.10.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 60] [Article Influence: 12.3] [Reference Citation Analysis]
556 Maciejko JJ, Jamoua R, Anne P. Assessment and Management of Patients with Hyperlipidemia Referred for Initiation of PCSK9 Inhibitor Therapy: A Lipid Clinic Experience. Am J Cardiovasc Drugs 2019;19:553-9. [PMID: 31119582 DOI: 10.1007/s40256-019-00352-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
557 Quispe R, Al-rifai M, Di Carlo PA, Michos ED, Amin NP, Kianoush S, Handy CE, Mcevoy JW, Blaha MJ, Nasir K, Blumenthal RS, Tota-maharaj R, Lima JA, Comin-colet J, Cainzos-achirica M. Breast Arterial Calcium. JACC: Cardiovascular Imaging 2019;12:2538-48. [DOI: 10.1016/j.jcmg.2018.07.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
558 Plante TB, Juraschek SP, Zakai NA, Tracy RP, Cushman M. Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial. Am J Cardiol 2019;124:1701-6. [PMID: 31575423 DOI: 10.1016/j.amjcard.2019.08.028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
559 Jellinger PS. Impact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelines. Journal of Diabetes 2019;12:105-9. [DOI: 10.1111/1753-0407.12998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
560 You D, Han L, Liu J, Li L, Wu Q, Zeng F. Trends in long-term cardiovascular and renal burdens of the 2017 clinical practice guideline for hypertension in US adults, 1998-2016. Eur J Prev Cardiol 2020;27:2279-83. [PMID: 31760799 DOI: 10.1177/2047487319888593] [Reference Citation Analysis]
561 Choi SY, Yang BR, Kang HJ, Park KS, Kim HS. Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases. Korean J Intern Med 2020;35:593-604. [PMID: 31752475 DOI: 10.3904/kjim.2018.312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
562 Hawley CE, Roefaro J, Forman DE, Orkaby AR. Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines. Drugs Aging 2019;36:687-99. [PMID: 31049807 DOI: 10.1007/s40266-019-00673-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
563 Ramos R, Masana L, Comas-Cufí M, García-Gil M, Martí-Lluch R, Ponjoan A, Plana N, Alves-Cabratosa L, Marrugat J, Elosua R, Dégano IR, Gomez-Marcos MA, Zamora A. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype. Atherosclerosis 2020;292:42-51. [PMID: 31759248 DOI: 10.1016/j.atherosclerosis.2019.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
564 Rosenblit PD. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD Risk. Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1246-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
565 La Fountaine MF, Cirnigliaro CM, Hobson JC, Lombard AT, Specht AF, Dyson-Hudson TA, Kirshblum SC, Bauman WA. A Four Month Randomized Controlled Trial on the Efficacy of Once-daily Fenofibrate Monotherapy in Persons with Spinal Cord Injury. Sci Rep 2019;9:17166. [PMID: 31748594 DOI: 10.1038/s41598-019-53753-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
566 Ma C, Na M, Neumann S, Gao X. Low-Density Lipoprotein Cholesterol and Risk of Hemorrhagic Stroke: a Systematic Review and Dose-Response Meta-analysis of Prospective Studies. Curr Atheroscler Rep 2019;21:52. [PMID: 31748963 DOI: 10.1007/s11883-019-0815-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
567 Opotowsky AR, Valente AM, Alshawabkeh L, Cheng S, Bradley A, Rimm EB, Landzberg MJ. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J 2018;39:3253-61. [PMID: 30010900 DOI: 10.1093/eurheartj/ehy362] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
568 Wong ND. Identifying the Very-High-Risk Atherosclerotic Cardiovascular Disease Patient: Does It Really Matter? J Am Coll Cardiol 2019;74:2508-10. [PMID: 31727289 DOI: 10.1016/j.jacc.2019.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
569 Hegele RA, Tsimikas S. Lipid-Lowering Agents. Circ Res. 2019;124:386-404. [PMID: 30702996 DOI: 10.1161/circresaha.118.313171] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 25.7] [Reference Citation Analysis]
570 Stone NJ, Grundy SM. The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future. Prog Cardiovasc Dis 2019;62:375-83. [PMID: 31733217 DOI: 10.1016/j.pcad.2019.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
571 Honigberg MC, Natarajan P. Bempedoic Acid for Lowering LDL Cholesterol. JAMA 2019;322:1769-71. [PMID: 31714973 DOI: 10.1001/jama.2019.16598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
572 Toth PP, Granowitz C, Hull M, Liassou D, Anderson A, Philip S. High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk. J Am Heart Assoc 2018;7:e008740. [PMID: 30371242 DOI: 10.1161/JAHA.118.008740] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 14.7] [Reference Citation Analysis]
573 Alamoudi BM, Ibrahim NK, Kalo BBM. Are proton pump inhibitors among the risk factors for acute coronary syndrome? A multi-centric case-control study between patients attending governmental hospitals in western Saudi Arabia. Saudi Med J 2019;40:1098-104. [PMID: 31707405 DOI: 10.15537/smj.2019.11.24602] [Reference Citation Analysis]
574 Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Eckel RH, Cannon CP, Lee LV, Bessac L, Pordy R, Letierce A, Ray KK. Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. J Am Heart Assoc 2018;7:e009221. [PMID: 30371190 DOI: 10.1161/JAHA.118.009221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
575 Miname MH, Bittencourt MS, Pereira AC, Jannes CE, Krieger JE, Nasir K, Santos RD. Vascular age derived from coronary artery calcium score on the risk stratification of individuals with heterozygous familial hypercholesterolaemia. European Heart Journal - Cardiovascular Imaging 2020;21:251-7. [DOI: 10.1093/ehjci/jez280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
576 Nishikido T, Ray KK. Targeting the peptidase PCSK9 to reduce cardiovascular risk: Implications for basic science and upcoming challenges. Br J Pharmacol 2021;178:2168-85. [PMID: 31465540 DOI: 10.1111/bph.14851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
577 Bowen KJ, Kris-Etherton PM, West SG, Fleming JA, Connelly PW, Lamarche B, Couture P, Jenkins DJA, Taylor CG, Zahradka P, Hammad SS, Sihag J, Chen X, Guay V, Maltais-Giguère J, Perera D, Wilson A, Juan SCS, Rempel J, Jones PJH. Diets Enriched with Conventional or High-Oleic Acid Canola Oils Lower Atherogenic Lipids and Lipoproteins Compared to a Diet with a Western Fatty Acid Profile in Adults with Central Adiposity. J Nutr 2019;149:471-8. [PMID: 30773586 DOI: 10.1093/jn/nxy307] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
578 Lan Y, Liu H, Liu J, Zhao H, Wang H. Is serum total bilirubin a predictor of prognosis in arteriosclerotic cardiovascular disease? A meta-analysis. Medicine (Baltimore) 2019;98:e17544. [PMID: 31626117 DOI: 10.1097/MD.0000000000017544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
579 Moon J, Yoo S, Koh G, Min KW, Shin HH. Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia. J Lipid Atheroscler 2020;9:162-71. [PMID: 32821729 DOI: 10.12997/jla.2020.9.1.162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
580 Evans CR, Long DL, Howard G, McClure LA, Zakai NA, Jenny NS, Kissela BM, Safford MM, Howard VJ, Cushman M. C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort. Am Heart J 2019;217:94-100. [PMID: 31520899 DOI: 10.1016/j.ahj.2019.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
581 Lichtenstein AH. Dietary Fat and Cardiovascular Disease: Ebb and Flow Over the Last Half Century. Adv Nutr 2019;10:S332-9. [PMID: 31728492 DOI: 10.1093/advances/nmz024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
582 Baum SJ, Sampietro T, Datta D, Moriarty PM, Knusel B, Schneider J, Somaratne R, Kurtz C, Hohenstein B. Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study. Journal of Clinical Lipidology 2019;13:901-909.e3. [DOI: 10.1016/j.jacl.2019.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
583 Shaikh K, Nakanishi R, Kim N, Budoff MJ. Coronary artery calcification and ethnicity. Journal of Cardiovascular Computed Tomography 2019;13:353-9. [DOI: 10.1016/j.jcct.2018.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
584 Khanimov I, Segal G, Wainstein J, Boaz M, Shimonov M, Leibovitz E. High-Intensity Statins Are Associated With Increased Incidence of Hypoglycemia During Hospitalization of Individuals Not Critically Ill. The American Journal of Medicine 2019;132:1305-10. [DOI: 10.1016/j.amjmed.2019.04.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
585 Han D, Beecy A, Anchouche K, Gransar H, Dunham PC, Lee JH, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Bax JJ, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, de Araújo Gonçalves P, Pontone G, Raff GL, Rubinshtein R, Villines TC, Lu Y, Peña JM, Shaw LJ, Min JK, Lin FY. Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]). Am J Cardiol 2019;124:1397-405. [PMID: 31547994 DOI: 10.1016/j.amjcard.2019.07.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
586 Samaras K, Makkar SR, Crawford JD, Kochan NA, Slavin MJ, Wen W, Trollor JN, Brodaty H, Sachdev PS. Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly. Journal of the American College of Cardiology 2019;74:2554-68. [DOI: 10.1016/j.jacc.2019.09.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
587 Lamiquiz-Moneo I, Giné-González J, Alisente S, Bea AM, Pérez-Calahorra S, Marco-Benedí V, Baila-Rueda L, Jarauta E, Cenarro A, Civeira F, Mateo-Gallego R. Effect of bergamot on lipid profile in humans: A systematic review. Crit Rev Food Sci Nutr 2020;60:3133-43. [PMID: 31670973 DOI: 10.1080/10408398.2019.1677554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
588 Jones JB, Liang S, Husby HM, Delatorre-Reimer JK, Mosser CA, Hudnut AG, Knobel K, MacDonald K, Yan XS. CM-SHARE: Development, Integration, and Adoption of an Electronic Health Record-Linked Digital Health Solution to Support Care for Diabetes in Primary Care. Clin Diabetes 2019;37:338-46. [PMID: 31660006 DOI: 10.2337/cd18-0057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
589 Horodinschi RN, Stanescu AMA, Bratu OG, Pantea Stoian A, Radavoi DG, Diaconu CC. Treatment with Statins in Elderly Patients. Medicina (Kaunas) 2019;55:E721. [PMID: 31671689 DOI: 10.3390/medicina55110721] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
590 Nanna MG, Peterson ED, Wojdyla D, Navar AM. The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults. J Gen Intern Med 2020;35:1701-8. [PMID: 31667745 DOI: 10.1007/s11606-019-05361-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
591 Calling S, Johansson SE, Wolff M, Sundquist J, Sundquist K. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovasc Disord 2019;19:239. [PMID: 31664919 DOI: 10.1186/s12872-019-1228-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
592 Ramanathan S. Coronary artery calcium data and reporting system: Strengths and limitations. World J Radiol 2019; 11(10): 126-133 [PMID: 31666937 DOI: 10.4329/wjr.v11.i10.126] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
593 Mendoza-Herrera K, Pedroza-Tobías A, Hernández-Alcaraz C, Ávila-Burgos L, Aguilar-Salinas CA, Barquera S. Attributable Burden and Expenditure of Cardiovascular Diseases and Associated Risk Factors in Mexico and other Selected Mega-Countries. Int J Environ Res Public Health 2019;16:E4041. [PMID: 31652519 DOI: 10.3390/ijerph16204041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
594 Madsen CM, Varbo A, Nordestgaard BG. Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study. Eur Heart J 2018;39:610-9. [PMID: 29182745 DOI: 10.1093/eurheartj/ehx659] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
595 Brotons Cuixart C, Alemán Sánchez JJ, Banegas Banegas JR, Fondón León C, Lobos-Bejarano JM, Martín Rioboó E, Navarro Pérez J, Orozco-Beltrán D, Villar Álvarez F; Grupo de Prevención Cardiovascular del PAPPS. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018. Aten Primaria 2018;50 Suppl 1:4-28. [PMID: 29866357 DOI: 10.1016/S0212-6567(18)30360-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
596 Li Y, Zhu G, Ding V, Jiang B, Boothroyd D, Rodriguez F, Fleischmann D, Desai M, Saloner D, Saba L, Hom J, Wintermark M. Carotid Artery Imaging Is More Strongly Associated With the 10-Year Atherosclerotic Cardiovascular Disease Score Than Coronary Artery Imaging. J Comput Assist Tomogr 2019;43:679-85. [PMID: 31609291 DOI: 10.1097/RCT.0000000000000920] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
597 Chen S, Hou X, Zhou X, Yu J, Xue H, Hu G, Sun Y, Chen P, Wu J, Liang Y, Bao Y, Jia W. The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting - A prospective diabetes management study. Prim Care Diabetes 2020;14:274-81. [PMID: 31606312 DOI: 10.1016/j.pcd.2019.09.006] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
598 Gnanenthiran SR, Ng ACC, Cumming R, Brieger DB, Le Couteur D, Waite L, Handelsman D, Naganathan V, Kritharides L, Blyth F. Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins. Heart 2020;106:698-705. [DOI: 10.1136/heartjnl-2019-315449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
599 Campitelli MA, Maxwell CJ, Maclagan LC, Ko DT, Bell CM, Jeffs L, Morris AM, Lapane KL, Daneman N, Bronskill SE. One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins. CMAJ 2019;191:E32-9. [PMID: 30642823 DOI: 10.1503/cmaj.180853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
600 Kwon Y, Lee HS, Chang H, Koh S, Lee J. Association of dietary lipid intake with low-density lipoprotein cholesterol levels: analysis of two independent population-based studies. Eur J Nutr 2020;59:2557-67. [DOI: 10.1007/s00394-019-02104-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
601 Lopes RD, de Barros E Silva PGM, de Andrade Jesuíno I, Santucci EV, Barbosa LM, Damiani LP, Nakagawa Santos RH, Laranjeira LN, Dall Orto FTC, Beraldo de Andrade P, de Castro Bienert IR, Alexander JH, Granger CB, Berwanger O. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial. JAMA Cardiol 2018;3:1113-8. [PMID: 30264159 DOI: 10.1001/jamacardio.2018.3408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
602 Malta DC, Szwarcwald CL, Machado ÍE, Pereira CA, Figueiredo AW, Sá ACMGN, Velasquez-Melendez G, Santos FMD, Souza Junior PB, Stopa SR, Rosenfeld LG. Prevalence of altered total cholesterol and fractions in the Brazilian adult population: National Health Survey. Rev Bras Epidemiol 2019;22Suppl 02:E190005.SUPL.2. [PMID: 31596376 DOI: 10.1590/1980-549720190005.supl.2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
603 Davidson J, Rotondo D. Control of serum triglyceride levels by the apolipoprotein C3 gene and its relationship to cardiovascular disease. Curr Opin Lipidol 2018;29:271-2. [PMID: 29715243 DOI: 10.1097/MOL.0000000000000510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
604 Navar AM, Wang TY, Mi X, Robinson JG, Virani SS, Roger VL, Wilson PWF, Goldberg AC, Peterson ED. Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences. JAMA Cardiol 2018;3:1192-9. [PMID: 30419113 DOI: 10.1001/jamacardio.2018.3680] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
605 Ghassemi E, Fuller S, Cisneros R, Barnes C, McLendon A, Wilson D. Impact of social media use on reading levels in third-year student pharmacists. Curr Pharm Teach Learn 2019;11:915-9. [PMID: 31570129 DOI: 10.1016/j.cptl.2019.05.009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
606 Cuixart CB. [Cardiovascular risk tables. Present and future]. Hipertens Riesgo Vasc 2019;36:173-5. [PMID: 31668298 DOI: 10.1016/j.hipert.2019.10.001] [Reference Citation Analysis]
607 Miller M. ACC/AHA lipids & ASCVD guidelines: 2018 update. Metabolism 2019;99:116-8. [PMID: 30974110 DOI: 10.1016/j.metabol.2019.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
608 Thompson-Paul AM, Palella FJ Jr, Rayeed N, Ritchey MD, Lichtenstein KA, Patel D, Yang Q, Gillespie C, Loustalot F, Patel P, Buchacz K; HIV Outpatient Study Investigators. Excess heart age in adult outpatients in routine HIV care. AIDS 2019;33:1935-42. [PMID: 31274539 DOI: 10.1097/QAD.0000000000002304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
609 Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. CMAJ 2018;190:E1192-206. [PMID: 30301743 DOI: 10.1503/cmaj.180194] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
610 Baldwin LM, Fischer MA, Powell J, Holden E, Tuzzio L, Fagnan LJ, Hummel J, Parchman ML. Virtual Educational Outreach Intervention in Primary Care Based on the Principles of Academic Detailing. J Contin Educ Health Prof 2018;38:269-75. [PMID: 30346338 DOI: 10.1097/CEH.0000000000000224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
611 DuBose-Briski V, Yao X, Dunlay SM, Dhruva SS, Ross JS, Shah ND, Noseworthy PA. Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment. J Am Heart Assoc 2019;8:e012065. [PMID: 31566106 DOI: 10.1161/JAHA.119.012065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
612 Willig A, Wright L, Galvin TA. Practice Paper of the Academy of Nutrition and Dietetics: Nutrition Intervention and Human Immunodeficiency Virus Infection. J Acad Nutr Diet 2018;118:486-98. [PMID: 29477186 DOI: 10.1016/j.jand.2017.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
613 Nishida C, Matsumoto Y, Fujimoto K, Shirakawa M, Wrishko RE, Behm MO, Furihata K. The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects. Clin Transl Sci 2019;12:704-12. [PMID: 31365188 DOI: 10.1111/cts.12677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
614 Davidson MH. Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C. Eur Heart J 2018;39:620-2. [PMID: 29342252 DOI: 10.1093/eurheartj/ehx741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
615 Jneid H, Bozkurt B, Fonarow GC. The 2017 AHA/ACC Performance and Quality Measures for Patients With Acute Myocardial Infarction. JAMA Cardiol 2018;3:659-60. [PMID: 29590290 DOI: 10.1001/jamacardio.2018.0263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
616 Triantafylidis LK, Hawley CE, Fagbote C, Li J, Genovese N, Paik JM. A Pilot Study Embedding Clinical Pharmacists Within an Interprofessional Nephrology Clinic for the Initiation and Monitoring of Empagliflozin in Diabetic Kidney Disease. J Pharm Pract 2021;34:428-37. [PMID: 31550992 DOI: 10.1177/0897190019876499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
617 Ooi GJ, Earnest A, Doyle L, Laurie C, Wentworth JM, Sikaris K, le Roux CW, Burton PR, O'Brien PE, Brown WA. Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery. Obes Surg 2018;28:1351-62. [PMID: 29159554 DOI: 10.1007/s11695-017-3015-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
618 Vancheri F, Longo G, Vancheri S, Danial JSH, Henein MY. Coronary Artery Microcalcification: Imaging and Clinical Implications. Diagnostics (Basel) 2019;9:E125. [PMID: 31547506 DOI: 10.3390/diagnostics9040125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
619 Levin MG, Kember RL, Judy R, Birtwell D, Williams H, Arany Z, Giri J, Guerraty M, Cappola T, Chen J, Rader DJ, Damrauer SM; Regeneron Genetics Center. Genomic Risk Stratification Predicts All-Cause Mortality After Cardiac Catheterization. Circ Genom Precis Med 2018;11:e002352. [PMID: 30571185 DOI: 10.1161/CIRCGEN.118.002352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
620 Kim YS, Han YE, Choi EA, You NY, Lee JW, You HS, Kim Y, Kim J, Kang HT. Statin use increased new-onset diabetes in hypercholesterolemic individuals: Data from the Korean National Health Insurance Service-National Health Screening Cohort database (NHIS-HEALS). Prim Care Diabetes 2020;14:246-53. [PMID: 31548127 DOI: 10.1016/j.pcd.2019.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
621 Salinero-Fort MA, Mostaza-Prieto JM, Lahoz-Rallo C, Vicente Díez JI, Cárdenas-Valladolid J. Population-based cross-sectional study of 11 645 Spanish nonagenarians with type 2 diabetes mellitus: cardiovascular profile, cardiovascular preventive therapies, achievement goals and sex differences. BMJ Open 2019;9:e030344. [PMID: 31542750 DOI: 10.1136/bmjopen-2019-030344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
622 Oni-Orisan A, Hoffmann TJ, Ranatunga D, Medina MW, Jorgenson E, Schaefer C, Krauss RM, Iribarren C, Risch N. Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort. Circ Genom Precis Med 2018;11:e002043. [PMID: 30354326 DOI: 10.1161/CIRCGEN.117.002043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
623 Venetsanaki V, Karabouta Z, Polyzos SA. Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis. Eur J Pharmacol. 2019;863:172661. [PMID: 31536725 DOI: 10.1016/j.ejphar.2019.172661] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
624 Li SY, Chen HH, Lin CL, Yeh SY, Kao CH. The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes. Dose Response 2019;17:1559325819876766. [PMID: 31555067 DOI: 10.1177/1559325819876766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
625 Mitchell JD, Fergestrom N, Gage BF, Paisley R, Moon P, Novak E, Cheezum M, Shaw LJ, Villines TC. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. J Am Coll Cardiol. 2018;72:3233-3242. [PMID: 30409567 DOI: 10.1016/j.jacc.2018.09.051] [Cited by in Crossref: 85] [Cited by in F6Publishing: 115] [Article Influence: 28.3] [Reference Citation Analysis]
626 Reynolds K, Mues KE, Harrison TN, Qian L, Chen S, Hsu JY, Philip KJ, Monda KL, Reading SR, Brar SS. Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system. Vasc Med 2020;25:3-12. [PMID: 31512991 DOI: 10.1177/1358863X19871100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
627 Khoo S, Wong VW, Goh GB, Fan J, Chan WK, Seto WK, Chow WC. Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2020;35:320-5. [PMID: 31336392 DOI: 10.1111/jgh.14794] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
628 Gallone G, Baldetti L, Pagnesi M, Latib A, Colombo A, Libby P, Giannini F. Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol 2018;72:2886-903. [PMID: 30522652 DOI: 10.1016/j.jacc.2018.09.052] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
629 Fukushima K, Harada S, Takeuchi A, Kurihara A, Iida M, Fukai K, Kuwabara K, Kato S, Matsumoto M, Hirata A, Akiyama M, Tomita M, Hirayama A, Sato A, Suzuki C, Sugimoto M, Soga T, Sugiyama D, Okamura T, Takebayashi T. Association between dyslipidemia and plasma levels of branched-chain amino acids in the Japanese population without diabetes mellitus. J Clin Lipidol 2019;13:932-939.e2. [PMID: 31601483 DOI: 10.1016/j.jacl.2019.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
630 Newman JD, Vani AK, Aleman JO, Weintraub HS, Berger JS, Schwartzbard AZ. The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review. J Am Coll Cardiol 2018;72:1856-69. [PMID: 30286929 DOI: 10.1016/j.jacc.2018.07.071] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 11.3] [Reference Citation Analysis]
631 Ference BA, Graham I, Tokgozoglu L, Catapano AL. Reprint of: Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol 2018;72:2980-95. [PMID: 30522632 DOI: 10.1016/j.jacc.2018.10.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
632 Pockros PJ, Fuchs M, Freilich B, Schiff E, Kohli A, Lawitz EJ, Hellstern PA, Owens-Grillo J, Van Biene C, Shringarpure R, MacConell L, Shapiro D, Cohen DE. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. Liver Int 2019;39:2082-93. [PMID: 31402538 DOI: 10.1111/liv.14209] [Cited by in Crossref: 36] [Cited by in F6Publishing: 66] [Article Influence: 12.0] [Reference Citation Analysis]
633 Vani A, Underberg JA. Lowering LDL-Cholesterol and CV Benefits: Is There a Limit to How Low LDL-C Needs to be for Optimal Health Benefits? Clin Pharmacol Ther 2018;104:290-6. [PMID: 29882959 DOI: 10.1002/cpt.1133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
634 Stuart JJ, Tanz LJ, Cook NR, Spiegelman D, Missmer SA, Rimm EB, Rexrode KM, Mukamal KJ, Rich-Edwards JW. Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction. J Am Coll Cardiol 2018;72:1252-63. [PMID: 30190003 DOI: 10.1016/j.jacc.2018.05.077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 62] [Article Influence: 14.3] [Reference Citation Analysis]
635 Ju A, Hanson CS, Banks E, Korda R, Craig JC, Usherwood T, MacDonald P, Tong A. Patient beliefs and attitudes to taking statins: systematic review of qualitative studies. Br J Gen Pract 2018;68:e408-19. [PMID: 29784867 DOI: 10.3399/bjgp18X696365] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
636 Reaver A, Hewlings S, Westerman K, Blander G, Schmeller T, Heer M, Rein D. A Randomized, Placebo-Controlled, Double-Blind Crossover Study to Assess a Unique Phytosterol Ester Formulation in Lowering LDL Cholesterol Utilizing a Novel Virtual Tracking Tool. Nutrients 2019;11:E2108. [PMID: 31491873 DOI: 10.3390/nu11092108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
637 Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk. J Am Coll Cardiol 2018;72:434-47. [PMID: 30025580 DOI: 10.1016/j.jacc.2018.05.027] [Cited by in Crossref: 235] [Cited by in F6Publishing: 288] [Article Influence: 78.3] [Reference Citation Analysis]
638 Choi S. The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers. J Lipid Atheroscler 2019;8:173-82. [PMID: 32821707 DOI: 10.12997/jla.2019.8.2.173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
639 Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C. Understanding the links between cardiovascular disease and Parkinson's disease. Mov Disord 2020;35:55-74. [PMID: 31483535 DOI: 10.1002/mds.27836] [Cited by in Crossref: 15] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
640 Stone GW, Mintz GS, Virmani R. Vulnerable Plaques, Vulnerable Patients, and Intravascular Imaging. J Am Coll Cardiol 2018;72:2022-6. [PMID: 30336825 DOI: 10.1016/j.jacc.2018.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
641 Adhyaru BB, Jacobson TA. Safety and efficacy of statin therapy. Nat Rev Cardiol 2018;15:757-69. [PMID: 30375494 DOI: 10.1038/s41569-018-0098-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 120] [Article Influence: 30.0] [Reference Citation Analysis]
642 Shau WY, Lai CL, Huang ST, Chen ST, Li JZ, Fung S, Tse VC, Lai MS. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan. Heart Asia 2019;11:e011176. [PMID: 31565075 DOI: 10.1136/heartasia-2018-011176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
643 Catov JM, Countouris M, Hauspurg A. Hypertensive Disorders of Pregnancy and CVD Prediction: Accounting for Risk Accrual During the Reproductive Years. J Am Coll Cardiol 2018;72:1264-6. [PMID: 30190004 DOI: 10.1016/j.jacc.2018.06.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
644 Bian Y, Li X, Li X, Ju J, Liang H, Hu X, Dong L, Wang N, Li J, Zhang Y, Yang B. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway. Biomedicine & Pharmacotherapy 2019;117:109176. [DOI: 10.1016/j.biopha.2019.109176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
645 Johnson D, Hughes D, Pirmohamed M, Jorgensen A. Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials. J Pers Med 2019;9:E42. [PMID: 31480618 DOI: 10.3390/jpm9030042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
646 Robinson JG. Lipid update 2020 - Introduction and foreword. Progress in Cardiovascular Diseases 2019;62:373-4. [DOI: 10.1016/j.pcad.2019.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
647 Robinson JG. Lipid management beyond the guidelines. Progress in Cardiovascular Diseases 2019;62:384-9. [DOI: 10.1016/j.pcad.2019.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
648 Ting DS, Peng L, Varadarajan AV, Keane PA, Burlina PM, Chiang MF, Schmetterer L, Pasquale LR, Bressler NM, Webster DR, Abramoff M, Wong TY. Deep learning in ophthalmology: The technical and clinical considerations. Progress in Retinal and Eye Research 2019;72:100759. [DOI: 10.1016/j.preteyeres.2019.04.003] [Cited by in Crossref: 112] [Cited by in F6Publishing: 137] [Article Influence: 37.3] [Reference Citation Analysis]
649 Toth PP, Philip S, Hull M, Granowitz C. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients. Mayo Clinic Proceedings 2019;94:1670-80. [DOI: 10.1016/j.mayocp.2019.03.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
650 Robinson JG. New insights into managing symptoms during statin therapy. Progress in Cardiovascular Diseases 2019;62:390-4. [DOI: 10.1016/j.pcad.2019.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
651 Hou C, Zheng B, Wang XG, Zhang B, Shi QP, Chen M. Renal impact of high-loading-dose statin pre-cardiac catheterization in patients with chronic kidney disease and long-term statin use. Exp Ther Med 2019;18:1609-18. [PMID: 31410116 DOI: 10.3892/etm.2019.7766] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
652 W Clark S, K Garofoli G, M Elswick B. Assessment of Patient Education about Statin Therapy on Quality Measures and Knowledge in an Independent Community Pharmacy. Innov Pharm 2019;10. [PMID: 34007557 DOI: 10.24926/iip.v10i2.1958] [Reference Citation Analysis]
653 Alghamdi J, Matou-Nasri S, Alghamdi F, Alghamdi S, Alfadhel M, Padmanabhan S. Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study. Int J Neuropsychopharmacol 2018;21:1067-75. [PMID: 29986042 DOI: 10.1093/ijnp/pyy060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
654 Al Mahmeed W, Bakir S, Beshyah SA, Morcos B, Wajih S, Horack M, Lautsch D, Ambegaonkar B, Brudi P, Baxter CA, Vyas A, Gitt AK. Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab Emirates. Heart Views 2019;20:37-46. [PMID: 31462957 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_32_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
655 Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol 2018;14:727-49. [PMID: 30361677 DOI: 10.1038/s41581-018-0072-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 79] [Article Influence: 20.3] [Reference Citation Analysis]
656 Lotteau S, Ivarsson N, Yang Z, Restagno D, Colyer J, Hopkins P, Weightman A, Himori K, Yamada T, Bruton J, Steele D, Westerblad H, Calaghan S. A Mechanism for Statin-Induced Susceptibility to Myopathy. JACC Basic Transl Sci 2019;4:509-23. [PMID: 31468006 DOI: 10.1016/j.jacbts.2019.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
657 Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes 2018;11:e004652. [PMID: 29748356 DOI: 10.1161/CIRCOUTCOMES.118.004652] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
658 Reiss AB, Arain HA, Kasselman LJ, Renna HA, Zhen J, Voloshyna I, DeLeon J, Carsons SE, Petri M. Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy. Medicina (Kaunas) 2019;55:E514. [PMID: 31438615 DOI: 10.3390/medicina55090514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
659 Mansour M, Tamim H, Nasreddine L, El Khoury C, Hwalla N, Chaaya M, Farhat A, Sibai AM. Prevalence and associations of behavioural risk factors with blood lipids profile in Lebanese adults: findings from WHO STEPwise NCD cross-sectional survey. BMJ Open 2019;9:e026148. [PMID: 31434763 DOI: 10.1136/bmjopen-2018-026148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
660 Zullig LL, Jazowski SA, Wang TY, Hellkamp A, Wojdyla D, Thomas L, Egbuonu-Davis L, Beal A, Bosworth HB. Novel application of approaches to predicting medication adherence using medical claims data. Health Serv Res 2019;54:1255-62. [PMID: 31429471 DOI: 10.1111/1475-6773.13200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
661 Patel SS, Rodriguez VA, Siddiqui MB, Faridnia M, Lin FP, Chandrakumaran A, Laurenzano J, Clinton J, Kowlgi GN, Kirkman D, Sima AP, Liptrap E, Bhati C, Siddiqui MS. The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation. Liver Transpl. 2019;25:1514-1523. [PMID: 31344758 DOI: 10.1002/lt.25613] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
662 Bae HJ, Cho YK, Park HS, Yoon HJ, Kim H, Han S, Hur SH, Kim YN, Kim KB, Ryu JK, Nah DY, Nam CW. Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry. Korean J Intern Med 2020;35:342-50. [PMID: 31422649 DOI: 10.3904/kjim.2018.272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
663 Donmez-Altuntas H, Bayram F, Coskun-Demirkalp AN, Baspınar O, Kocer D, Toth PP. Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients. Exp Biol Med (Maywood) 2019;244:1089-95. [PMID: 31426681 DOI: 10.1177/1535370219871895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
664 Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP). The Role of Nutraceuticals in Statin Intolerant Patients. J Am Coll Cardiol 2018;72:96-118. [PMID: 29957236 DOI: 10.1016/j.jacc.2018.04.040] [Cited by in Crossref: 161] [Cited by in F6Publishing: 137] [Article Influence: 53.7] [Reference Citation Analysis]
665 Dun Y, Thomas RJ, Smith JR, Medina-Inojosa JR, Squires RW, Bonikowske AR, Huang H, Liu S, Olson TP. High-intensity interval training improves metabolic syndrome and body composition in outpatient cardiac rehabilitation patients with myocardial infarction. Cardiovasc Diabetol 2019;18:104. [PMID: 31412869 DOI: 10.1186/s12933-019-0907-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
666 Sandesara PB, Virani SS, Fazio S, Shapiro MD. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev 2019;40:537-57. [PMID: 30312399 DOI: 10.1210/er.2018-00184] [Cited by in Crossref: 78] [Cited by in F6Publishing: 113] [Article Influence: 26.0] [Reference Citation Analysis]
667 Tao J. Response Letter to Letter by Venu Jonnalagadda. Cardiovasc Drugs Ther 2019;33:765-6. [PMID: 31396748 DOI: 10.1007/s10557-019-06897-7] [Reference Citation Analysis]
668 Li Q, Lin F, Ke D, Cheng Q, Gui Y, Zhou Y, Wu Y, Wang Y, Zhu P. Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition. J Atheroscler Thromb 2020;27:331-41. [PMID: 31406054 DOI: 10.5551/jat.50898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
669 Virani SS, Akeroyd JM, Ahmed ST, Krittanawong C, Martin LA, Slagle J, Gobbel GT, Matheny ME, Ballantyne CM, Petersen LA. The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. J Clin Lipidol 2019;13:797-803.e1. [PMID: 31501043 DOI: 10.1016/j.jacl.2019.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
670 Simard T, Jung R, Labinaz A, Faraz MA, Ramirez FD, Di Santo P, Perry-Nguyen D, Pitcher I, Motazedian P, Gaudet C, Rochman R, Marbach J, Boland P, Sarathy K, Alghofaili S, Russo JJ, Couture E, Promislow S, Beanlands RS, Hibbert B. Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations. J Am Heart Assoc 2019;8:e012228. [PMID: 31379241 DOI: 10.1161/JAHA.119.012228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
671 Abed E, LaBarbera B, Dvorak J, Zhang Y, Beck J, Talsania M. Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: evaluation of statin prescribing. J Pediatr Endocrinol Metab 2019;32:327-34. [PMID: 30860978 DOI: 10.1515/jpem-2018-0383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
672 Gilstrap LG, Chernew ME, Nguyen CA, Alam S, Bai B, McWilliams JM, Landon BE, Landrum MB. Association Between Clinical Practice Group Adherence to Quality Measures and Adverse Outcomes Among Adult Patients With Diabetes. JAMA Netw Open 2019;2:e199139. [PMID: 31411713 DOI: 10.1001/jamanetworkopen.2019.9139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
673 Toyota T, Morimoto T, Yamashita Y, Shiomi H, Kato T, Makiyama T, Nakagawa Y, Saito N, Shizuta S, Ono K, Kimura T. More- Versus Less-Intensive Lipid-Lowering Therapy: Systematic Review and Meta-Analysis. Circ: Cardiovascular Quality and Outcomes 2019;12. [DOI: 10.1161/circoutcomes.118.005460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
674 Li L, Wang S, Huang H, Cai Y, Xi Y, Bai Y, Ma C. Effects of Rosuvastatin and Aspirin on Retinal Vascular Structures in Hypercholesterolemic Patients with Low-to-Moderate Risk of Coronary Artery Disease. Am J Cardiovasc Drugs 2019;19:415-20. [PMID: 30793259 DOI: 10.1007/s40256-019-00330-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
675 Yang L, Guo W, Zeng D, Ma L, Lai X, Fang Q, Guo H, Zhang X. Heart rate variability mediates the association between polycyclic aromatic hydrocarbons exposure and atherosclerotic cardiovascular disease risk in coke oven workers. Chemosphere 2019;228:166-73. [DOI: 10.1016/j.chemosphere.2019.04.101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
676 Gilkey MB, Marcus JL, Garrell JM, Powell VE, Maloney KM, Krakower DS. Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers. AIDS Patient Care STDS 2019;33:372-8. [PMID: 31210551 DOI: 10.1089/apc.2019.0056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
677 Kolovou GD, Watts GF, Mikhailidis DP, Pérez-martínez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-miranda J, Tybjærg-hansen A, Tentolouris N, Nordestgaard BG. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. CVP 2019;17:515-37. [DOI: 10.2174/1570161117666190503123911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
678 Scicali R, Di Pino A, Urbano F, Ferrara V, Marchisello S, Di Mauro S, Scamporrino A, Filippello A, Piro S, Rabuazzo AM, Purrello F. Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia. Acta Diabetol 2019;56:899-906. [PMID: 30963307 DOI: 10.1007/s00592-019-01338-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
679 Endo H, Dohi T, Miyauchi K, Kuramitsu S, Kato Y, Okai I, Yokoyama M, Yokoyama T, Ando K, Okazaki S, Shimada K, Suwa S, Daida H. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. Journal of Cardiology 2019;74:102-8. [DOI: 10.1016/j.jjcc.2018.12.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
680 Rosenzweig JL, Bakris GL, Berglund LF, Hivert MF, Horton ES, Kalyani RR, Murad MH, Vergès BL. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab 2019:jc. [PMID: 31365087 DOI: 10.1210/jc.2019-01338] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
681 Walsh A, Perrem L, Khashan AS, Henry MT, Ni Chroinin M. Statins versus placebo for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2019;7:CD011959. [PMID: 31425628 DOI: 10.1002/14651858.CD011959.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
682 Fairman KA, Romanet D, Early NK, Goodlet KJ. Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms. J Cardiovasc Pharmacol Ther 2020;25:27-36. [PMID: 31353942 DOI: 10.1177/1074248419866153] [Reference Citation Analysis]
683 Wu CK, Juang JJ, Chiang JY, Li YH, Tsai CT, Chiang FT. The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care. J Am Coll Cardiol 2018;71:1273-83. [PMID: 29544612 DOI: 10.1016/j.jacc.2018.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
684 Cheng EM, Cunningham WE, Towfighi A, Sanossian N, Bryg RJ, Anderson TL, Barry F, Douglas SM, Hudson L, Ayala-Rivera M, Guterman JJ, Gross-Schulman S, Beanes S, Jones AS, Liu H, Vickrey BG. Efficacy of a Chronic Care-Based Intervention on Secondary Stroke Prevention Among Vulnerable Stroke Survivors: A Randomized Controlled Trial. Circ Cardiovasc Qual Outcomes 2018;11:e003228. [PMID: 29321134 DOI: 10.1161/CIRCOUTCOMES.116.003228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
685 Phelps GA, Qiao Y, Buckley MG, Wang J, Li MS, Bhuyan SS, Chisholm-Burns MA. Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics. Res Social Adm Pharm 2020;16:544-52. [PMID: 31371234 DOI: 10.1016/j.sapharm.2019.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
686 Herrett E, Gadd S, Jackson R, Bhaskaran K, Williamson E, van Staa T, Sofat R, Timmis A, Smeeth L. Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study. Lancet 2019;394:663-71. [PMID: 31353050 DOI: 10.1016/S0140-6736(19)31359-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
687 Teoh RJJ, Huang CJ, Chan CP, Chien LY, Chung CP, Sung SH, Chen CH, Chiang CE, Cheng HM. Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis. Ther Adv Neurol Disord 2019;12:1756286419864830. [PMID: 31384308 DOI: 10.1177/1756286419864830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
688 Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R, Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR, Ramos R. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients. J Clin Med 2019;8:E1080. [PMID: 31340450 DOI: 10.3390/jcm8071080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
689 Cheezum MK, Shah NR. Is a Picture Worth a Thousand Guidelines? JACC Cardiovasc Imaging 2020;13:449-51. [PMID: 31326489 DOI: 10.1016/j.jcmg.2019.06.004] [Reference Citation Analysis]
690 Rosenblit PD. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Curr Diab Rep 2019;19:61. [PMID: 31332544 DOI: 10.1007/s11892-019-1178-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
691 Honigberg MC, Lander BS, Baliyan V, Jones-O'Connor M, Healy EW, Scholtz JE, Nagurney JT, Hoffmann U, Ghoshhajra BB, Natarajan P. Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department. JACC Cardiovasc Imaging 2020;13:437-48. [PMID: 31326481 DOI: 10.1016/j.jcmg.2019.04.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
692 Tibrewala A, Jivan A, Oetgen WJ, Stone NJ. A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still. J Am Coll Cardiol 2018;71:794-9. [PMID: 29447742 DOI: 10.1016/j.jacc.2017.12.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
693 Alashi A, Riaz H, Lang R, Seballos R, Feinleib S, Sukol R, Cho L, Cremer P, Jaber W, Griffin BP, Desai MY. Incremental Prognostic Value of Exercise Stress Testing in Primary Prevention. Am J Cardiol 2019;124:216-23. [PMID: 31104779 DOI: 10.1016/j.amjcard.2019.04.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
694 Ramsaran E, Preusse P, Sundaresan D, DiMario S, Patel J, Harrison D, Munsell M, Menzin J. Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular Disease. Am J Cardiol 2019;124:169-75. [PMID: 31104775 DOI: 10.1016/j.amjcard.2019.04.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
695 Jung IY, Ahn K, Kim J, Choi JY, Kim HY, Uh Y, Kim YK. Higher Fatality for Severe Fever with Thrombocytopenia Syndrome Complicated by Hemophagocytic Lymphohistiocytosis. Yonsei Med J 2019;60:592-6. [PMID: 31124344 DOI: 10.3349/ymj.2019.60.6.592] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
696 Curtis JR, Yang S, Singh JA, Xie F, Chen L, Yun H, Muntner P, Kent ST, Levitan EB, Safford MM, Saag KG, Zhang J. Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus? Arthritis Care Res (Hoboken) 2018;70:1694-9. [PMID: 29409152 DOI: 10.1002/acr.23535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
697 Tummalapalli SL, Powe NR, Keyhani S. Trends in Quality of Care for Patients with CKD in the United States. Clin J Am Soc Nephrol 2019;14:1142-50. [PMID: 31296503 DOI: 10.2215/CJN.00060119] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
698 Zigmont VA, Shoben AB, Lu B, Kaye GL, Clinton SK, Harris RE, Olivo-Marston SE. Statin users have an elevated risk of dysglycemia and new-onset-diabetes. Diabetes Metab Res Rev 2019;35:e3189. [PMID: 31125480 DOI: 10.1002/dmrr.3189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
699 Wood M, Delate T, Stadler SL, Denham AM, Ruppe LK, Hornak R, Olson KL. Trends in high intensity statin use among secondary prevention patients 76 years and older. Pharm Pract (Granada) 2019;17:1402. [PMID: 31275492 DOI: 10.18549/PharmPract.2019.2.1402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
700 Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Sci Rep 2019;9:9772. [PMID: 31278280 DOI: 10.1038/s41598-019-46120-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 68] [Article Influence: 17.3] [Reference Citation Analysis]
701 Miedema MD, Dardari ZA, Nasir K, Blankstein R, Knickelbine T, Oberembt S, Shaw L, Rumberger J, Michos ED, Rozanski A, Berman DS, Budoff MJ, Blaha MJ. Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults. JAMA Netw Open 2019;2:e197440. [PMID: 31322693 DOI: 10.1001/jamanetworkopen.2019.7440] [Cited by in Crossref: 36] [Cited by in F6Publishing: 60] [Article Influence: 12.0] [Reference Citation Analysis]
702 Chen G, Farris MS, Cowling T, Colgan SM, Xiang P, Pericleous L, Rogoza RM, Tai M, Anderson T. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta. Canadian Journal of Cardiology 2019;35:884-91. [DOI: 10.1016/j.cjca.2019.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
703 Siddiqui MB, Arshad T, Patel S, Lee E, Albhaisi S, Sanyal AJ, Stravitz RT, Driscoll C, Sterling RK, Reichman T, Bhati C, Siddiqui MS. Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients. Hepatology 2019;70:98-107. [PMID: 30672598 DOI: 10.1002/hep.30518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
704 Yoon YE, Kim KM, Han JS, Kang S, Chun EJ, Ahn S, Kim SM, Choi SI, Yun BL, Suh J. Prediction of Subclinical Coronary Artery Disease With Breast Arterial Calcification and Low Bone Mass in Asymptomatic Women. JACC: Cardiovascular Imaging 2019;12:1202-11. [DOI: 10.1016/j.jcmg.2018.07.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
705 Lalwani ND, Hanselman JC, Macdougall DE, Sterling LR, Cramer CT. Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial. Journal of Clinical Lipidology 2019;13:568-79. [DOI: 10.1016/j.jacl.2019.05.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
706 Robinson JG, Jayanna MB, Brown AS, Aspry K, Orringer C, Gill EA, Goldberg A, Jones LK, Maki K, Dixon DL, Saseen JJ, Soffer D. Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association. Journal of Clinical Lipidology 2019;13:525-37. [DOI: 10.1016/j.jacl.2019.05.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
707 Arps K, Pallazola VA, Cardoso R, Meyer J, Jones R, Latina J, Gluckman TJ, Stone NJ, Blumenthal RS, Mcevoy JW. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2. The American Journal of Medicine 2019;132:e599-609. [DOI: 10.1016/j.amjmed.2019.01.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
708 Kolovou G, Giannakopoulou V, Kalogeropoulos P, Anagnostopoulou K, Goumas G, Kazianis G, Limberi S, Perrea D, Mihas C, Kolovou V, Bilianou H. Hellenic Postprandial Lipemia Study (HPLS): Rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease. Contemporary Clinical Trials 2019;82:101-5. [DOI: 10.1016/j.cct.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
709 Lang W, Frishman WH. Angiopoietin-Like 3 Protein Inhibition: A New Frontier in Lipid-Lowering Treatment. Cardiology in Review 2019;27:211-7. [DOI: 10.1097/crd.0000000000000258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
710 Blom DJ, Almahmeed W, Al-rasadi K, Azuri J, Daclin V, Kayikcioglu M, Mercier F, Ruiz AJ, Santos RD. Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study. Journal of Clinical Lipidology 2019;13:594-600. [DOI: 10.1016/j.jacl.2019.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
711 Chiou CC, Tsai TH, Lee CH, Lin CJ, Chung WJ, Hsuch SK, Wu PJ, Cheng CI. Impact of Pharmacist Interventions on the Long-Term Clinical Outcomes in Patients with Myocardial Infarction. Acta Cardiol Sin 2019;35:290-300. [PMID: 31249459 DOI: 10.6515/ACS.201905_35(3).20181122B] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
712 Liu W, Chen W, Fang X, Li Y, Li T. Monte Carlo modeling of photon migration in realistic human thoracic tissues for noninvasive monitoring of cardiac hemodynamics. J Biophotonics 2019;12:e201900148. [PMID: 31251454 DOI: 10.1002/jbio.201900148] [Reference Citation Analysis]
713 Grundy SM, Stone NJ. Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines. J Clin Lipidol 2019;13:356-9. [PMID: 31229022 DOI: 10.1016/j.jacl.2019.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
714 Gaviola ML, Scribe EC, Leverett HN, Howard ML. Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections. J Pharm Pract 2020;33:497-505. [PMID: 31216928 DOI: 10.1177/0897190019854956] [Reference Citation Analysis]
715 Lin HQ, Wu JY, Chen ML, Chen FQ, Liao YJ, Wu YT, Guo ZJ. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study. Clin Interv Aging 2019;14:1119-29. [PMID: 31354254 DOI: 10.2147/CIA.S207665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
716 Pryor JB, Weber BR, Weber JV, Lockridge JB, Olyaei AJ. Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review. Drugs Ther Perspect 2019;35:431-41. [DOI: 10.1007/s40267-019-00646-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
717 Alves-Cabratosa L, Garcia-Gil M, Comas-Cufí M, Blanch J, Ponjoan A, Martí-Lluch R, Elosua-Bayes M, Parramon D, Camós L, Ramos R. Role of Low Ankle-Brachial Index in Cardiovascular and Mortality Risk Compared with Major Risk Conditions. J Clin Med 2019;8:E870. [PMID: 31216703 DOI: 10.3390/jcm8060870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
718 Phan DQ, Duan L, Lam B, Hekimian A, Wee D, Zadegan R, Lee MS. Statin Adherence and Mortality in Patients Aged 80 Years and Older After Acute Myocardial Infarction. J Am Geriatr Soc 2019;67:2045-9. [PMID: 31206603 DOI: 10.1111/jgs.16037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
719 Merdler I, Rozenbaum Z, Finkelstein A, Arbel Y, Banai S, Bazan S, Halkin A, Zhitomirsky S, Horen S, Shacham Y, Steinvil A. Effect of Statin Therapy and Long-Term Mortality Following Transcatheter Aortic Valve Implantation. Am J Cardiol 2019;123:1978-82. [PMID: 30967288 DOI: 10.1016/j.amjcard.2019.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
720 Bergland AK, Soennesyn H, Dalen I, Rodriguez-Mateos A, Berge RK, Giil LM, Rajendran L, Siow R, Tassotti M, Larsen AI, Aarsland D. Effects of Anthocyanin Supplementation on Serum Lipids, Glucose, Markers of Inflammation and Cognition in Adults With Increased Risk of Dementia - A Pilot Study. Front Genet 2019;10:536. [PMID: 31244884 DOI: 10.3389/fgene.2019.00536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [